Odluka o izmjeni i dopuni Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje
NN 153/2022 (27.12.2022.), Odluka o izmjeni i dopuni Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje
HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE
2407
Na osnovi članka 20. stavka 7. Zakona o obveznom zdravstvenom osiguranju (»Narodne novine«, broj 80/13., 137/13. i 98/19.) i članka 26. točke 10. Statuta Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine«, broj 18/09., 33/10., 08/11., 18/13., 1/14., 83/15. i 108/21.) Upravno vijeće Hrvatskog zavoda za zdravstveno osiguranje na 66. izvanrednoj sjednici održanoj 20. prosinca 2022. godine, uz prethodno pribavljeno mišljenje Hrvatske liječničke komore, donijelo je
ODLUKU
O IZMJENI I DOPUNI ODLUKE O UTVRĐIVANJU OSNOVNE LISTE LIJEKOVA HRVATSKOG ZAVODA ZA ZDRAVSTVENO OSIGURANJE
Članak 1.
U Odluci o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine«, broj 143/22.), Osnovna lista lijekova iz članka 2. stavka 5., s cijenama u eurima, mijenja se i čini sastavni dio ove Odluke.
U tablici: »Indikacije i smjernice« dodaje se nova smjernica pod oznakom: »’RN29« koja glasi:
»RN29: Samo za liječenje uznapredovalog stadija Parkinsonove bolesti, kad više nije moguće stabilizirati klinički status dostupnom kombiniranom peroralnom terapijom, po preporuci bolničkog specijaliste neurologa. Liječenje odobrava Bolničko povjerenstvo za lijekove. Odobrenje Bolničkog povjerenstva za lijekove se može izdati za razdoblje od najviše 12 mjeseci. Prvih 14 dana lijek se primjenjuje na teret sredstva bolničkog proračuna (2 pakiranja lijeka), a u nastavku se lijek može propisivati na recept Zavoda. Lijek se može propisivati na recept Zavoda isključivo temeljem važećeg odobrenja Bolničkog povjerenstva za lijekove.«.
Članak 2.
Ova Odluka objavljuje se u »Narodnim novinama«, a stupa na snagu 1. siječnja 2023. godine.
Klasa: 025-04/22-01/336
Urbroj: 338-01-01-22-01
Zagreb, 20. prosinca 2022.
Predsjednik
Upravnog vijeća Hrvatskog zavoda
za zdravstveno osiguranje
prof. dr. sc. Drago Prgomet, dr. med. spec., v. r.
Osnovna lista lijekova u eurima – 1. dio
| Šifra ATK | Oznaka | Nezaštićeno ime lijeka | DDD i jed. mj. | Cijena u EUR za DDD (bez PDV-a) | Način primjene | Nositelj odobrenja | Proizvođač | Zaštićeno ime lijeka | Oblik, jačina i pakiranje lijeka | Cijena u EUR za jed. obl. (bez PDV-a) | Cijena u EUR za orig. pak. (bez PDV-a) | R/RS | Stopa PDV-a |
| 1. | 2. | 3. | 4. | 5. | 6. | 7. | 8. | 9. | 10. | 11. | 12. | 13. | 14. |
| A01AB12 451 | DS | heksetidin | | | O | | | | | | | | 5% |
| A01AD11 263 | | polivinil-pirolidon + natrij-hijalurat + gliciretinična kiselinaNA101 | | | L | Helsinn Birex Pharmaceuticals Ltd. | Helsinn Healthcare SA | Gelclair | gel oralni konc., boč. 1x180 ml | 30,0816 | 30,08 | RSRA01 | 5% |
| A02BA02 051 | DS | ranitidin | 0,3 g | | P | | | | | | | | 5% |
| A02BA03 141 | | famotidin | 40 mg | 0,2469 | O | Alkaloid d.o.o. | Alkaloid | Famosan | tbl. 20x20 mg | 0,1234 | 2,47 | R | 5% |
| A02BA03 142 | | famotidin | 40 mg | 0,2398 | O | Alkaloid d.o.o. | Alkaloid | Famosan | tbl. 10x40 mg | 0,2398 | 2,40 | R | 5% |
| A02BC01 112 | | omeprazol | 20 mg | 0,1342 | O | Belupo d.d. | Belupo | Target plus | caps. 28x20 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC01 118 | | omeprazol | 20 mg | 0,1342 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Ortalox | caps. 28x20 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC01 131 | | omeprazol | 20 mg | 0,1342 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ultop | caps. 14x20 mg | 0,1342 | 1,88 | RRA02 | 5% |
| A02BC01 134 | | omeprazol | 20 mg | 0,1018 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ultop | caps. 28x40 mg | 0,2035 | 5,70 | RRA02 | 5% |
| A02BC01 135 | | omeprazol | 20 mg | 0,1342 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ultop | caps. 28x20 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC02 011 | DS | pantoprazolNA201 | 40 mg | 2,3943 | P | Belupo d.d. | Belupo | Zoltex | praš. za otop. za inj., boč. stakl. 1x40 mg | 2,3943 | 2,39 | | 5% |
| A02BC02 021 | DS | pantoprazolNA201 | 40 mg | 3,2836 | P | Sandoz d.o.o. | Sandoz-Lek | Pantoprazol Sandoz | praš. za otop. za inj., boč. stakl. 1x40 mg | 3,2836 | 3,28 | | 5% |
| A02BC02 030 | DS | pantoprazolNA201 | 40 mg | 3,2836 | P | KRKA-FARMA d.o.o. | Krka d.d. | Nolpaza | praš. za otop. za inj., boč. 1x40 mg | 3,2836 | 3,28 | | 5% |
| A02BC02 072 | DS | pantoprazolNA201 | 40 mg | 1,9394 | P | Apta Medica International d.o.o. | Sofarimex Indústria Quimica e Farmaceutica S.A. | Pantoprazol AptaPharma | praš. za otop. za inj., boč. stakl. 10x40 mg | 1,9394 | 19,39 | | 5% |
| A02BC02 101 | | pantoprazol | 40 mg | 0,1387 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Zipantola | tbl. 28x20 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC02 102 | | pantoprazol | 40 mg | 0,1249 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Zipantola | tbl. 56x20 mg | 0,0624 | 3,50 | RRA02 | 5% |
| A02BC02 103 | | pantoprazol | 40 mg | 0,1342 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Zipantola | tbl. 14x40 mg | 0,1342 | 1,88 | RRA02 | 5% |
| A02BC02 104 | | pantoprazol | 40 mg | 0,1342 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Zipantola | tbl. 28x40 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC02 111 | | pantoprazol | 40 mg | 0,1387 | O | Belupo d.d. | Belupo | Zoltex | tbl. 28x20 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC02 112 | | pantoprazol | 40 mg | 0,1249 | O | Belupo d.d. | Belupo | Zoltex | tbl. 56x20 mg | 0,0624 | 3,50 | RRA02 | 5% |
| A02BC02 114 | | pantoprazol | 40 mg | 0,1342 | O | Belupo d.d. | Belupo | Zoltex | tbl. 28x40 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC02 121 | | pantoprazol | 40 mg | 0,1387 | O | Sandoz d.o.o. | Sandoz-Lek | Acipan | tbl. žel. otp. 28x20 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC02 122 | | pantoprazol | 40 mg | 0,1249 | O | Sandoz d.o.o. | Sandoz-Lek | Acipan | tbl. žel. otp. 56x20 mg | 0,0624 | 3,50 | RRA02 | 5% |
| A02BC02 123 | | pantoprazol | 40 mg | 0,1342 | O | Sandoz d.o.o. | Sandoz-Lek | Acipan | tbl. žel. otp. 14x40 mg | 0,1342 | 1,88 | RRA02 | 5% |
| A02BC02 124 | | pantoprazol | 40 mg | 0,1342 | O | Sandoz d.o.o. | Sandoz-Lek | Acipan | tbl. žel. otp. 28x40 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC02 126 | | pantoprazol | 40 mg | 0,1387 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Zoprax | tbl. žel. otp. 28x20 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC02 127 | | pantoprazol | 40 mg | 0,1249 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Zoprax | tbl. žel. otp. 56x20 mg | 0,0624 | 3,50 | RRA02 | 5% |
| A02BC02 128 | | pantoprazol | 40 mg | 0,1342 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Zoprax | tbl. žel. otp. 28x40 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC02 129 | | pantoprazol | 40 mg | 0,1208 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Zoprax | tbl. žel. otp. 56x40 mg | 0,1208 | 6,76 | RRA02 | 5% |
| A02BC02 131 | | pantoprazol | 40 mg | 0,1387 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Nolpaza | tbl. film obl. žel. otp. 28x20 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC02 132 | | pantoprazol | 40 mg | 0,1249 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Nolpaza | tbl. film obl. žel. otp. 56x20 mg | 0,0624 | 3,50 | RRA02 | 5% |
| A02BC02 133 | | pantoprazol | 40 mg | 0,1387 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Nolpaza | tbl. film obl. žel. otp. 30x20 mg | 0,0694 | 2,08 | RRA02 | 5% |
| A02BC02 134 | | pantoprazol | 40 mg | 0,1249 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Nolpaza | tbl. film obl. žel. otp. 60x20 mg | 0,0624 | 3,75 | RRA02 | 5% |
| A02BC02 135 | | pantoprazol | 40 mg | 0,1342 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Nolpaza | tbl. film obl. žel. otp. 14x40 mg | 0,1342 | 1,88 | RRA02 | 5% |
| A02BC02 136 | | pantoprazol | 40 mg | 0,1342 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Nolpaza | tbl. film obl. žel. otp. 28x40 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC02 137 | | pantoprazol | 40 mg | 0,1387 | O | Alkaloid d.o.o. | Atlantic Pharma – Produçoes Farmaceuticas, S.A. | Pantoprazol Alkaloid | tbl. žel. otp. 28x20 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC02 138 | | pantoprazol | 40 mg | 0,1301 | O | Alkaloid d.o.o. | West Pharma, Atlantic Pharma | Pantoprazol Alkaloid | tbl. žel. otp. 28x40 mg | 0,1301 | 3,64 | RRA02 | 5% |
| A02BC02 141 | | pantoprazol | 40 mg | 0,1387 | O | PharmaS d.o.o. | PharmaS d.o.o. | Pantoprazol PharmaS | tbl. žel. otp. 28x20 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC02 142 | | pantoprazol | 40 mg | 0,1140 | O | PharmaS d.o.o. | PharmaS d.o.o. | Pantoprazol PharmaS | tbl. žel. otp. 56x20 mg | 0,0570 | 3,19 | RRA02 | 5% |
| A02BC02 144 | | pantoprazol | 40 mg | 0,1187 | O | PharmaS d.o.o. | PharmaS d.o.o. | Pantoprazol PharmaS | tbl. žel. otp. 28x40 mg | 0,1187 | 3,32 | RRA02 | 5% |
| A02BC02 162 | | pantoprazol | 40 mg | 0,1342 | O | Takeda Pharmaceuticals Croatia d.o.o. | Takeda | Controloc | tbl. 28x40 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC02 181 | | pantoprazol | 40 mg | 0,1249 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Apazol A | tbl. žel. otp. 28x20 mg | 0,0624 | 1,75 | RRA02 | 5% |
| A02BC02 182 | | pantoprazol | 40 mg | 0,1176 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Apazol A | tbl. žel. otp. 56x20 mg | 0,0588 | 3,29 | RRA02 | 5% |
| A02BC02 183 | | pantoprazol | 40 mg | 0,1208 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Apazol A | tbl. žel. otp. 28x40 mg | 0,1208 | 3,38 | RRA02 | 5% |
| A02BC03 111 | | lanzoprazol | 30 mg | 0,1387 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Larona | caps. žel. otp. tvrde 28x15 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC03 112 | | lanzoprazol | 30 mg | 0,1342 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Larona | caps. žel. otp. tvrde 28x30 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC03 131 | | lanzoprazol | 30 mg | 0,1342 | O | KRKA-FARMA d.o.o. | Krka d.d. | Lanzul | caps. 14x30 mg | 0,1342 | 1,88 | RRA02 | 5% |
| A02BC03 132 | | lanzoprazol | 30 mg | 0,1387 | O | KRKA-FARMA d.o.o. | Krka d.d. | Lanzul S | caps. 28x15 mg | 0,0694 | 1,94 | RRA02 | 5% |
| A02BC03 133 | | lanzoprazol | 30 mg | 0,1342 | O | KRKA-FARMA d.o.o. | Krka d.d. | Lanzul | caps. 28x30 mg | 0,1342 | 3,76 | RRA02 | 5% |
| A02BC05 061 | DS | esomeprazolNA201 | 30 mg | 2,9715 | P | AstraZeneca d.o.o. | AstraZeneca | Nexium | boč. 10x40 mg | 3,8629 | 38,63 | | 5% |
| A02BC05 131 | | esomeprazol | 30 mg | 0,0924 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Emanera | caps. žel. otp. 14x20 mg | 0,0924 | 1,29 | RRA02 | 5% |
| A02BC05 132 | | esomeprazol | 30 mg | 0,0925 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Emanera | caps. žel. otp. 28x20 mg | 0,0925 | 2,59 | RRA02 | 5% |
| A02BC05 133 | | esomeprazol | 30 mg | 0,0895 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Emanera | caps. žel. otp. 14x40 mg | 0,1789 | 2,50 | RRA02 | 5% |
| A02BC05 134 | | esomeprazol | 30 mg | 0,0895 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Emanera | caps. žel. otp. 28x40 mg | 0,1789 | 5,01 | RRA02 | 5% |
| A02BC05 135 | | esomeprazol | 30 mg | 0,1249 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Emanera | caps. žel. otp. 56x20 mg | 0,0832 | 4,66 | RRA02 | 5% |
| A02BC05 136 | | esomeprazol | 30 mg | 0,1208 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Emanera | caps. žel. otp. 56x40 mg | 0,1610 | 9,02 | RRA02 | 5% |
| A02BC05 163 | | esomeprazol | 30 mg | 0,0925 | O | AstraZeneca d.o.o. | AstraZeneca | Nexium | tbl. 28x20 mg | 0,0925 | 2,59 | RRA02 | 5% |
| A02BX05 131 | | bizmut oksid | 0,48 g | 0,5362 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ulcamed | tbl. film obl. 56x120 mg | 0,1341 | 7,51 | RRA16 | 5% |
| A03AA04 111 | | mebeverin | 0,3 g | 2,9806 | O | Belupo d.d. | Belupo | Rudakol | obl. tbl. 50x135 mg | 0,0703 | 3,52 | R | 5% |
| A03AX04 161 | | pinaverij bromid | 0,15 g | 0,1513 | O | Mylan Hrvatska d.o.o. | Mylan Laboratories SAS | Dicetel | tbl. film obl. 30x100 mg | 0,1009 | 3,03 | R | 5% |
| A03BA01 051 | PR | atropin | 1,5 mg | | P | | | | | | | | 5% |
| A03BB01 051 | DS | hioscin-butilbromid | 60 mg | | P | | | | | | | | 5% |
| A03BB01 551 | | hioscin-butilbromid | 60 mg | | R | | | | | | | R | 5% |
| A03BB01 563 | DS | hioscin-butilbromid | 60 mg | | O | | | | | | | | 5% |
| A03FA01 051 | PR | metoklopramid | 30 mg | | P | | | | | | | | 5% |
| A03FA01 111 | | metoklopramid | 30 mg | 0,1793 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Metopran | tbl. 40x10 mg | 0,0598 | 2,39 | R | 5% |
| A03FA01 142 | | metoklopramid | 30 mg | 0,1793 | O | Alkaloid d.o.o. | Alkaloid | Reglan | tbl. 40x10 mg | 0,0598 | 2,39 | R | 5% |
| A03FA01 241 | | metoklopramid | 30 mg | 0,3292 | O | Alkaloid d.o.o. | Alkaloid | Reglan | otop. oral. 120 ml (5mg/5ml) | 1,3166 | 1,32 | R | 5% |
| A04AA01 071 | DS | ondansetronNA401 | 16 mg | 15,8206 | P | Fresenius Kabi d.o.o. | Labesfal-Laboratorios Almiro | Ondanzetron Kabi | otop. za inj., boč. stakl. 5x2 ml (2 mg/ml) | 3,1641 | 15,82 | | 5% |
| A04AA01 072 | DS | ondansetronNA401 | 16 mg | 14,9114 | P | Fresenius Kabi d.o.o. | Labesfal-Laboratorios Almiro | Ondanzetron Kabi | otop. za inj., boč. stakl. 5x4 ml (2 mg/ml) | 5,9646 | 29,82 | | 5% |
| A04AA01 122 | | ondansetron | 16 mg | 4,0096 | O | Sandoz d.o.o. | Sandoz-Salutas | Ondantor | tbl. film obl. 10x8 mg | 2,0048 | 20,05 | RSRA17 | 5% |
| A04AA02 086 | DS | granisetronNA401 | 3 mg | 11,0314 | P | Fresenius Kabi d.o.o. | Labesfal – Laboratorios Almiro S.A. | Granizetron Kabi | otop. za inj., amp. 5x1 mg/ml | 3,6772 | 18,39 | | 5% |
| A04AA02 087 | DS | granisetronNA401 | 3 mg | 5,8207 | P | Fresenius Kabi d.o.o. | Labesfal – Laboratorios Almiro S.A. | Granizetron Kabi | otop. za inj., amp. 5x3 mg/3 ml | 5,8207 | 29,10 | | 5% |
| A04AA05 041 | DS | palonosetronNA402 | 0,25 mg | 39,0935 | P | Accord Healthcare S.L.U. | Accord Healthcare Ltd | Palonosetron Accord | otop. za inj. boč. stakl. 1x250 mcg/5 ml | 39,0935 | 39,09 | | 5% |
| A04AA05 071 | DS | palonosetronNA402 | 0,25 mg | 39,0935 | P | Medochemie Ltd. | Medochemie Ltd. | Ferant | otop. za inj., amp. 1x250 mcg/5 ml | 39,0935 | 39,09 | | 5% |
| A04AA55 131 | DS | netupitant + palonozetronNA402 | | | O | Helsinn Birex Pharmaceuticals Ltd. | Helsinn Birex Pharmaceuticals Ltd. | Akynzeo | caps. tvrda 1x(300 mg+0,5 mg) | 72,4733 | 72,47 | | 5% |
| A04AD12 101 | DS | aprepitantNA402 | 165 mg | 20,6941 | O | Teva B.V. | Merckle GmbH | Aprepitant Teva | caps. tvrda 1x125 mg +2x80 mg | 11,9150 | 35,74 | | 5% |
| A04AD12 161 | DS | aprepitantNA402 | 165 mg | 20,6941 | O | Merck Sharp & Dohme B.V. | Merck Sharp & Dohme | Emend | caps. tvrda 1x125 mg +2x80 mg | 11,9150 | 35,74 | | 5% |
| A04AD12 171 | DS | aprepitantNA402 | 165 mg | 20,6941 | O | ALPHA-MEDICAL d.o.o. | Pharmathen International S.A., Pharmathen S.A. | Aprepitant Alpha-Medical | caps. tvrda 1x125 mg +2x80 mg | 11,9150 | 35,74 | | 5% |
| A05AA02 161 | | ursodeoksikolna kiselina | 0,75 g | 0,7751 | O | Dr. Falk Pharma GmbH | Dr. Falk Pharma GmbH | Ursofalk | caps. 100x250 mg | 0,2584 | 25,84 | RSRA03 | 5% |
| A05AA02 171 | | ursodeoksikolna kiselina | 0,75 g | 0,5997 | O | AS GRINDEKS | AS Grindeks | Ursogrix | caps. 100x250 mg | 0,1999 | 19,99 | RSRA03 | 5% |
| A06AD11 361 | | laktuloza | 6,7 g | 0,0755 | O | Mylan Hrvatska d.o.o. | Abbott | Duphalac sirup | boč. plast. s čaš. mjern. plast. 1x500 ml (66,7 g/100 ml) | 3,7600 | 3,76 | RRA12 | 5% |
| A06AD11 365 | | laktuloza | 6,7 g | 0,0775 | O | MIP Pharma Croatia d.o.o. | Chephasaar Chem.-pharm. Fabrik GmbH | Lactulose-MIP sirup | boč. plast. 1x500 ml (65 g/100 ml) | 3,7600 | 3,76 | RRA12 | 5% |
| A07AA12 161 | DS | fidaksomicinNA700 | 0,4 g | 147,7859 | O | Tillotts Pharma GmbH | Tillotts Pharma GmbH | Dificlir | tbl. film obl. 20x200 mg | 73,8930 | 1.477,86 | | 5% |
| A07BA01 111 | DS | aktivni (medicinski) ugljen | 5 g | 4,0554 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Carbomed | tbl. 30x150 mg | 0,1217 | 3,65 | | 5% |
| A07BA01 312 | DS | aktivni (medicinski) ugljen | 5 g | 1,7030 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Carbomed | granule 1x50 g (19,25 g u 50 g) | 6,5565 | 6,56 | | 5% |
| A07CA01 351 | | natrij-klorid + kalij-klorid + natrij-citrat | | | O | | | | | | | R | 5% |
| A07EC01 131 | | sulfasalazin | 2 g | 0,3498 | O | KRKA-FARMA d.o.o. | Krka d.d. | Sulfasalazin Krka EN | tbl. žel. otp. 50x500 mg | 0,0874 | 4,37 | R | 5% |
| A07EC01 182 | | sulfasalazin | 2 g | 0,3497 | O | Pfizer Croatia d.o.o. | Kemwell | Salazopyrin | tbl. 100x500 mg | 0,0874 | 8,74 | R | 5% |
| A07EC02 172 | | mesalazin | 1,5 g | 0,7465 | O | Dr. Falk Pharma GmbH | Dr. Falk Pharma GmbH | Salofalk | tbl. 100x500 mg | 0,2488 | 24,88 | RSpa03 | 5% |
| A09AA02 172 | | enzimi gušterače (visoko dozirani) | | | O | Mylan Hrvatska d.o.o. | Abbott | Kreon 10.000 | caps. 100x1 kom. | 0,1008 | 10,08 | RSRA15 | 5% |
| A09AA02 173 | | enzimi gušterače (visoko dozirani) | | | O | Mylan Hrvatska d.o.o. | Abbott | Kreon 25.000 | caps. 100x1 kom. | 0,2681 | 26,81 | RSRA15 | 5% |
| A09AA02 175 | | enzimi gušterače (visoko dozirani) | | | O | Mylan Hrvatska d.o.o. | Abbott Laboratories GmbH | Kreon 35.000 | caps. 50x1 kom. | 0,4590 | 22,95 | RSRA15 | 5% |
| A10AB01 061 | | inzulin | 40 IU | 0,5900 | P | Eli Lilly Hrvatska d.o.o. | Lilly France | Humulin R | otop. za inj., uložak 5x3 ml (100 IU/ml), susp. | 4,4250 | 22,12 | R | 5% |
| A10AB01 072 | | inzulin | 40 IU | 0,4653 | P | Novo Nordisk A/S | Novo Nordisk | Actrapid | otop. za inj., boč. 1x10 ml (100 IU/ml) | 11,6318 | 11,63 | R | 5% |
| A10AB04 082 | | inzulin lispro | 40 U | 0,8546 | P | Eli Lilly Nederland B.V. | Lilly France S.A.S. | Humalog | otop. za inj., brizg. napunj. Junior KwikPen 5x3 ml (100 U/ml) | 6,4092 | 32,05 | R | 5% |
| A10AB04 083 | | inzulin lispro | 40 U | 0,7822 | P | Eli Lilly Nederland B.V. | Lilly France | Humalog | otop. za inj., uložak 5x3 ml (100 U/ml) | 5,8664 | 29,33 | R | 5% |
| A10AB04 084 | | inzulin lispro | 40 U | 0,8546 | P | Eli Lilly Nederland B.V. | Lilly France | Humalog | otop. za inj., brizg. napunj. KwikPen 5x3 ml (100 U/ml) | 6,4092 | 32,05 | R | 5% |
| A10AB04 085 | | inzulin lispro | 40 U | 0,8546 | P | Eli Lilly Nederland B.V. | Lilly France | Humalog | otop. za inj., brizg. napunj. KwikPen 5x3 ml (200 U/ml) | 12,8184 | 64,09 | R | 5% |
| A10AB05 071 | | inzulin aspart | 40 U | 0,8546 | P | Novo Nordisk A/S | Novo Nordisk | NovoRapid | otop. za inj., brizg. napunj. FlexPen 5x3 ml (100 U/ml) | 6,4092 | 32,05 | R | 5% |
| A10AB05 072 | | inzulin aspart | 40 U | 0,7822 | P | Novo Nordisk A/S | Novo Nordisk | NovoRapid | otop. za inj., uložak stakl. Penfil 5x3 ml (100 U/ml) | 5,8664 | 29,33 | R | 5% |
| A10AB05 076 | | inzulin aspartNA912 | 40 U | 0,6852 | P | Novo Nordisk A/S | Novo Nordisk A/S | NovoRapid | otop. za inj., boč. 1x10 ml (100 U/ml) | 17,1292 | 17,13 | RPA29 | 5% |
| A10AB05 077 | | inzulin aspart | 40 U | 0,7822 | P | Novo Nordisk A/S | Novo Nordisk A/S | Fiasp | otop. za inj., uložak stakl. Penfil 5x3 ml (100 U/ml) | 5,8664 | 29,33 | R | 5% |
| A10AB06 061 | | inzulin glulizin | 40 U | 0,8065 | P | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis GmbH | Apidra | otop. za inj., brizg. napunj. SoloStar 5x3 ml (100 U/ml) | 6,0490 | 30,24 | R | 5% |
| A10AC01 066 | | inzulin | 40 IU | 0,5900 | P | Eli Lilly Hrvatska d.o.o. | Lilly France | Humulin N | susp. za inj. uložak 5x3 ml (100 IU/ml) | 4,4250 | 22,12 | R | 5% |
| A10AC01 077 | | inzulin human | 40 IU | 0,6455 | P | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutchland GmbH | Insuman Basal | susp. za inj., brizg. napunj. SoloStar 5x3 ml (100 IU/ml) | 4,8409 | 24,20 | R | 5% |
| A10AD01 083 | | inzulin | 40 IU | 0,5900 | P | Eli Lilly Hrvatska d.o.o. | Lilly France | Humulin M3 | susp. za inj., uložak 5x3 ml (100 IU/ml) | 4,4250 | 22,12 | R | 5% |
| A10AD04 081 | | inzulin lispro | 40 U | 0,7822 | P | Eli Lilly Nederland B.V. | Lilly France | Humalog Mix 25 | susp. za inj., uložak 5x3 ml (100 U/ml) | 5,8664 | 29,33 | R | 5% |
| A10AD04 083 | | inzulin lispro | 40 U | 0,7822 | P | Eli Lilly Nederland B.V. | Lilly France | Humalog Mix 50 | susp. za inj., uložak 5x3 ml (100 U/ml) | 5,8664 | 29,33 | R | 5% |
| A10AD04 085 | | inzulin lispro | 40 U | 0,8782 | P | Eli Lilly Nederland B.V. | Lilly France | Humalog Mix 25 | susp. za inj., brizg, napunj. KwikPen 5x3 ml (100 U/ml) | 6,5865 | 32,93 | R | 5% |
| A10AD04 086 | | inzulin lispro | 40 U | 0,8745 | P | Eli Lilly Nederland B.V. | Lilly France | Humalog Mix 50 | susp. za inj., brizg. napunj. KwikPen 5x3 ml (100 U/ml) | 6,5586 | 32,79 | R | 5% |
| A10AD05 073 | | inzulin aspart | 40 U | 0,8760 | P | Novo Nordisk A/S | Novo Nordisk | NovoMix 30 | susp. za inj., brizg. napunj. FlexPen 5x3 ml (100 U/ml) | 6,5698 | 32,85 | R | 5% |
| A10AD06 071 | | inzulin degludek + inzulin aspart | 40 U | 1,0224 | P | Novo Nordisk A/S | Novo Nordisk A/S | Ryzodeg | otop. za inj., brizg. napunj. 5x3 mL (100 U/mL) | 7,6677 | 38,34 | R | 5% |
| A10AE04 062 | | inzulin glargin | 40 U | 1,1159 | P | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis GmbH | Lantus | otop. za inj., brizg. napunj. SoloStar 5x3 ml (100 U/ml) | 8,3695 | 41,85 | RRA08 | 5% |
| A10AE04 071 | | inzulin glargin | 40 U | 1,1159 | P | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Toujeo | otop. za inj., brizg. napunj. SoloStar 3x1,5 ml (300 U/ml) | 12,5543 | 37,66 | RRA08 | 5% |
| A10AE04 082 | | inzulin glargin | 40 U | 0,9339 | P | Eli Lilly Nederland B.V. | Lilly France S.A.S. | Abasaglar | otop. za inj., brizg. napunj. KwikPen 5x3 ml (100 U/ml) | 7,0043 | 35,02 | RRA08 | 5% |
| A10AE04 091 | | inzulin glargin | 40 U | 0,9339 | P | Viatris Limited | McDermott Laboratories t/a Mylan Dublin Biologics | Semglee | otop. za inj., brizg. napunj. 5x3 ml (100 U/ml) | 7,0043 | 35,02 | RRA08 | 5% |
| A10AE05 071 | | inzulin detemir | 40 U | 1,3202 | P | Novo Nordisk A/S | Novo Nordisk | Levemir | otop. za inj., brizg. napunj. FlexPen 5x3 ml (100 U/ml) | 9,9011 | 49,51 | RRA08 | 5% |
| A10AE06 061 | | degludek inzulin | 40 U | 1,3803 | P | Novo Nordisk A/S | Novo Nordisk | Tresiba | otop. za inj., brizg. napunj. FlexTouch 5x3 ml (100 U/ml) | 10,3524 | 51,76 | RRA08 | 5% |
| A10BA02 101 | | metformin | 2 g | 0,0750 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Gluformin | tbl. film obl. 80x850 mg | 0,0319 | 2,55 | R | 5% |
| A10BA02 102 | | metformin | 2 g | 0,0712 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Gluformin | tbl. film obl. 80x1000 mg | 0,0356 | 2,85 | R | 5% |
| A10BA02 103 | | metformin | 2 g | 0,0750 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Gluformin | tbl. film obl. 30x850 mg | 0,0319 | 0,96 | R | 5% |
| A10BA02 104 | | metformin | 2 g | 0,0765 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Gluformin | tbl. film obl. 30x1000 mg | 0,0382 | 1,15 | R | 5% |
| A10BA02 111 | | metformin | 2 g | 0,0941 | O | Belupo d.d. | Belupo | Belformin | tbl. film obl. 100x500 mg | 0,0235 | 2,35 | R | 5% |
| A10BA02 112 | | metformin | 2 g | 0,0750 | O | Belupo d.d. | Belupo | Belformin | tbl. film obl. 30x850 mg | 0,0319 | 0,96 | R | 5% |
| A10BA02 113 | | metformin | 2 g | 0,0765 | O | Belupo d.d. | Belupo | Belformin | tbl. film obl. 30x1000 mg | 0,0382 | 1,15 | R | 5% |
| A10BA02 114 | | metformin | 2 g | 0,0750 | O | Belupo d.d. | Belupo | Belformin | tbl. film obl. 120x850 mg | 0,0319 | 3,82 | R | 5% |
| A10BA02 115 | | metformin | 2 g | 0,0712 | O | Belupo d.d. | Belupo | Belformin | tbl. film obl. 120x1000 mg | 0,0356 | 4,27 | R | 5% |
| A10BA02 122 | | metformin | 2 g | 0,0941 | O | Sandoz d.o.o. | Sandoz-Lek | Meglucon | tbl. film obl. 120x500 mg | 0,0235 | 2,82 | R | 5% |
| A10BA02 124 | | metformin | 2 g | 0,0750 | O | Sandoz d.o.o. | Sandoz-Lek | Meglucon | tbl. film obl. 120x850 mg | 0,0319 | 3,82 | R | 5% |
| A10BA02 125 | | metformin | 2 g | 0,0712 | O | Sandoz d.o.o. | Sandoz-Lek | Meglucon | tbl. film obl. 120x1000 mg | 0,0356 | 4,27 | R | 5% |
| A10BA02 173 | | metformin | 2 g | 0,0941 | O | Medis Adria d.o.o. | Weifa | Aglurab | tbl. film obl. 100x500 mg | 0,0235 | 2,35 | R | 5% |
| A10BA02 174 | | metformin | 2 g | 0,0750 | O | Medis Adria d.o.o. | Weifa | Aglurab | tbl. film obl. 100x850 mg | 0,0319 | 3,19 | R | 5% |
| A10BA02 175 | | metformin | 2 g | 0,0712 | O | Medis Adria d.o.o. | Weifa | Aglurab | tbl. film obl. 60x1000 mg | 0,0356 | 2,14 | R | 5% |
| A10BA02 181 | | metformin | 2 g | 0,0941 | O | Berlin-Chemie Menarini Hrvatska d.o.o. | Berlin-Chemie AG | Siofor 500 | tbl. film obl. 120x500 mg | 0,0235 | 2,82 | R | 5% |
| A10BB01 161 | | glibenklamid-mikrokrist. | 7 mg | 0,1394 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Glibenclamid Genericon | tbl. 30x3,5 mg | 0,0697 | 2,09 | R | 5% |
| A10BB09 111 | | gliklazid | 60 mg | 0,1014 | O | Belupo d.d. | Belupo d.d. | Glika | tbl. s prod. oslob. 60x30 mg | 0,0507 | 3,04 | R | 5% |
| A10BB09 112 | | gliklazid | 60 mg | 0,0735 | O | Belupo d.d. | Belupo d.d. | Glika | tbl. s prilag. oslob. 30x60 mg | 0,0735 | 2,20 | R | 5% |
| A10BB09 113 | | gliklazid | 60 mg | 0,0735 | O | Belupo d.d. | Belupo d.d. | Glika | tbl. s prilag. oslob. 60x60 mg | 0,0735 | 4,41 | R | 5% |
| A10BB09 114 | | gliklazid | 60 mg | 0,0735 | O | Belupo d.d. | Belupo d.d. | Glika | tbl. s prilag. oslob. 90x60 mg | 0,0735 | 6,61 | R | 5% |
| A10BB09 131 | | gliklazid | 60 mg | 0,1014 | O | KRKA-FARMA d.o.o. | Krka d.d. | Gliclada | tbl. s prilag. osl. 60x30 mg | 0,0507 | 3,04 | R | 5% |
| A10BB09 134 | | gliklazid | 60 mg | 0,0657 | O | KRKA-FARMA d.o.o. | Krka d.d. | Gliclada | tbl. s prilag. osl. 30x90 mg | 0,0986 | 2,96 | R | 5% |
| A10BB12 111 | | glimepirid | 2 mg | 0,0735 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Betaglid | tbl. 30x2 mg | 0,0735 | 2,20 | R | 5% |
| A10BB12 112 | | glimepirid | 2 mg | 0,0657 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Betaglid | tbl. 30x3 mg | 0,0986 | 2,96 | R | 5% |
| A10BB12 145 | | glimepirid | 2 mg | 0,0730 | O | PharmaS d.o.o. | PharmaS d.o.o. | Glimepirid PharmaS | tbl. 30x2 mg | 0,0730 | 2,19 | R | 5% |
| A10BB12 146 | | glimepirid | 2 mg | 0,0735 | O | PharmaS d.o.o. | PharmaS d.o.o. | Glimepirid PharmaS | tbl. 60x2 mg | 0,0735 | 4,41 | R | 5% |
| A10BB12 147 | | glimepirid | 2 mg | 0,0648 | O | PharmaS d.o.o. | PharmaS d.o.o. | Glimepirid PharmaS | tbl. 30x3 mg | 0,0972 | 2,92 | R | 5% |
| A10BB12 148 | | glimepirid | 2 mg | 0,0657 | O | PharmaS d.o.o. | PharmaS d.o.o. | Glimepirid PharmaS | tbl. 60x3 mg | 0,0986 | 5,91 | R | 5% |
| A10BB12 161 | | glimepirid | 2 mg | 0,0735 | O | sanofi-aventis groupe | Sanofi-Aventis GmbH, Sanofi-Aventis S.p.A., Sanofi Winthrop Tours | Amaryl | tbl. 30x2 mg | 0,0735 | 2,20 | R | 5% |
| A10BB12 162 | | glimepirid | 2 mg | 0,0657 | O | sanofi-aventis groupe | Sanofi-Aventis GmbHSanofi-Aventis S.p.A.Sanofi Winthrop Tours | Amaryl | tbl. 30x3 mg | 0,0986 | 2,96 | R | 5% |
| A10BD02 171 | | metformin + glibenklamid | | | O | MERCK d.o.o. | Merck | Glucovance | tbl. film obl. 30x(500 mg +5 mg) | 0,0790 | 2,37 | R | 5% |
| A10BD05 161 | | pioglitazon + metformin | | | O | Cheplapharm Arzneimittel GmbH | Takeda | Competact | tbl. film obl. 56x(15 mg+850 mg) | 0,3315 | 18,56 | R | 5% |
| A10BD07 101 | | sitagliptin + metformin | | | O | PLIVA HRVATSKA d.o.o. | Merckle GmbH, Adamed Pharma S.A. | Gluformin Combi | tbl. s prod. oslob. 56x(50 mg +1000 mg) | 0,1955 | 10,95 | R | 5% |
| A10BD07 111 | | sitagliptin + metformin | | | O | Teva GmbH | Laboratorios Liconsa S.A. | Sitagliptin/metforminklorid Teva | tbl. film obl. 56x(50 mg +1000 mg) | 0,1950 | 10,92 | R | 5% |
| A10BD07 125 | | sitagliptin + metformin | | | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Eprocliv | tbl. film obl. 56x(50 mg +1000 mg) | 0,1950 | 10,92 | R | 5% |
| A10BD07 131 | | sitagliptin + metformin | | | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Maymetsi | tbl. film obl. 56x(50 mg +1000 mg) | 0,1950 | 10,92 | R | 5% |
| A10BD07 171 | | sitagliptin + metformin | | | O | STADA d.o.o. | STADA Arzneimittel AG | Fordiab | tbl. film obl. 56x(50 mg +1000 mg) | 0,1950 | 10,92 | R | 5% |
| A10BD07 181 | | sitagliptin + metformin | | | O | Viatris Limited | Mylan Hungary Kft, Medis International A.S. | Glerova | tbl. film obl. 56x(50 mg +1000 mg) | 0,1849 | 10,35 | R | 5% |
| A10BD07 182 | | sitagliptin + metformin | | | O | Zentiva k.s. | Laboratorios Liconsa S.A. | Jamesi | tbl. film obl. 56x(50 mg +1000 mg) | 0,1857 | 10,40 | R | 5% |
| A10BD07 183 | | sitagliptin + metformin | | | O | Novatin Limited | SAG Manufacturing S.L.U. | Zaxoran | tbl. film obl. 56x(50 mg +850 mg) | 0,1756 | 9,83 | R | 5% |
| A10BD07 184 | | sitagliptin + metformin | | | O | Novatin Limited | SAG Manufacturing S.L.U. | Zaxoran | tbl. film obl. 56x(50 mg +1000 mg) | 0,1756 | 9,83 | R | 5% |
| A10BD07 185 | | sitagliptin + metformin | | | O | Accord Healthcare S.L.U. | Accord Healthcare Polska Sp. z.o.o., Accord Healthcare B.V. | Sitagliptin/metforminklorid Accord | tbl. film obl. 56x(50 mg +1000 mg) | 0,1669 | 9,34 | R | 5% |
| A10BD08 111 | | vildagliptin + metformin | | | O | Belupo d.d. | Belupo | Agnis Combi | tbl. film obl. 60x(50 mg+850 mg) | 0,1852 | 11,11 | R | 5% |
| A10BD08 112 | | vildagliptin + metformin | | | O | Belupo d.d. | Belupo | Agnis Combi | tbl. film obl. 60x(50 mg+1000 mg) | 0,1852 | 11,11 | R | 5% |
| A10BD08 121 | | vildagliptin + metformin | | | O | Sandoz d.o.o. | Sandoz-Lek | Vilspox | tbl. film obl. 60x(50 mg +1000 mg) | 0,1950 | 11,70 | R | 5% |
| A10BD08 141 | | vildagliptin + metformin | | | O | Accord Healthcare S.L.U. | LABORATORI FUNDACIÓ DAU, Pharmadox Healthcare Ltd. | Vildagliptin/metforminklorid Accord | tbl. film obl. 60x(50 mg+1000 mg) | 0,1671 | 10,03 | R | 5% |
| A10BD08 171 | | vildagliptin + metformin | | | O | Medochemie Ltd. | Medochemie Ltd. | Daltex | tbl. film obl. 60x(50 mg +1000 mg) | 0,1950 | 11,70 | R | 5% |
| A10BD08 181 | | vildagliptin + metformin | | | O | Zentiva k.s. | Pharmathen S.A., Pharmathen International S.A. | Ipinzan | tbl. film obl. 60x(50 mg+1000 mg) | 0,1760 | 10,56 | R | 5% |
| A10BD08 191 | | vildagliptin + metformin | | | O | STADA d.o.o. | STADA Arzneimittel AG | Vilbaco | tbl. film obl. 60x(50 mg+1000 mg) | 0,1760 | 10,56 | R | 5% |
| A10BD08 192 | | vildagliptin + metformin | | | O | Genericon Pharma Gesellschaft m.b.H. | SAG Manufacturing S.L.U., Galenicum Health S.L. | Vildagliptin/metforminklorid Genericon | tbl. film obl. 60x(50 mg+1000 mg) | 0,1588 | 9,53 | R | 5% |
| A10BG03 101 | | pioglitazon | 30 mg | 0,6464 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Pioglitazon Pliva tbl. 15 mg | tbl. 30x15 mg | 0,3232 | 9,70 | R | 5% |
| A10BG03 102 | | pioglitazon | 30 mg | 0,4853 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Pioglitazon Pliva tbl. 30 mg | tbl. 30x30 mg | 0,4853 | 14,56 | R | 5% |
| A10BG03 133 | | pioglitazon | 30 mg | 0,4854 | O | ACTAVIS GROUP PTC ehf. | Actavis Ltd. | Pioglitazon Actavis | tbl. 28x45 mg | 0,7280 | 20,38 | R | 5% |
| A10BG03 181 | | pioglitazon | 30 mg | 0,6464 | O | Cheplapharm Arzneimittel GmbH | Takeda | Actos | tbl. 28x15 mg | 0,3232 | 9,05 | R | 5% |
| A10BG03 182 | | pioglitazon | 30 mg | 0,4853 | O | Cheplapharm Arzneimittel GmbH | Takeda | Actos | tbl. 28x30 mg | 0,4853 | 13,59 | R | 5% |
| A10BG03 183 | | pioglitazon | 30 mg | 0,6141 | O | Novatin Limited | Laboratori Fundacio Dau | Novapio | tbl. 30x15 mg | 0,3070 | 9,21 | R | 5% |
| A10BG03 184 | | pioglitazon | 30 mg | 0,4611 | O | Novatin Limited | Laboratori Fundacio Dau | Novapio | tbl. 30x30 mg | 0,4611 | 13,83 | R | 5% |
| A10BG03 185 | | pioglitazon | 30 mg | 0,4611 | O | Novatin Limited | Laboratori Fundacio Dau | Novapio | tbl. 30x45 mg | 0,6916 | 20,75 | R | 5% |
| A10BH01 101 | | sitagliptin | 0,1 g | 0,3159 | O | Teva B.V. | Teva Gyogyszergyar Zrt., Teva Operations Poland Sp. z o.o. | Sitagliptin Teva | tbl. film obl. 28x100 mg | 0,3159 | 8,84 | R | 5% |
| A10BH01 122 | | sitagliptin | 0,1 g | 0,5701 | O | Jadran – Galenski Laboratorij d.d. | Zakłady Farmaceutyczne Polpharma S.A., Pharmacare Premium Ltd. | Sigazix | tbl. film obl. 28x50 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 123 | | sitagliptin | 0,1 g | 0,2851 | O | Jadran – Galenski Laboratorij d.d. | Zakłady Farmaceutyczne Polpharma S.A., Pharmacare Premium Ltd. | Sigazix | tbl. film obl. 28x100 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 124 | | sitagliptin | 0,1 g | 1,1403 | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Adimuplan | tbl. film obl. 28x25 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 125 | | sitagliptin | 0,1 g | 0,5701 | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Adimuplan | tbl. film obl. 28x50 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 126 | | sitagliptin | 0,1 g | 0,2851 | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Adimuplan | tbl. film obl. 28x100 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 131 | | sitagliptin | 0,1 g | 1,2635 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Maysiglu | tbl. film obl. 28x25 mg | 0,3159 | 8,84 | R | 5% |
| A10BH01 132 | | sitagliptin | 0,1 g | 0,6318 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Maysiglu | tbl. film obl. 28x50 mg | 0,3159 | 8,84 | R | 5% |
| A10BH01 133 | | sitagliptin | 0,1 g | 0,3159 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Maysiglu | tbl. film obl. 28x100 mg | 0,3159 | 8,84 | R | 5% |
| A10BH01 164 | | sitagliptin | 0,1 g | 1,1403 | O | ALPHA-MEDICAL d.o.o. | Adamed Pharma S.A. | Dowim | tbl. film obl. 28x25 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 165 | | sitagliptin | 0,1 g | 0,5701 | O | ALPHA-MEDICAL d.o.o. | Adamed Pharma S.A. | Dowim | tbl. film obl. 28x50 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 166 | | sitagliptin | 0,1 g | 0,2851 | O | ALPHA-MEDICAL d.o.o. | Adamed Pharma S.A. | Dowim | tbl. film obl. 28x100 mg | 0,2851 | 7,98 | R | 5% |
| A10BH01 167 | | sitagliptin | 0,1 g | 1,0832 | O | Accord Healthcare S.L.U. | Accord Healthcare Polska Sp. z.o.o. | Sitagliptin Accord | tbl. film obl. 28x25 mg | 0,2708 | 7,58 | R | 5% |
| A10BH01 168 | | sitagliptin | 0,1 g | 0,5416 | O | Accord Healthcare S.L.U. | Accord Healthcare Polska Sp. z.o.o. | Sitagliptin Accord | tbl. film obl. 28x50 mg | 0,2708 | 7,58 | R | 5% |
| A10BH01 169 | | sitagliptin | 0,1 g | 0,2708 | O | Accord Healthcare S.L.U. | Accord Healthcare Polska Sp. z.o.o. | Sitagliptin Accord | tbl. film obl. 28x100 mg | 0,2708 | 7,58 | R | 5% |
| A10BH01 175 | | sitagliptin | 0,1 g | 0,2708 | O | Novatin Limited | SAG Manufacturing S.L.U. | Zaxivia | tbl. film obl. 28x100 mg | 0,2708 | 7,58 | R | 5% |
| A10BH01 181 | | sitagliptin | 0,1 g | 1,0290 | O | Mylan Ireland Limited | Mylan Hungary Kft, Medis International A.S. | Jaglix | tbl. film obl. 28x25 mg | 0,2573 | 7,20 | R | 5% |
| A10BH01 182 | | sitagliptin | 0,1 g | 0,5145 | O | Mylan Ireland Limited | Mylan Hungary Kft, Medis International A.S. | Jaglix | tbl. film obl. 28x50 mg | 0,2573 | 7,20 | R | 5% |
| A10BH01 183 | | sitagliptin | 0,1 g | 0,2573 | O | Mylan Ireland Limited | Mylan Hungary Kft, Medis International A.S. | Jaglix | tbl. film obl. 28x100 mg | 0,2573 | 7,20 | R | 5% |
| A10BH02 111 | | vildagliptin | 0,1 g | 0,3159 | O | Belupo d.d. | Belupo d.d. | Agnis | tbl. 60x50 mg | 0,1579 | 9,48 | R | 5% |
| A10BH02 121 | | vildagliptin | 0,1 g | 0,3159 | O | Sandoz d.o.o. | Sandoz-Lek | Saxotin | tbl. 56x50 mg | 0,1579 | 8,84 | R | 5% |
| A10BH02 131 | | vildagliptin | 0,1 g | 0,3154 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma Gmbh | Glypvilo | tbl. 60x50 mg | 0,1577 | 9,46 | R | 5% |
| A10BJ01 062 | | eksenatid | 15 mcg | 1,7668 | P | AstraZeneca AB | AstraZeneca AB | Byetta | otop. za inj., brizg. napunj. 1x2,4 ml, 10 mcg/40 mcl, (0,25 mg/ml) | 70,6722 | 70,67 | RSRA11 | 5% |
| A10BJ03 061 | | liksisenatid | 20 mcg | 5,0480 | P | sanofi-aventis groupe | Sanofi-Aventis Deutchland GmbH | Lyxumia | otop. za inj., brizg. napunj. 1x3 ml (10 mcg/doza) | 35,3361 | 35,34 | RSRA11 | 5% |
| A10BJ03 062 | | liksisenatid | 20 mcg | 2,5240 | P | sanofi-aventis groupe | Sanofi-Aventis Deutchland GmbH | Lyxumia | otop. za inj., brizg. napunj. 2x3 ml (20 mcg/doza) | 35,3361 | 70,67 | RSRA11 | 5% |
| A10BJ05 061 | | dulaglutid | 0.16 mg | 3,7692 | P | Eli Lilly Nederland B.V. | Eli Lilly Italia S.p.A. | Trulicity | otop. za inj., brizg. napunj. 2x0,75 mg/0,5 ml | 17,6681 | 35,34 | RSRA11 | 5% |
| A10BJ05 062 | | dulaglutid | 0.16 mg | 1,8846 | P | Eli Lilly Nederland B.V. | Eli Lilly Italia S.p.A. | Trulicity | otop. za inj., brizg. napunj. 2x1,5 mg/0,5 ml | 17,6681 | 35,34 | RSRA11 | 5% |
| A10BJ05 063 | | dulaglutid | 0.16 mg | 0,9423 | P | Eli Lilly Nederland B.V. | Eli Lilly Italia S.p.A. | Trulicity | otop. za inj., brizg. napunj. 2x3,0 mg/0,5 ml | 17,6681 | 35,34 | RSRA11 | 5% |
| A10BJ05 064 | | dulaglutid | 0.16 mg | 0,6282 | P | Eli Lilly Nederland B.V. | Eli Lilly Italia S.p.A. | Trulicity | otop. za inj., brizg. napunj. 2x4,5 mg/0,5 ml | 17,6681 | 35,34 | RSRA11 | 5% |
| A10BJ06 071 | | semaglutid | 0.11 mg | 7,7740 | P | Novo Nordisk A/S | Novo Nordisk A/S | Ozempic | otop. za inj., brizg. napunj., 1x1,5 ml (0,25 mg/doza) | 70,6722 | 70,67 | RSRA11 | 5% |
| A10BJ06 072 | | semaglutid | 0.11 mg | 3,8870 | P | Novo Nordisk A/S | Novo Nordisk A/S | Ozempic | otop. za inj., brizg. napunj., 1x1,5 ml (0,5 mg/doza) | 70,6722 | 70,67 | RSRA11 | 5% |
| A10BJ06 073 | | semaglutid | 0.11 mg | 1,9435 | P | Novo Nordisk A/S | Novo Nordisk A/S | Ozempic | otop. za inj., brizg. napunj., 1x3 ml (1 mg/doza) | 70,6722 | 70,67 | RSRA11 | 5% |
| A10BX02 101 | | repaglinid | 4 mg | 0,1284 | O | DOUBLE-E-PHARMA Limited | Pliva Hrvatska d.o.o. | Reodon | tbl. 90x0,5 mg | 0,0160 | 1,44 | R | 5% |
| A10BX02 102 | | repaglinid | 4 mg | 0,1283 | O | DOUBLE-E-PHARMA Limited | Pliva Hrvatska d.o.o. | Reodon | tbl. 90x1 mg | 0,0321 | 2,89 | R | 5% |
| A10BX02 103 | | repaglinid | 4 mg | 0,1215 | O | DOUBLE-E-PHARMA Limited | Pliva Hrvatska d.o.o. | Reodon | tbl. 90x2 mg | 0,0608 | 5,47 | R | 5% |
| A10BX02 112 | | repaglinid | 4 mg | 0,1283 | O | Belupo d.d. | Belupo | Reglinid | tbl. 90x1 mg | 0,0321 | 2,89 | R | 5% |
| A10BX02 113 | | repaglinid | 4 mg | 0,1215 | O | Belupo d.d. | Belupo | Reglinid | tbl. 90x2 mg | 0,0608 | 5,47 | R | 5% |
| A10BX02 127 | | repaglinid | 4 mg | 0,1215 | O | PharmaS d.o.o. | PharmaS d.o.o. | Repaglinid PharmaS | tbl. 90x2 mg | 0,0608 | 5,47 | R | 5% |
| A11CC02 251 | | dihidrotahisterol | 1 mg | | O | | | | | | | R | 5% |
| A11CC04 051 | DS | kalcitriol | 1 mcg | | P | | | | | | | | 5% |
| A11CC05 161 | | kolekalciferol | 20 mcg | 0,0252 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Dekristol | caps. meka 14x20 000 IU (0,5 mg) | 0,6295 | 8,81 | R | 5% |
| A11CC05 201 | | kolekalciferol | 20 mcg | 0,0444 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivit D3 | boč. 1x10 ml (4.000 i.j./ml) | 2,2205 | 2,22 | R | 5% |
| A11CC05 261 | | kolekalciferol | 20 mcg | 0,0311 | O | Fresenius Kabi d.o.o. | Fresenius Kabi | Oleovit D3 | oralne kapi, boč. 1x12,5 ml (14400 i.j./ml) | 6,9945 | 6,99 | R | 5% |
| A11CC05 271 | | kolekalciferol | 20 mcg | 0,0280 | O | PROXIMUM d.o.o. | SMB Technology S.A. | D-VITAL | oralna otop., amp. 4x1 ml (25 000 IU/ml) | 0,8743 | 3,50 | R | 5% |
| A11CC05 272 | | kolekalciferol | 20 mcg | 0,0266 | O | PROXIMUM d.o.o. | SMB Technology S.A. | D-VITAL | oralna otop., amp. 3x1 ml (100 000 IU/ml) | 3,3225 | 9,97 | RSRA31 | 5% |
| A11EA01 051 | DS | vitamini B kompleksa | | | P | | | | | | | | 5% |
| A12AA02 051 | PR | kalcij-glukobionat | | | P | | | | | | | | 5% |
| A12AA04 131 | | kalcij-karbonat | 3 g | 0,3902 | O | KRKA-FARMA d.o.o. | Krka d.d. | Kalcijev karbonat | tbl. 50x1 g | 0,1301 | 6,50 | R | 5% |
| A12BA01 111 | | kalij-klorid | 3 g | 0,6055 | O | Belupo d.d. | Belupo | Kalijev klorid Belupo | tbl. za oral. otop. 30x500 mg | 0,1009 | 3,03 | R | 5% |
| A12BA01 112 | | kalij-klorid | 3 g | 0,6055 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Kalijev klorid Jadran | tbl. 30x500 mg | 0,1009 | 3,03 | R | 5% |
| A12BA02 321 | | kalijev citrat | | | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Kalijev citrat JGL | praš. za oral. otop., vreć. 15x1 (20,5 mg/ml) | 0,2389 | 3,58 | R | 5% |
| A12BA30 161 | | kalij-citrat + kalij-hidrogenkarbonat | | | O | Desma GmbH | E-Pharma Trento S.p.A. | Kalinor | tbl. šum. 15x1 tbl. (2,17 g+2 g/tbl.) | 0,2655 | 3,98 | R | 5% |
| A16AA01 051 | DS | levokarnitin | 2 g | | P | | | | | | | | 5% |
| A16AA01 151 | DS | levokarnitin | 2 g | | O | | | | | | | | 5% |
| A16AA05 161 | DS | karglumatna kiselinaNA501 | 200 mg | 60,1664 | O | Recordati Rare Diseases | Recordati Rare Diseases | Carbaglu | tbl. za oral. susp. 60x200 mg | 60,1664 | 3.609,98 | | 5% |
| A16AB02 062 | KS | imiglucerazaNA903 | 300 j. | 1.004,5035 | P | Genzyme Europe B.V. | Genzyme | Cerezyme | praš. za konc. za otop. za inf., stakl. boč. 1x400 j. | 1.339,3045 | 1.339,30 | | 5% |
| A16AB03 062 | KS | agalzidaza alfaNA904 | 1 mg | 453,0224 | P | Takeda Pharmaceuticals International AG Ireland Branch | Shire Pharmaceuticals Ireland Limited | Replagal | konc. za inf., boč. 1x3,5 mg/3,5 ml | 1.585,5783 | 1.585,58 | | 5% |
| A16AB04 061 | KS | agalzidaza betaNA904 | 5 mg | 440,9444 | P | Genzyme Europe B.V. | Genzyme | Fabrazyme | praš. za konc. za otop. za inf., boč. stakl. 1x35 mg | 3.086,6109 | 3.086,61 | | 5% |
| A16AB04 062 | KS | agalzidaza betaNA904 | 5 mg | 481,9112 | P | Genzyme Europe B.V. | Genzyme | Fabrazyme | praš. za konc. za otop. za inf., boč. stakl. 1x5 mg | 481,9112 | 481,91 | | 5% |
| A16AB05 061 | KS | laronidazaNA906 | 1 T j. | 1.285,9062 | P | Genzyme Europe B.V. | Genzyme | Aldurazyme | praš. za konc. za otop. za inf., boč. stakl. 1x500 j./5 ml (100j./ml) | 642,9531 | 642,95 | | 5% |
| A16AB07 061 | KS | alglukozidaza alfaNA907 | 0,1 g | 983,0725 | P | Genzyme Europe B.V. | Genzyme | Myozyme | praš. za konc. za otop. za inf., boč. 1x50 mg | 491,5363 | 491,54 | | 5% |
| A16AB08 061 | KS | galsulfazaNA908 | | | P | BioMarin International Limited | BioMarin International Limited | Naglazyme | konc. otop. za inf., boč. 1x5 mg/5 ml | 1.373,6890 | 1.373,69 | | 5% |
| A16AB09 071 | KS | idursulfaza NA909 | | | P | Takeda Pharmaceuticals International AG Ireland Branch | Shire Pharmaceuticals Ireland Limited | Elaprase | boč. stakl. 1x6 mg/3 ml (2 mg/ml) | 2.655,2061 | 2.655,21 | | 5% |
| A16AB10 061 | KS | velagluceraza alfaNA903 | 300 U | 1.038,4154 | P | Takeda Pharmaceuticals International AG Ireland Branch | Shire Pharmaceuticals Ireland Limited | Vpriv | praš. za otop. za inf., boč. stakl. 1x400 U/20 ml (nakon rekonstitucije 100 U/1ml) | 1.384,5192 | 1.384,52 | | 5% |
| A16AB12 071 | KS | elosulfaza alfaNA913 | 20 mg | 3.327,0051 | P | BioMarin International Limited | BioMarin International Ltd. | Vimizim | konc. za otop. za inf., boč. stakl. 1x5 ml (1 mg/ml) | 831,7513 | 831,75 | | 5% |
| A16AB17 071 | KL | cerliponaza alfaNA915 | 21 mg | 1.706,5773 | P | BioMarin International Limited | BioMarin International Limited | Brineura | otop. za inf., boč. 2x150 mg/5 ml (30mg/ml) | 12.189,8255 | 24.379,65 | | 5% |
| A16AX04 151 | KS | nitizinonNA905 | 20 mg | | O | | | | | | | | 5% |
| A16AX08 072 | KL | teduglutidNA914 | 5 mg | 1.158,1472 | P | Takeda Pharmaceuticals International AG Ireland Branch | Shire Pharmaceuticals Ireland Limited | Revestive | praš. boč. 28x1,25 mg+0,5 ml otap. za otop. za inj. u štrc. napunj. (2,5 mg/ml) | 289,5368 | 8.107,03 | | 5% |
| A16AX08 073 | KL | teduglutidNA914 | 5 mg | 596,2603 | P | Takeda Pharmaceuticals International AG Ireland Branch | Shire Pharmaceuticals Ireland Limited | Revestive | praš. boč. 28x5 mg+0,5 ml otap. za otop. za inj. u štrc. napunj. (10 mg/ml) | 596,2603 | 16.695,29 | | 5% |
| A16AX10 161 | KS | eliglustatNA910 | | | O | Genzyme Europe B.V. | Genzyme Ireland Ltd. | Cerdelga | caps. tvrda 56x84 mg | 341,0370 | 19.098,07 | | 5% |
| A16AX14 161 | KS | migalastatNA911 | | | O | Amicus Therapeutics Europe Limited | Almac Pharma Services (Ireland) Limited | Galafold | caps. tvrde 14x123 mg | 1.036,4703 | 14.510,58 | | 5% |
| B01AA03 162 | | varfarin | 7,5 mg | 0,1383 | O | Orion Corporation | Orion | Martefarin | tbl. 100x3 mg | 0,0553 | 5,53 | R | 5% |
| B01AB01 011 | DS | heparin | 10 T i.j. | 1,9378 | P | Belupo d.d. | Belupo | Heparin Belupo | otop. za inj., lio amp. 10x25.000 i.j./5 ml | 4,8444 | 48,44 | | 5% |
| B01AB01 061 | DS | heparinnatrij | 10 T i.j. | 1,7555 | P | Panpharma | Panpharma GmbH | Heparin Panpharma | otop. za inj./inf., 5.000 i.j./ml (10x5 ml) | 4,3888 | 43,89 | | 5% |
| B01AB02 061 | DS | antitrombin IIINB101 | 2.1 T i.j. | 526,7663 | P | CSL Behring GmbH | CSL Behring GmbH | Kybernin | lio boč. 1x500 i.j./10ml | 125,4231 | 125,42 | | 5% |
| B01AB02 071 | DS | antitrombin IIINB101 | 2.1 T i.j. | 526,7663 | P | Jana Pharm d.o.o. | Octapharma | ATenativ | lio boč. 1x500 i.j./10ml | 125,4231 | 125,42 | | 5% |
| B01AB02 082 | DS | antitrombin IIINB101 | 2.1 T i.j. | 526,7663 | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Antithrombin III Baxalta 50 IU/ml | praš. i otap. za otop. za inj./inf., boč. 1x500 IU/10 ml (50 IU/ml) | 125,4231 | 125,42 | | 5% |
| B01AB04 071 | DSPO | dalteparinNB102 | 2.5 T i.j. | 9,0271 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | štrc. 10x2.500 i.j./0,2ml | 1,8054 | 18,05 | | 5% |
| B01AB04 072 | DSPO | dalteparinNB102 | 2.5 T i.j. | 8,5981 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | štrc. 10x5.000 i.j./0,2ml | 3,4393 | 34,39 | | 5% |
| B01AB04 073 | DSPO | dalteparinNB102 | 2.5 T i.j. | 1,3958 | P | Pfizer Croatia d.o.o. | Pfizer | Fragmin | štrc. 10x7.500 i.j./0,3ml | 4,1874 | 41,87 | RSRB10 | 5% |
| B01AB04 080 | | dalteparin | 2.5 T i.j. | 1,3360 | P | Pfizer Croatia d.o.o. | Pfizer Manufacturing Belgium N.V. | Fragmin | otop. za inj., štrc. napunj. 5x10.000 i.j./0,4 ml | 5,3440 | 26,72 | RSRB10 | 5% |
| B01AB04 081 | | dalteparin | 2.5 T i.j. | 1,2105 | P | Pfizer Croatia d.o.o. | Pfizer Manufacturing Belgium N.V. | Fragmin | otop. za inj., štrc. napunj. 5x12.500 i.j./0,5 ml | 6,0527 | 30,26 | RSRB10 | 5% |
| B01AB04 082 | | dalteparin | 2.5 T i.j. | 1,1338 | P | Pfizer Croatia d.o.o. | Pfizer Manufacturing Belgium N.V. | Fragmin | otop. za inj., štrc. napunj. 5x15.000 i.j./0,6 ml | 6,8028 | 34,01 | RSRB10 | 5% |
| B01AB05 061 | DSPO | enoksaparinNB506 | 2.0 T i.j. | 1,3949 | P | Techdow Europe AB | Health-Med spółka z ograniczoną odpowiedzialnością sp.k. | Inhixa | šprica 10x20 mg/0,2 ml | 1,3949 | 13,95 | RSRB11 | 5% |
| B01AB05 062 | DSPO | enoksaparinNB506 | 2.0 T i.j. | 1,3129 | P | Techdow Europe AB | Health-Med spółka z ograniczoną odpowiedzialnością sp.k. | Inhixa | šprica 6x40 mg/0,4 ml | 2,6257 | 15,75 | RSRB11 | 5% |
| B01AB05 063 | DSPO | enoksaparinNB506 | 2.0 T i.j. | 1,3129 | P | Techdow Europe AB | Health-Med spółka z ograniczoną odpowiedzialnością sp.k. | Inhixa | šprica 10x40 mg/0,4 ml | 2,6258 | 26,26 | RSRB11 | 5% |
| B01AB05 064 | DSPO | enoksaparinNB102 | 2.0 T i.j. | 1,1599 | P | Techdow Europe AB | Health-Med spółka z ograniczoną odpowiedzialnością sp.k. | Inhixa | šprica 6x60 mg/0,6 ml | 3,4796 | 20,88 | | 5% |
| B01AB05 065 | DSPO | enoksaparinNB102 | 2.0 T i.j. | 1,1598 | P | Techdow Europe AB | Health-Med spółka z ograniczoną odpowiedzialnością sp.k. | Inhixa | šprica 10x60 mg/0,6 ml | 3,4795 | 34,79 | | 5% |
| B01AB05 066 | DSPO | enoksaparinNB102 | 2.0 T i.j. | 1,0270 | P | Techdow Europe AB | Health-Med spółka z ograniczoną odpowiedzialnością sp.k. | Inhixa | šprica 10x80 mg/0,8 ml | 4,1082 | 41,08 | | 5% |
| B01AB05 067 | DSPO | enoksaparinNB102 | 2.0 T i.j. | 0,8408 | P | Techdow Europe AB | Health-Med spółka z ograniczoną odpowiedzialnością sp.k. | Inhixa | šprica 10x100 mg/1 ml | 4,2037 | 42,04 | | 5% |
| B01AB05 085 | DSPO | enoksaparinNB506 | 2.0 T i.j. | 0,1502 | P | sanofi-aventis groupe | Sanofi Winthrop Maisons Alfort, Sanofi Winthrop Le Trait, Sanofi Aventis Alcorcon | Clexane | šprica 10x20 mg/0,2 ml | 1,5020 | 15,02 | RSRB11 | 5% |
| B01AB05 086 | DSPO | enoksaparinNB506 | 2.0 T i.j. | 0,1449 | P | sanofi-aventis groupe | Sanofi Winthrop Maisons Alfort, Sanofi Winthrop Le Trait, Sanofi Aventis Alcorcon | Clexane | šprica 10x40 mg/0,4 ml | 2,8977 | 28,98 | RSRB11 | 5% |
| B01AB05 087 | DSPO | enoksaparinNB102 | 2.0 T i.j. | 0,1326 | P | sanofi-aventis groupe | Sanofi Winthrop Maisons Alfort, Sanofi Winthrop Le Trait, Sanofi Aventis Alcorcon | Clexane | šprica 10x60 mg/0,6 ml | 3,9777 | 39,78 | | 5% |
| B01AB05 088 | DSPO | enoksaparinNB102 | 2.0 T i.j. | 0,1176 | P | sanofi-aventis groupe | Sanofi Winthrop Maisons Alfort, Sanofi Winthrop Le Trait, Sanofi Aventis Alcorcon | Clexane | šprica 10x80 mg/0,8 ml | 4,7028 | 47,03 | | 5% |
| B01AB05 089 | DSPO | enoksaparinNB102 | 2.0 T i.j. | 0,1051 | P | sanofi-aventis groupe | Sanofi Winthrop Maisons Alfort, Sanofi Winthrop Le Trait, Sanofi Aventis Alcorcon | Clexane | šprica 10x100 mg/1 ml | 5,2546 | 52,55 | | 5% |
| B01AB06 021 | DSPO | nadroparinNB102 | 2.85 T i.j. | 1,8909 | P | Mylan Hrvatska d.o.o. | Aspen Notre Dame de Bondeville | Fraxiparine | štrc. 10x2850 i.j. anti Xa/0,3 ml | 1,8909 | 18,91 | RSRB11 | 5% |
| B01AB06 022 | DSPO | nadroparinNB102 | 2.85 T i.j. | 1,7178 | P | Mylan Hrvatska d.o.o. | Aspen Notre Dame de Bondeville | Fraxiparine | štrc. 10x5.700 i.j. anti Xa/0,6 ml | 3,4355 | 34,36 | RSRB11 | 5% |
| B01AB06 023 | DSPO | nadroparinNB102 | 2.85 T i.j. | 1,2460 | P | Mylan Hrvatska d.o.o. | Aspen Notre Dame de Bondeville | Fraxiparine | štrc. 10x7.600 i.j. anti Xa/0,8 ml | 3,3227 | 33,23 | | 5% |
| B01AB06 024 | DSPO | nadroparinNB102 | 2.85 T i.j. | 1,8973 | P | Mylan Hrvatska d.o.o. | Aspen Notre Dame de Bondeville | Fraxiparine | štrc. 10x3.800 i.j. anti Xa/0,4 ml | 2,5297 | 25,30 | RSRB11 | 5% |
| B01AC04 111 | | klopidogrel | 75 mg | 0,3005 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Pigrel | tbl. film obl. 28x75 mg | 0,3005 | 8,41 | RSRB01 | 5% |
| B01AC04 115 | | klopidogrel | 75 mg | 0,2871 | O | Belupo d.d. | Belupo | Klopidex | tbl. film obl. 30x75 mg | 0,2871 | 8,61 | RSRB01 | 5% |
| B01AC04 125 | | klopidogrel | 75 mg | 0,2871 | O | Sandoz d.o.o. | Sandoz-Lek | Kogrel | tbl. film obl. 30x75 mg | 0,2871 | 8,61 | RSRB01 | 5% |
| B01AC04 126 | | klopidogrel | 75 mg | 0,2637 | O | Sandoz d.o.o. | Sandoz-Lek | Kogrel | tbl. film obl. 60x75 mg | 0,2637 | 15,82 | RSRB01 | 5% |
| B01AC04 131 | | klopidogrel | 75 mg | 0,3005 | O | Krka d.d., Novo mesto | KRKA-FARMA d.o.o. | Zyllt | tbl. film obl. 28x75 mg | 0,3005 | 8,41 | RSRB01 | 5% |
| B01AC04 135 | | klopidogrel | 75 mg | 0,3005 | O | Mylan Hrvatska d.o.o. | Phamathen International SA | Gardin | tbl. film obl. 28x75 mg | 0,3005 | 8,41 | RSRB01 | 5% |
| B01AC04 145 | | klopidogrel | 75 mg | 0,3005 | O | PharmaS d.o.o. | PharmaS d.o.o. | Klopidogrel PharmaS | tbl. film obl. 28x75 mg | 0,3005 | 8,41 | RSRB01 | 5% |
| B01AC04 163 | DS | klopidogrelNB103 | 75 mg | 0,4539 | O | sanofi-aventis groupe | Sanofi Winthrop Industrie | Plavix | tbl. film obl. 30x300 mg | 1,8157 | 54,47 | | 5% |
| B01AC06 151 | DS | acetilsalicilna kiselina | 100 mg | | O | | | | | | | | 5% |
| B01AC07 051 | DS | dipiridamolNB104 | 0,2 g | | P | | | | | | | | 5% |
| B01AC11 062 | KS | iloprostNB105 | 0,15 mg | 183,9671 | I | Bayer AG | Berlimed S.A. | Ventavis | otop. za atomizator, amp. stakl. 90x2 ml (10 mcg/ml) | 24,5289 | 2.207,61 | | 5% |
| B01AC16 062 | DS | eptifibatidNB106 | | | P | GlaxoSmithKline (Ireland) Limited | Glaxo Operations UK Ltd., GlaxoSmithKline Manufacturing S.P.A. | Integrilin | boč. 1x100 ml (0,75 mg/ml) | 55,7754 | 55,78 | | 5% |
| B01AC16 071 | DS | eptifibatidNB106 | | | P | Accord Healthcare S.L.U. | Accord Healthcare Ltd | Eptifibatid Accord | otop. za inj., boč. stakl. 1x10 ml (2 mg/ml) | 12,6896 | 12,69 | | 5% |
| B01AC16 072 | DS | eptifibatidNB106 | | | P | Accord Healthcare S.L.U. | Accord Healthcare Ltd | Eptifibatid Accord | otop. za inj., boč. stakl. 1x100 ml (0,75 mg/ml) | 39,9562 | 39,96 | | 5% |
| B01AC22 101 | | prasugrel | 10 mg | 1,0078 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prasugrel Pliva | tbl. film obl. 28x10 mg | 1,0078 | 28,22 | RS RB02 | 5% |
| B01AC22 131 | | prasugrel | 10 mg | 0,9823 | O | KRKA-FARMA d.o.o. | Krka d.d. | Eliskardia | tbl. film obl. 28x10 mg | 0,9823 | 27,51 | RS RB02 | 5% |
| B01AC22 141 | | prasugrel | 10 mg | 0,9521 | O | Alkaloid-INT d.o.o. | Alkaloid – INT d.o.o. | Tosynal | tbl. film obl. 30x10 mg | 0,9521 | 28,56 | RS RB02 | 5% |
| B01AC22 171 | | prasugrel | 10 mg | 0,9332 | O | Mylan Pharmaceuticals Limited | McDermott Laboratories t/a Gerard Laboratories t/a Mylan Dublin, Mylan Hungary Kft./Mylan Hungary Ltd. | Prasugrel Mylan | tbl. film obl. 28x10 mg | 0,9332 | 26,13 | RS RB02 | 5% |
| B01AC24 111 | | tikagrelor | 0,18 g | 1,0078 | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Greccas | tbl. film obl. 56x90 mg | 0,5039 | 28,22 | RS RB02 | 5% |
| B01AC24 171 | | tikagrelor | 0,18 g | 1,0078 | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Tilobrastil | tbl. film obl. 56x90 mg | 0,5039 | 28,22 | RS RB02 | 5% |
| B01AC24 174 | | tikagrelor | 0,18 g | 1,0078 | O | PharmaS d.o.o. | S.C Labormed – Pharma SA, AdAlvo Limited | Tikagrelor PharmaS | tbl. film obl. 56x90 mg | 0,5039 | 28,22 | RS RB02 | 5% |
| B01AC24 181 | | tikagrelor | 0,18 g | 1,0078 | O | KRKA-FARMA d.o.o. | Krka d.d. | Atixarso | tbl. film obl. 56x90 mg | 0,5039 | 28,22 | RS RB02 | 5% |
| B01AC24 182 | | tikagrelor | 0,18 g | 1,0078 | O | Abdi Farma Unipessoal Ltd. | Interpharma Services Ltd., Pharmadox Healthcare Limited | Tikagrelor Abdi | tbl. film obl. 56x90 mg | 0,5039 | 28,22 | RS RB02 | 5% |
| B01AC24 191 | | tikagrelor | 0,18 g | 1,0078 | O | Mylan Ireland Limited | PharOS MT Ltd | Igzelym | tbl. film obl. 56x90 mg | 0,5039 | 28,22 | RS RB02 | 5% |
| B01AC24 192 | | tikagrelor | 0,18 g | 1,0078 | O | STADA d.o.o. | STADA Arzneimittel AG | Tigrix | tbl. film obl. 60x90 mg | 0,5039 | 30,23 | RS RB02 | 5% |
| B01AD02 061 | DS | alteplazaNB107 | 0,1 g | 824,2485 | P | Boehringer Ingelheim Zagreb d.o.o. | Boehringer Ingelheim | Actilyse | lio boč. 1x50 mg | 412,1242 | 412,12 | | 5% |
| B01AE07 162 | DS | dabigatran eteksilat NB108 | 0,22 g | 3,0094 | O | Boehringer Ingelheim International GmbH | Boehringer Ingelheim | Pradaxa | caps. tvrda 30x75 mg | 1,0260 | 30,78 | | 5% |
| B01AE07 164 | DS | dabigatran eteksilat NB108 | 0,22 g | 2,0448 | O | Boehringer Ingelheim International GmbH | Boehringer Ingelheim | Pradaxa | caps. tvrda 30x110 mg | 1,0224 | 30,67 | | 5% |
| B01AF01 161 | DS | rivaroksaban NB108 | 20 mg | 4,2400 | O | Bayer AG | Bayer AG | Xarelto | tbl. film obl. 10x10 mg | 2,1200 | 21,20 | | 5% |
| B01AF01 162 | DS | rivaroksaban NB108 | 20 mg | 4,0183 | O | Bayer AG | Bayer AG | Xarelto | tbl. film obl. 30x10 mg | 2,0092 | 60,27 | | 5% |
| B01AF01 361 | | rivaroksaban | 20 mg | 2,1899 | O | Bayer AG | Bayer AG | Xarelto | gran. za oral. susp. 1 mg/ml, 100 ml boca | 10,9496 | 10,95 | RSRB13 | 5% |
| B01AF01 362 | | rivaroksaban | 20 mg | 1,7519 | O | Bayer AG | Bayer AG | Xarelto | gran. za oral. susp. 1 mg/ml, 250 ml boca | 21,8993 | 21,90 | RSRB13 | 5% |
| B01AF01 964 | | rivaroksaban | 20 mg | 2,6789 | O | Bayer AG | Bayer AG | Xarelto | film obl. tbl. 28x15 mg | 2,0091 | 56,26 | RSRB14 | 5% |
| B01AF01 965 | | rivaroksaban | 20 mg | 2,6789 | O | Bayer AG | Bayer AG | Xarelto | film obl.tbl. 42x15 mg | 2,0092 | 84,39 | RSRB14 | 5% |
| B01AF01 966 | | rivaroksaban | 20 mg | 2,0091 | O | Bayer AG | Bayer AG | Xarelto | film obl.tbl. 28x20 mg | 2,0091 | 56,26 | RSRB15 | 5% |
| B01AF02 161 | DS | apiksabanNB108 | 10 mg | 4,0183 | O | Bristol-Myers Squibb/Pfizer EEIG | Bristol-Myers Squibb S.r.l. | Eliquis | tbl. film obl. 20x2,5 mg | 1,0046 | 20,09 | | 5% |
| B01AX05 061 | DS | fondaparinuksNB109 | 2,5 mg | 4,3179 | P | Mylan IRE Healthcare Ltd | Aspen Notre Dame de Bondeville | Arixtra | otop. za inj., štrc. napunj. 10x2,5 mg/0,5 ml | 4,3179 | 43,18 | | 5% |
| B02AA01 052 | DS | aminokapronska kiselina | 16 g | | P | | | | | | | | 5% |
| B02AA02 051 | DS | traneksamična kiselinaNB201 | 2 g | | P | | | | | | | | 5% |
| B02AA02 061 | DS | traneksamatna kiselina | 2 g | 7,0354 | P | Makpharm d.o.o. | Bioindustria Lim SPA | Trenolk | amp. 5x5 ml (100 mg/ml) | 1,7588 | 8,79 | | 5% |
| B02AA02 151 | DS | traneksamična kiselinaNB201 | 2 g | | O | | | | | | | | 5% |
| B02AB01 051 | DS | aprotinin NB202 | 500 T i.j. | | P | | | | | | | | 5% |
| B02BA01 062 | PR | fitomenadion | 20 mg | 1,0299 | P | Cheplapharm Arzneimittel GmbH | Cheplapharm Arzneimittel GmbH | Konakion | amp. 5x10 mg/ml | 0,5150 | 2,57 | | 5% |
| B02BA01 151 | | fitomenadion | 20 mg | | O | | | | | | | R | 5% |
| B02BB01 071 | DS | fibrinogen | 5 g | 1.949,6981 | P | Jana Pharm d.o.o. | Octapharma Pharmazeutika Produktionsges.m.b.H., Octapharma AB | Fibryga | praš. i otap. za otop. za inj./inf., stak. boč. 1x1 g | 389,9396 | 389,94 | | 5% |
| B02BC30 962 | DS | ljudski fibrinogen, ljudski trombin | | | L | Corza Medical GmbH | Takeda | TachoSil | 1 matrica tkivnog ljepila 9,5 cm x 4,8 cm | 247,6847 | 247,68 | | 5% |
| B02BC30 963 | DS | ljudski fibrinogen, ljudski trombin | | | L | Corza Medical GmbH | Takeda | TachoSil | 1 matrica tkivnog ljepila 3,0 cm x 2,5 cm | 47,1989 | 47,20 | | 5% |
| B02BC30 964 | DS | ljudski fibrinogen, ljudski trombin | | | L | Corza Medical GmbH | Takeda Austria GmbH | TachoSil | 2 matrice tkivnog ljepila od 4,8 x 4,8 cm | 168,6164 | 337,23 | | 5% |
| B02BC30 965 | DS | ljudski fibrinogen, ljudski trombin | | | L | Corza Medical GmbH | Takeda Austria GmbH | TachoSil | 1 prethodno zarolana matrica tkivnog ljepila od 4,8 x 4,8 cm | 205,0236 | 205,02 | | 5% |
| B02BD01 071 | DS | ljudski protrombinski kompleksNB203 | | | P | Jana Pharm d.o.o. | Octapharma | Octaplex 500 IU | praš. i otap. za otop. za inf. boč. stakl. boč. s praš., boč. stakl. 1x500 i.j., s 20 ml otap. i 1 set za prijenos (igla za filtraciju i dvostrana igla) | 210,3365 | 210,34 | | 5% |
| B02BD01 081 | DS | ljudski protrombinski kompleksNB203 | | | P | CSL Behring GmbH | CSL Behring GmbH | Beriplex | praš. i otap. za otop. za inf. boč. stakl. boč. s praš., boč. stakl. 1x500 i.j., s 20 ml otap. i 1 set za prijenos s filterom | 219,1333 | 219,13 | | 5% |
| B02BD01 082 | DS | ljudski protrombinski kompleksNB203 | | | P | CSL Behring GmbH | CSL Behring GmbH | Beriplex | praš. i otap. za otop. za inf. boč. stakl. boč. s praš., boč. stakl. 1x1000 i.j., s 40 ml otap. i 1 set za prijenos s filterom | 442,4195 | 442,42 | | 5% |
| B02BD02 001 | DS | rekombinantni čimbenik VIIIFc (efmoroktokog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB | Elocta | praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. | 167,7643 | 167,76 | | 5% |
| B02BD02 002 | DS | rekombinantni čimbenik VIIIFc (efmoroktokog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB | Elocta | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 335,5299 | 335,53 | | 5% |
| B02BD02 003 | DS | rekombinantni čimbenik VIIIFc (efmoroktokog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB | Elocta | praš. i otap. za otop. za inj., boč. stakl. 1x750 i.j. | 503,2955 | 503,30 | | 5% |
| B02BD02 004 | DS | rekombinantni čimbenik VIIIFc (efmoroktokog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB | Elocta | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 671,0598 | 671,06 | | 5% |
| B02BD02 005 | DS | rekombinantni čimbenik VIIIFc (efmoroktokog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB | Elocta | praš. i otap. za otop. za inj., boč. stakl. 1x1500 i.j. | 1.006,5897 | 1.006,59 | | 5% |
| B02BD02 006 | DS | rekombinantni čimbenik VIIIFc (efmoroktokog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB | Elocta | praš. i otap. za otop. za inj., boč. stakl. 1x2000 i.j. | 1.342,1196 | 1.342,12 | | 5% |
| B02BD02 007 | DS | rekombinantni čimbenik VIIIFc (efmoroktokog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB | Elocta | praš. i otap. za otop. za inj., boč. stakl. 1x3000 i.j. | 2.013,1807 | 2.013,18 | | 5% |
| B02BD02 008 | DS | rekombinantni čimbenik VIII (lonoktokog alfa)NB205 | | | P | CSL Behring GmbH | CSL Behring GmbH | Afstyla | praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. | 153,6267 | 153,63 | | 5% |
| B02BD02 009 | DS | rekombinantni čimbenik VIII (lonoktokog alfa)NB205 | | | P | CSL Behring GmbH | CSL Behring GmbH | Afstyla | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 307,2533 | 307,25 | | 5% |
| B02BD02 010 | DS | rekombinantni čimbenik VIII (lonoktokog alfa)NB205 | | | P | CSL Behring GmbH | CSL Behring GmbH | Afstyla | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 614,5066 | 614,51 | | 5% |
| B02BD02 011 | DS | rekombinantni čimbenik VIII (damoktokog alfa pegol)NB207 | | | P | Bayer AG | Bayer AG | Jivi 500 IU | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 404,1410 | 404,14 | | 5% |
| B02BD02 012 | DS | rekombinantni čimbenik VIII (damoktokog alfa pegol)NB207 | | | P | Bayer AG | Bayer AG | Jivi 1000 IU | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 808,2819 | 808,28 | | 5% |
| B02BD02 013 | DS | rekombinantni čimbenik VIII (damoktokog alfa pegol)NB207 | | | P | Bayer AG | Bayer AG | Jivi 2000 IU | praš. i otap. za otop. za inj., boč. stakl. 1x2000 i.j. | 1.616,5638 | 1.616,56 | | 5% |
| B02BD02 014 | DS | rekombinantni čimbenik VIII (damoktokog alfa pegol)NB207 | | | P | Bayer AG | Bayer AG | Jivi 3000 IU | praš. i otap. za otop. za inj., boč. stakl. 1x3000 i.j. | 2.424,8457 | 2.424,85 | | 5% |
| B02BD02 021 | DS | rekombinantni čimbenik VIII (rurioktokog alfa pegol)NB207 | | | P | Baxalta Innovations GmbH | Baxalta Belgium Manufacturing SA | Adynovi | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 374,4376 | 374,44 | | 5% |
| B02BD02 022 | DS | rekombinantni čimbenik VIII (rurioktokog alfa pegol)NB207 | | | P | Baxalta Innovations GmbH | Baxalta Belgium Manufacturing SA | Adynovi | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 736,6726 | 736,67 | | 5% |
| B02BD02 023 | DS | rekombinantni čimbenik VIII (turoktokog alfa pegol)NB207 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | Esperoct | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 327,8253 | 327,83 | | 5% |
| B02BD02 024 | DS | rekombinantni čimbenik VIII (turoktokog alfa pegol)NB207 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | Esperoct | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 655,6507 | 655,65 | | 5% |
| B02BD02 025 | DS | rekombinantni čimbenik VIII (turoktokog alfa pegol)NB207 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | Esperoct | praš. i otap. za otop. za inj., boč. stakl. 1x3000 i.j. | 1.966,9520 | 1.966,95 | | 5% |
| B02BD02 031 | DS | rekombinantni čimbenik VIII (turoktokog alfa)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | NovoEight | praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. | 157,8857 | 157,89 | | 5% |
| B02BD02 033 | DS | rekombinantni čimbenik VIII (turoktokog alfa)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | NovoEight | praš. i otap. za otop. za inj., boč. stakl. 1x1.000 i.j. | 619,8806 | 619,88 | | 5% |
| B02BD02 034 | DS | rekombinantni čimbenik VIII (turoktokog alfa)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | NovoEight | praš. i otap. za otop. za inj., boč. stakl. 1x1.500 i.j. | 918,9422 | 918,94 | | 5% |
| B02BD02 035 | DS | rekombinantni čimbenik VIII (turoktokog alfa)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | NovoEight | praš. i otap. za otop. za inj., boč. stakl. 1x2.000 i.j. | 1.239,7611 | 1.239,76 | | 5% |
| B02BD02 036 | DS | rekombinantni čimbenik VIII (turoktokog alfa)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | NovoEight | praš. i otap. za otop. za inj., boč. stakl. 1x3.000 i.j. | 1.837,8844 | 1.837,88 | | 5% |
| B02BD02 061 | DS | čimbenik VIIINB204 | | | P | Kedrion S.p.A. | Kedrion S.p.A. | Emoclot | praš. i otap. za otop. za inf., boč. stakl. 1x500 i.j. (50 IU/ml) | 170,5329 | 170,53 | | 5% |
| B02BD02 062 | DS | čimbenik VIIINB204 | | | P | Kedrion S.p.A. | Kedrion S.p.A. | Emoclot | praš. i otap. za otop. za inf., boč. stakl. 1x1000 i.j. (100 IU/ml) | 315,0176 | 315,02 | | 5% |
| B02BD02 072 | DS | čimbenik VIIINB204 | | | P | Jana Pharm d.o.o. | Octapharma | Octanate | lio. boč. 500 i.j. | 189,4817 | 189,48 | | 5% |
| B02BD02 073 | DS | čimbenik VIIINB204 | | | P | Jana Pharm d.o.o. | Octapharma | Octanate | lio. boč. 1.000 i.j. | 350,0206 | 350,02 | | 5% |
| B02BD02 079 | DS | rekombinantni čimbenik VIII (oktokog alfa)NB205 | | | P | Takeda Manufacturing Austria AG | Baxalta Belgium Manufacturing SA | Advate | praš. i otap. za otop. za inj., boč. stakl. 1x500 IU/5 ml | 339,1758 | 339,18 | | 5% |
| B02BD02 080 | DS | rekombinantni čimbenik VIII (oktokog alfa)NB205 | | | P | Takeda Manufacturing Austria AG | Baxalta Belgium Manufacturing SA | Advate | praš. i otap. za otop. za inj., boč. stakl. 1x1.000 IU/5 ml | 678,8745 | 678,87 | | 5% |
| B02BD02 082 | DS | rekombinantni čimbenik VIII (moroktokog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | ReFacto AF | praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. | 161,1573 | 161,16 | | 5% |
| B02BD02 083 | DS | rekombinantni čimbenik VIII (moroktokog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | ReFacto AF | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 305,2585 | 305,26 | | 5% |
| B02BD02 084 | DS | rekombinantni čimbenik VIII (moroktokog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | ReFacto AF | praš. i otap. za otop. za inj., boč. stakl. 1x1.000 i.j. | 632,7255 | 632,73 | | 5% |
| B02BD02 085 | DS | rekombinantni čimbenik VIII (moroktokog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | ReFacto AF | praš. i otap. za otop. za inj., boč. stakl. 1x2.000 i.j. | 1.265,4509 | 1.265,45 | | 5% |
| B02BD02 086 | DS | rekombinantni čimbenik VIII (simoktokog alfa)NB205 | | | P | Octapharma AB | Octapharma AB | Nuwiq | praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. | 157,8857 | 157,89 | | 5% |
| B02BD02 087 | DS | rekombinantni čimbenik VIII (simoktokog alfa)NB205 | | | P | Octapharma AB | Octapharma AB | Nuwiq | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 299,0617 | 299,06 | | 5% |
| B02BD02 088 | DS | rekombinantni čimbenik VIII (simoktokog alfa)NB205 | | | P | Octapharma AB | Octapharma AB | Nuwiq | praš. i otap. za otop. za inj., boč. stakl. 1x1.000 i.j. | 619,8806 | 619,88 | | 5% |
| B02BD02 095 | DS | rekombinantni čimbenik VIII (oktokog alfa)NB205 | | | P | Bayer AG | Bayer AG | Kovaltry | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 335,5299 | 335,53 | | 5% |
| B02BD02 096 | DS | rekombinantni čimbenik VIII (oktokog alfa)NB205 | | | P | Bayer AG | Bayer AG | Kovaltry | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 671,0598 | 671,06 | | 5% |
| B02BD02 097 | DS | rekombinantni čimbenik VIII (oktokog alfa)NB205 | | | P | Bayer AG | Bayer AG | Kovaltry | praš. i otap. za otop. za inj., boč. stakl. 1x2000 i.j. | 1.342,1196 | 1.342,12 | | 5% |
| B02BD03 063 | DS | aktivirani koncentrat čimbenika protrombinskog kompleksaNB204 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Feiba 50 U/ml | praš. i otap. za otop. za inf., boč. 1x500 U/10 ml (50 U/ml) | 386,4039 | 386,40 | | 5% |
| B02BD04 063 | DS | čimbenik IX NB204 | | | P | Jana Pharm d.o.o. | Octapharma | Octanine F | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j.+5 ml otap.+set | 185,9831 | 185,98 | | 5% |
| B02BD04 072 | DS | čimbenik IX NB204 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Immunine 600 IU | praš. i otap. za otop. za inj./inf., boč. 1x600 IU/5 ml | 212,4892 | 212,49 | | 5% |
| B02BD04 074 | DS | rekombinantni čimbenik IXFc (eftrenonakog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Alprolix | praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. | 252,0074 | 252,01 | | 5% |
| B02BD04 075 | DS | rekombinantni čimbenik IXFc (eftrenonakog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Alprolix | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 504,0149 | 504,01 | | 5% |
| B02BD04 076 | DS | rekombinantni čimbenik IXFc (eftrenonakog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Alprolix | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 1.008,0297 | 1.008,03 | | 5% |
| B02BD04 077 | DS | rekombinantni čimbenik IXFc (eftrenonakog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Alprolix | praš. i otap. za otop. za inj., boč. stakl. 1x2000 i.j. | 2.016,0595 | 2.016,06 | | 5% |
| B02BD04 078 | DS | rekombinantni čimbenik IXFc (eftrenonakog alfa)NB205 | | | P | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Alprolix | praš. i otap. za otop. za inj., boč. stakl. 1x3000 i.j. | 3.024,0892 | 3.024,09 | | 5% |
| B02BD04 091 | DS | rekombinantni humani faktor IX (nonakog beta pegol)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | Refixia | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 629,7697 | 629,77 | | 5% |
| B02BD04 092 | DS | rekombinantni humani faktor IX (nonakog beta pegol)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | Refixia | praš. i otap. za otop. za inj., boč. stakl. 1x1000 i.j. | 1.259,5395 | 1.259,54 | | 5% |
| B02BD04 093 | DS | rekombinantni humani faktor IX (nonakog beta pegol)NB205 | | | P | Novo Nordisk A/S | Novo Nordisk A/S | Refixia | praš. i otap. za otop. za inj., boč. stakl. 1x2000 i.j. | 2.519,0789 | 2.519,08 | | 5% |
| B02BD04 095 | DS | rekombinantni čimbenik IX (nonakog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | BeneFIX | praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j. | 118,2812 | 118,28 | | 5% |
| B02BD04 096 | DS | rekombinantni čimbenik IX (nonakog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | BeneFIX | praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j. | 236,5625 | 236,56 | | 5% |
| B02BD04 097 | DS | rekombinantni čimbenik IX (nonakog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | BeneFIX | praš. i otap. za otop. za inj., boč. stakl. 1x1.000 i.j. | 473,1250 | 473,12 | | 5% |
| B02BD04 098 | DS | rekombinantni čimbenik IX (nonakog alfa)NB205 | | | P | Pfizer Europe MA EEIG | Wyeth Farma S.A. | BeneFIX | praš. i otap. za otop. za inj., boč. stakl. 1x2.000 i.j. | 946,2499 | 946,25 | | 5% |
| B02BD06 075 | DS | koagulacijski faktor VIII, ljudski, von Willebrandov faktor, ljudskiNB206 | | | P | Jana Pharm d.o.o. | Octapharma | Wilate 500, 500 IU FVIII i 500 IU vWF | praš. i otap. za otop. za inj., boč. 1x500 IU i 500 IU | 267,3674 | 267,37 | | 5% |
| B02BD06 076 | DS | konc. čimbenik VIII s von Willebrandovim čimbenikomNB204 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Immunate 500 IU FVIII/375 IU vWF | praš. i otap. za otop. za inj., boč. 1x500 IU FVIII/375 IU vWF/5 ml | 194,8676 | 194,87 | | 5% |
| B02BD06 077 | DS | koagulacijski faktor VIII, ljudski, von Willebrandov faktor, ljudskiNB206 | | | P | CSL Behring GmbH | CSL Behring GmbH | Haemate P 1200 IU VWF/500 IU FVIII | praš. i otap. za otop. za inj., boč. 1x1.200 IU vWF/500 IU FVIII | 241,8648 | 241,86 | | 5% |
| B02BD07 051 | DS | čimbenik ugrušavanja krvi XIIINB204 | | | P | | | | | | | | 5% |
| B02BD08 084 | DS | aktivirani rekombinantni čimbenik VII A NB204 | | | P | Novo Nordisk A/S | Novo Nordisk | NovoSeven | praš. i otap. za otop. za inj., 1x1 mg (50 KIU) | 591,2430 | 591,24 | | 5% |
| B02BD08 088 | DS | aktivirani rekombinantni čimbenik VII A NB204 | | | P | Novo Nordisk A/S | Novo Nordisk | NovoSeven | praš. i otap. za otop. za inj., 1x2 mg (100 KIU) | 1.171,4500 | 1.171,45 | | 5% |
| B02BD08 089 | DS | aktivirani rekombinantni čimbenik VII A NB204 | | | P | Novo Nordisk A/S | Novo Nordisk | NovoSeven | praš. i otap. za otop. za inj., 1x5 mg (250 KIU) | 2.910,7665 | 2.910,77 | | 5% |
| B02BX04 063 | KS | romiplostimNB504 | 30 mcg | 65,6028 | P | Amgen Europe B.V. | Amgen Europe B.V. | Nplate | praš. i otap. za otop. za inj., štrc. napunj. 1x250 mcg | 546,6879 | 546,69 | | 5% |
| B02BX04 064 | KS | romiplostimNB504 | 30 mcg | 66,0358 | P | Amgen Europe B.V. | Amgen Europe B.V. | Nplate | praš. i otap. za otop. za inj., štrc. napunj. 1x500 mcg | 1.100,5986 | 1.100,60 | | 5% |
| B02BX05 161 | KS | eltrombopagNB504 | 50 mg | 64,3474 | O | Novartis Europharm Limited Irska | Lek d.d., Novartis Pharma GmbH | Revolade | tbl. film obl. 28x25 mg | 32,1737 | 900,86 | | 5% |
| B02BX05 162 | KS | eltrombopagNB504 | 50 mg | 64,3475 | O | Novartis Europharm Limited Irska | Lek d.d., Novartis Pharma GmbH | Revolade | tbl. film obl. 28x50 mg | 64,3475 | 1.801,73 | | 5% |
| B02BX06 071 | DS | emicizumabNB507 | 15 mg | 1.069,1413 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x1 ml (30 mg/ml) | 2.138,2826 | 2.138,28 | | 5% |
| B02BX06 072 | DS | emicizumabNB507 | 15 mg | 1.065,2120 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x0,4 ml (150 mg/ml) | 4.260,8481 | 4.260,85 | | 5% |
| B02BX06 073 | DS | emicizumabNB507 | 15 mg | 1.063,1228 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x0,7 ml (150 mg/ml) | 7.441,8595 | 7.441,86 | | 5% |
| B02BX06 074 | DS | emicizumabNB507 | 15 mg | 1.062,2877 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x1 ml (150 mg/ml) | 10.622,8774 | 10.622,88 | | 5% |
| B02BX06 971 | DS | emicizumabNB510 | 15 mg | 1.069,1413 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x1 ml (30 mg/ml) | 2.138,2826 | 2.138,28 | | 5% |
| B02BX06 972 | DS | emicizumabNB510 | 15 mg | 1.065,2120 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x0,4 ml (150 mg/ml) | 4.260,8481 | 4.260,85 | | 5% |
| B02BX06 973 | DS | emicizumabNB510 | 15 mg | 1.063,1228 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x0,7 ml (150 mg/ml) | 7.441,8595 | 7.441,86 | | 5% |
| B02BX06 974 | DS | emicizumabNB510 | 15 mg | 1.062,2877 | P | Roche Registration GmbH | Roche Austria GmbH | Hemlibra | otop. za inj., boč. stakl. 1x1 ml (150 mg/ml) | 10.622,8774 | 10.622,88 | | 5% |
| B02BX08 171 | KS | avatrombopagNB504 | 20 mg | 64,3480 | O | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Doptelet | tbl. film obl. 10x20 mg | 64,3480 | 643,48 | | 5% |
| B02BX08 172 | KS | avatrombopagNB504 | 20 mg | 64,3480 | O | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Doptelet | tbl. film obl. 15x20 mg | 64,3480 | 965,22 | | 5% |
| B02BX08 173 | KS | avatrombopagNB504 | 20 mg | 64,3480 | O | Swedish Orphan Biovitrum AB (publ) | Swedish Orphan Biovitrum AB (publ) | Doptelet | tbl. film obl. 30x20 mg | 64,3480 | 1.930,44 | | 5% |
| B03AA02 141 | | željezo II -fumarat | 0,2 g | 0,0653 | O | Alkaloid d.o.o. | Alkaloid | Heferol | caps. 30x350 mg | 0,1142 | 3,43 | R | 5% |
| B03AC01 021 | DS | željezo karboksimaltoza | 100 mg | 19,7813 | P | Vifor France S.A. | Vifor France S.A. | Ferinject | otop. za inj. ili inf. , boč. 1x10 ml (50 mg/ml) | 98,9064 | 98,91 | | 5% |
| B03AC01 022 | DS | željezo karboksimaltoza | 100 mg | 18,7921 | P | Vifor France S.A. | Vifor France S.A. | Ferinject | otop. za inj. ili inf. , boč. 1x20 ml (50 mg/ml) | 187,9209 | 187,92 | | 5% |
| B03AC02 051 | DS | željezo III-oksid saharat | 100 mg | 5,8876 | P | | | | 1x100 mg | 5,8876 | | | 5% |
| B03AC05 051 | PO | željezo III-sorbitol glukonska kiselina | | | P | | | | | | | | 5% |
| B03AC06 062 | DS | željezova(III) derizomaltoza | 100 mg | 19,7813 | P | Pharmacosmos A/S | Pharmacosmos A/S | Monofer | otop. za inj./inf., amp./boč. 5x5 ml (100 mg/ml) | 98,9064 | 494,53 | | 5% |
| B03BA01 051 | PR | cijanokobalamin | 20 mcg | | P | | | | | | | | 5% |
| B03BB01 161 | | folatna kiselina | 10 mg | 0,2166 | O | Makpharm d.o.o. | G.L. Pharma GmbH | Folbella | tbl. 30x5 mg | 0,1083 | 3,25 | R | 5% |
| B03XA01 001 | DSPO | eritropoetin thetaNB301 | 1 T i.j. | 5,0231 | P | ratiopharm GmbH | Pliva Hrvatska d.o.o | Eporatio | otop. za inj., štrc. napunj. 6x2.000 i.j./0,5 ml | 10,0462 | 60,28 | | 5% |
| B03XA01 002 | DSPO | eritropoetin thetaNB301 | 1 T i.j. | 5,0194 | P | ratiopharm GmbH | Pliva Hrvatska d.o.o | Eporatio | otop. za inj., štrc. napunj. 6x3.000 i.j./0,5 ml | 15,0583 | 90,35 | | 5% |
| B03XA01 003 | DSPO | eritropoetin thetaNB301 | 1 T i.j. | 4,9787 | P | ratiopharm GmbH | Pliva Hrvatska d.o.o | Eporatio | otop. za inj. štrc. napunj. 6x4.000 i.j./0,5 ml | 19,9146 | 119,49 | | 5% |
| B03XA01 004 | DSPO | eritropoetin thetaNB301 | 1 T i.j. | 4,6439 | P | ratiopharm GmbH | Pliva Hrvatska d.o.o | Eporatio | otop. za inj., štrc. napunj. 6x10.000 i.j./ml | 46,4388 | 278,63 | | 5% |
| B03XA01 005 | DSPO | eritropoetin thetaNB301 | 1 T i.j. | 4,6152 | P | ratiopharm GmbH | Pliva Hrvatska d.o.o | Eporatio | otop. za inj., štrc. napunj. 1x20.000 i.j./ml | 92,3034 | 92,30 | | 5% |
| B03XA01 021 | DSPO | epoetin alfaNB301 | 1 T i.j. | 4,5208 | P | Sandoz GmbH | Sandoz | Binocrit | otop. za inj., štrc. napunj. 6x2.000 i.j/ml | 9,0415 | 54,25 | | 5% |
| B03XA01 023 | DSPO | epoetin alfaNB301 | 1 T i.j. | 4,4808 | P | Sandoz GmbH | Sandoz | Binocrit | otop. za inj., štrc. napunj. 6x4.000 i.j/0,4 ml | 17,9231 | 107,54 | | 5% |
| B03XA01 075 | DSPO | epoetin betaNB301 | 1 T i.j. | 4,5418 | P | Roche Registration GmbH | Roche | NeoRecormon | šprica 6x2.000 i.j/0,3 ml | 9,0836 | 54,50 | | 5% |
| B03XA01 077 | DSPO | epoetin betaNB301 | 1 T i.j. | 4,4137 | P | Roche Registration GmbH | Roche | NeoRecormon | šprica 6x4.000 i.j/0,3 ml | 17,6548 | 105,93 | | 5% |
| B03XA01 078 | DSPO | epoetin betaNB301 | 1 T i.j. | 4,3430 | P | Roche Registration GmbH | Roche | NeoRecormon | šprica 6x10.000 i.j/0,6 ml | 43,4300 | 260,58 | | 5% |
| B03XA01 081 | DSPO | eritropoetin zetaNB301 | 1 T i.j. | 5,0231 | P | Pfizer Europe MA EEIG | STADA Arzneimittel AG, Hospira Enterprises B.V. | Retacrit | otop. za inj., štrc. napunj. 6x2.000 i.j/0,6 ml | 10,0462 | 60,28 | | 5% |
| B03XA01 082 | DSPO | eritropoetin zetaNB301 | 1 T i.j. | 4,9787 | P | Pfizer Europe MA EEIG | STADA Arzneimittel AG, Hospira Enterprises B.V. | Retacrit | otop. za inj., štrc. napunj. 6x4.000 i.j/0,4 ml | 19,9146 | 119,49 | | 5% |
| B03XA01 083 | DSPO | eritropoetin zetaNB301 | 1 T i.j. | 4,4448 | P | Pfizer Europe MA EEIG | STADA Arzneimittel AG, Hospira Enterprises B.V. | Retacrit | otop. za inj., štrc. napunj. 6x10.000 i.j/ml | 44,4480 | 266,69 | | 5% |
| B03XA02 061 | DSPO | darbepoetin alfaNB301 | 4,5 mcg | 7,0315 | P | Amgen Europe B.V. | Amgen Europe B.V. | Aranesp | otop. za inj., štrc. stakl. 1x10 mcg/0,4 ml (25 mcg/ml) | 15,6255 | 15,63 | | 5% |
| B03XA02 062 | DSPO | darbepoetin alfaNB301 | 4,5 mcg | 6,8544 | P | Amgen Europe B.V. | Amgen Europe B.V. | Aranesp | otop. za inj., štrc. stakl. 1x30 mcg/0,3ml (100 mcg/ml) | 45,6965 | 45,70 | | 5% |
| B03XA02 063 | DSPO | darbepoetin alfaNB301 | 4,5 mcg | 7,6624 | P | Amgen Europe B.V. | Amgen Europe B.V. | Aranesp | otop. za inj., štrc. stakl. 1x20 mcg/0,5 ml (40 mcg/ml) | 30,6497 | 30,65 | | 5% |
| B03XA02 064 | DSPO | darbepoetin alfaNB301 | 4,5 mcg | 6,8959 | P | Amgen Europe B.V. | Amgen Europe B.V. | Aranesp | otop. za inj., štrc. stakl. 1x40 mcg/0,4 ml (100 mcg/ml) | 61,2967 | 61,30 | | 5% |
| B03XA02 065 | DSPO | darbepoetin alfaNB301 | 4,5 mcg | 6,8959 | P | Amgen Europe B.V. | Amgen Europe B.V. | Aranesp | otop. za inj., štrc. stakl. 1x50 mcg/0,5 ml (100 mcg/ml) | 76,6209 | 76,62 | | 5% |
| B03XA02 066 | DSPO | darbepoetin alfaNB301 | 4,5 mcg | 6,8959 | P | Amgen Europe B.V. | Amgen Europe B.V. | Aranesp | otop. za inj., štrc. stakl. 1x60 mcg/0,3 ml (200 mcg/ml) | 91,9451 | 91,95 | | 5% |
| B03XA02 067 | DSPO | darbepoetin alfaNB301 | 4,5 mcg | 6,8959 | P | Amgen Europe B.V. | Amgen Europe B.V. | Aranesp | otop. za inj., štrc. stakl. 1x80 mcg/0,4 ml (200 mcg/ml) | 122,5934 | 122,59 | | 5% |
| B03XA03 062 | DSPO | metoksi polietilenglikol-epoetin betaNB301 | 4 mcg | 6,1667 | P | Roche Registration GmbH | Roche | Mircera | otop. za inj., štrc. napunj. 1x50 mcg/0,3 ml | 77,0841 | 77,08 | | 5% |
| B03XA03 063 | DSPO | metoksi polietilenglikol-epoetin betaNB301 | 4 mcg | 6,0464 | P | Roche Registration GmbH | Roche | Mircera | otop. za inj., štrc. napunj. 1x75 mcg/0,3 ml | 113,3705 | 113,37 | | 5% |
| B03XA03 064 | DSPO | metoksi polietilenglikol-epoetin betaNB301 | 4 mcg | 6,0464 | P | Roche Registration GmbH | Roche | Mircera | otop. za inj., štrc. napunj. 1x100 mcg/0,3ml | 151,1593 | 151,16 | | 5% |
| B03XA03 065 | DSPO | metoksi polietilenglikol-epoetin betaNB301 | 4 mcg | 6,0464 | P | Roche Registration GmbH | Roche | Mircera | otop. za inj., štrc. napunj. 1x120 mcg/0,3ml | 181,3909 | 181,39 | | 5% |
| B03XA03 066 | DSPO | metoksi polietilenglikol-epoetin betaNB301 | 4 mcg | 6,0464 | P | Roche Registration GmbH | Roche | Mircera | otop. za inj., štrc. napunj. 1x150 mcg/0,3ml | 226,7383 | 226,74 | | 5% |
| B03XA03 067 | DSPO | metoksi polietilenglikol-epoetin betaNB301 | 4 mcg | 6,0464 | P | Roche Registration GmbH | Roche | Mircera | otop. za inj. štrc. napunj. 1x200 mcg/0,3ml | 302,3187 | 302,32 | | 5% |
| B05AA01 011 | DS | ljudski albumin 5%NB501 | | | P | Imunološki zavod | Imunološki zavod | Albumin ljudski 50 g/l | otop. za inf., boca stakl. 1x250 ml | 34,2425 | 34,24 | | 5% |
| B05AA01 012 | DS | ljudski albumin 20%NB502 | | | P | Imunološki zavod | Imunološki zavod | Albumin (ljudski) 20% | otop. za inf., boca stakl. 1x50 ml | 26,6468 | 26,65 | | 5% |
| B05AA01 013 | DS | ljudski albumin 20%NB502 | | | P | Imunološki zavod | Imunološki zavod | Albumin (ljudski) 20% | otop. za inf., boca stakl. 1x100 ml | 54,2292 | 54,23 | | 5% |
| B05AA01 064 | DS | ljudski albumin 20%NB502 | | | P | Jana Pharm d.o.o. | Octapharma | Albunorm 20% (non HR) | otop. za inf., boč. stakl. 1x100 ml | 54,2292 | 54,23 | | 5% |
| B05AA01 065 | DS | ljudski albumin 5%NB501 | | | P | Jana Pharm d.o.o. | Octapharma Pharmazeutika Octapharma S.A.S., Octapharma AB, Octapharma Produktionsgesellschaft, Octapharma GmbH | Albunorm 5% | otop. za inf., boca stakl. 1x250 ml | 34,2425 | 34,24 | | 5% |
| B05AA01 066 | DS | ljudski albumin 20%NB502 | | | P | Jana Pharm d.o.o. | Octapharma | Albunorm 20% | otop. za inf., boca stakl. 1x50 ml | 26,6468 | 26,65 | | 5% |
| B05AA01 067 | DS | ljudski albumin 5%NB501 | | | P | Jana Pharm d.o.o. | Octapharma Pharmazeutika Octapharma S.A.S., Octapharma AB, Octapharma Produktionsgesellschaft, Octapharma GmbH | Albunorm 5% | otop. za inf., boca stakl. 1x100 ml | 16,2386 | 16,24 | | 5% |
| B05AA01 075 | DS | ljudski albumin 20%NB502 | | | P | Kedrion S.p.A. | Kedrion S.p.A. | Human albumin Kedrion | otop. za inf., stakl. boč. 1x50 ml (200 g/l) | 26,6468 | 26,65 | | 5% |
| B05AA01 076 | DS | ljudski albumin 20%NB502 | | | P | Kedrion S.p.A. | Kedrion S.p.A. | Human albumin Kedrion | otop. za inf., stakl. boč. 1x100 ml (200 g/l) | 54,2292 | 54,23 | | 5% |
| B05AA01 081 | DS | ljudski albumin 20%NB502 | | | P | CSL Behring GmbH | CSL Behring GmbH | Albumeon 200 g/l | boč. 1x50 ml | 26,6468 | 26,65 | | 5% |
| B05AA01 083 | DS | ljudski albumin 20%NB502 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Flexbumin | otop. za inf. (200 g/l), vreć. 1x50 ml/kutija | 26,6468 | 26,65 | | 5% |
| B05AA01 084 | DS | ljudski albumin 20%NB502 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Flexbumin | otop. za inf. (200 g/l), vreć. 12x50 ml/kutija, 2 kutije | 26,6468 | 639,52 | | 5% |
| B05AA01 085 | DS | ljudski albumin 20%NB502 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Flexbumin | otop. za inf. (200 g/l), vreć. 1x50 ml/kutija, 24 kutije | 26,6468 | 639,52 | | 5% |
| B05AA01 086 | DS | ljudski albumin 20%NB502 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Flexbumin | otop. za inf. (200 g/l), vreć. 1x100 ml/kutija | 54,2292 | 54,23 | | 5% |
| B05AA01 087 | DS | ljudski albumin 20%NB502 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Flexbumin | otop. za inf. (200 g/l), vreć. 6x100 ml/kutija, 2 kutije | 54,2292 | 650,75 | | 5% |
| B05AA01 088 | DS | ljudski albumin 20%NB502 | | | P | Baxalta Innovations GmbH | Takeda Manufacturing Austria AG | Flexbumin | otop. za inf. (200 g/l), vreć. 1x100 ml/kutija, 12 kutija | 54,2292 | 650,75 | | 5% |
| B05AA01 089 | DS | ljudski albumin 20%NB502 | | | P | CSL Behring GmbH | CSL Behring GmbH | Albumeon 200 g/l | boč. 1x100 ml | 51,5177 | 51,52 | | 5% |
| B05AA01 964 | DS | ljudski albumin 20%NB502 | | | P | Jana Pharm d.o.o. | Octapharma | Albunorm 20% (HR) | otop. za inf., boč. stakl. 1x100 ml | 43,3831 | 43,38 | | 5% |
| B05AA02 061 | DS | proteini ljudske plazmeNV701 | | | P | Octapharma (IP) SPRL | Octapharma Pharmazeutika Produktionsges.m.b.H., Octapharma AB | octaplasLG | otop. za inf., vreć. 1x200 ml (45-70 mg/ml) | 86,0004 | 86,00 | | 5% |
| B05AA05 002 | PR | dekstran 40 | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Soludeks 40 | otop. za inf., boca stakl. 10x500 ml (100 mg/ml) | 5,6606 | 56,61 | | 5% |
| B05AA06 051 | DS | želatina | | | P | | | | | | | | 5% |
| B05AA07 063 | DS | hidroksietil škrob | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Voluven 6% | boca 10x500 ml | 6,5578 | 65,58 | | 5% |
| B05AA07 064 | DS | hidroksietil škrob | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Voluven 6% | vreć. plast. 20x500 ml | 6,5578 | 131,16 | | 5% |
| B05AA07 081 | DS | hidroksietil škrob (poli-o-2-hidroksietil škrob) | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Volulyte 6% | otop. za inf., vreć. poliolef. 20x500 ml | 5,3118 | 106,24 | | 5% |
| B05BA01 081 | DS | infuzije aminokiselina (N (2)-L-alanin-L-glutamin) | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Dipeptiven | boč. 10x100 ml | 31,0486 | 310,49 | | 5% |
| B05BA01 091 | DS | infuzije aminokiselina | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Nephrotect 10% | boč. 10x500 ml | 14,7123 | 147,12 | | 5% |
| B05BA02 065 | DS | otopine masti i masnih kiselina | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SMOFlipid 20% emulzija za infuziju | boca stakl. 10x100 ml | 4,6772 | 46,77 | | 5% |
| B05BA02 066 | DS | otopine masti i masnih kiselina | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SMOFlipid 20% emulzija za infuziju | boca stakl. 10x500 ml | 12,4454 | 124,45 | | 5% |
| B05BA03 008 | PO | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza HZTM 5% otopina za infuziju | otop. za inf., boca stakl. 10x500 ml (50 mg/ml) | 0,9092 | 9,09 | | 5% |
| B05BA03 010 | PO | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza HZTM 10% otopina za infuziju | otop. za inf., boca stakl. 10x500 ml (100 mg/ml) | 1,1759 | 11,76 | | 5% |
| B05BA03 012 | DS | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza HZTM 10% otopina za infuziju | otop. za inf., boca stakl. 10x250 ml (100 mg/ml) | 1,0074 | 10,07 | | 5% |
| B05BA03 021 | PO | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza 5% | otop. za inf., boca stakl. 10x500 ml (50 mg/ml) | 0,9092 | 9,09 | | 5% |
| B05BA03 022 | PR | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza HZTM 5% otopina za infuziju | otop. za inf., boca stakl. 10x250 ml (50 mg/ml) | 0,8229 | 8,23 | | 5% |
| B05BA03 023 | DS | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza HZTM 5% otopina za infuziju | otop. za inf., boč. stakl. 20x100 ml (50 mg/ml) | 0,7778 | 15,56 | | 5% |
| B05BA03 024 | PO | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza 10% | otop. za inf., boca stakl. 10x500 ml (100 mg/ml) | 1,1759 | 11,76 | | 5% |
| B05BA03 026 | DS | glukoza | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukoza HZTM 10% otopina za infuziju | otop. za inf., boč. stakl. 20x100 ml (100 mg/ml) | 0,8587 | 17,17 | | 5% |
| B05BA03 061 | DS | glukoza | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Glukoza 5% Viaflo | otop. za inf.,vreć. plast. 50x100 ml (50mg/ml) | 0,8667 | 43,33 | | 5% |
| B05BA03 062 | PR | glukoza | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Glukoza 5% Viaflo | otop. za inf., vreć. plast. 30x250 ml (50mg/ml) | 0,9198 | 27,59 | | 5% |
| B05BA03 063 | PO | glukoza | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Glukoza 5% Viaflo | otop. za inf., vreć. plast. 20x500 ml (50mg/ml) | 1,0153 | 20,31 | | 5% |
| B05BA03 067 | DS | glukoza | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Glukoza 5% Viaflo | otop. za inf., vreć. plast. 60x100 ml (50mg/ml) | 0,7406 | 44,44 | | 5% |
| B05BA03 071 | DS | glukoza | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Glukoza B. Braun 50 mg/ml | otop. za inf., 50 mg/ml, polietil. Ecoflac plus boca, 20x100 ml | 0,7800 | 15,60 | | 5% |
| B05BA03 072 | PR | glukoza | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Glukoza B. Braun 50 mg/ml | otop. za inf., 50 mg/ml, polietil. Ecoflac plus boca, 10x250 ml | 0,8278 | 8,28 | | 5% |
| B05BA03 073 | PO | glukoza | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Glukoza B. Braun 50 mg/ml | otop. za inf., 50 mg/ml, polietil. Ecoflac plus boca, 10x500 ml | 0,9138 | 9,14 | | 5% |
| B05BA03 074 | DS | glukoza | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Glukoza B. Braun 50 mg/ml | otop. za inf., 50 mg/ml, polietil. Ecoflac plus boca, 10x1000 ml | 1,5817 | 15,82 | | 5% |
| B05BA03 075 | PO | glukoza | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Glukoza B. Braun 100 mg/ml | otop. za inf., 100 mg/ml, polietil. Ecoflac plus boca, 10x500 ml | 1,1799 | 11,80 | | 5% |
| B05BA03 076 | DS | glukoza | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Glukoza B. Braun 100 mg/ml | otop. za inf., 100 mg/ml, polietil. Ecoflac plus boca, 10x1000 ml | 1,6362 | 16,36 | | 5% |
| B05BA03 077 | DS | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., boca plast. 40x100 ml | 0,7021 | 28,08 | | 5% |
| B05BA03 078 | PO | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 10% | otop. za inf., boca plast. 10x500 ml | 1,0618 | 10,62 | | 5% |
| B05BA03 079 | PR | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., boca plast. 20x250 ml | 0,7454 | 14,91 | | 5% |
| B05BA03 080 | PO | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., boca plast. 10x500 ml | 0,8225 | 8,22 | | 5% |
| B05BA03 081 | DS | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., vreć. plast. 60x50 ml | 0,7036 | 42,21 | | 5% |
| B05BA03 084 | PO | glukoza | | | P | Baxter d.o.o. | Bieffe Medital S.A. | Glukoza 10% Viaflo | otop. za inf., vreć. plast. 20x500 ml, (100 mg/ml) | 0,9556 | 19,11 | | 5% |
| B05BA03 086 | DS | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., vreć. plast. 50x100 ml | 0,7800 | 39,00 | | 5% |
| B05BA03 087 | PR | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., vreć. plast. 30x250 ml | 0,8278 | 24,83 | | 5% |
| B05BA03 088 | PO | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., vreć. plast. 20x500 ml | 0,9138 | 18,28 | | 5% |
| B05BA03 089 | DS | glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Glukoza Fresenius Kabi 5% | otop. za inf., vreć. plast. 10x1000 ml | 1,7363 | 17,36 | | 5% |
| B05BA10 025 | DS | otopina aminokiselina s elektrolitima + otopina glukoze + lipidna emulzija | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi AB | SmofKabiven Nutribase | vreć. plast. 4x1026 ml | 25,5000 | 102,00 | | 5% |
| B05BA10 026 | DS | otopina aminokiselina s elektrolitima + otopina glukoze + lipidna emulzija | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi AB | SmofKabiven Nutribase | vreć. plast. 4x1539 ml | 32,1242 | 128,50 | | 5% |
| B05BA10 031 | DS | glukoza + otopina aminokiselina s elektrolitima + masna emulzija | | | P | B. Braun Melsungen AG | B. Braun Melsungen AG | Nutriflex Omega peri | emulzija za infuziju, vreć. 5x1250 ml | 27,3807 | 136,90 | | 5% |
| B05BA10 032 | DS | glukoza + otopina aminokiselina s elektrolitima + masna emulzija | | | P | B. Braun Melsungen AG | B. Braun Melsungen AG | Nutriflex Omega peri | emulzija za infuziju, vreć. 5x1875 ml | 34,4827 | 172,41 | | 5% |
| B05BA10 033 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | B. Braun Melsungen AG | B. Braun Melsungen AG | Nutriflex Omega 56/144 specijal | emulzija za infuziju, vreć. 5x625 ml | 15,6600 | 78,30 | | 5% |
| B05BA10 034 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | B. Braun Melsungen AG | B. Braun Melsungen AG | Nutriflex Omega 38/120 plus | emulzija za infuziju, vreć. 5x1250 ml | 23,2026 | 116,01 | | 5% |
| B05BA10 047 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | B. Braun Melsungen AG | B. Braun Melsungen AG | Nutriflex Omega 56/144 specijal | emulzija za infuziju, vreć. 5x1250 ml | 27,0595 | 135,30 | | 5% |
| B05BA10 048 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | B. Braun Melsungen AG | B. Braun Melsungen AG | Nutriflex Omega 56/144 specijal | emulzija za infuziju, vreć. 5x1875 ml | 36,9208 | 184,60 | | 5% |
| B05BA10 049 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | B. Braun Melsungen AG | B. Braun Melsungen AG | Nutriflex Omega 38/120 plus | emulzija za infuziju, vreć. 5x1875 ml | 31,6836 | 158,42 | | 5% |
| B05BA10 060 | DS | glukoza + otopina aminokiselina + emulzija lipidaNB400 | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi AB | SmofKabiven extra Nitrogen bez elektrolita | emulz. za inf., vreć. 4x2025 ml | 80,7393 | 322,96 | | 5% |
| B05BA10 061 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Baxter d.o.o. | Baxter S.A. | OliClinomel N4-550E | emulz. za inf., vreć. plast. 6x1000 ml | 21,3890 | 128,33 | | 5% |
| B05BA10 062 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Baxter d.o.o. | Baxter S.A. | OliClinomel N4-550E | emulz. za inf., vreć. plast. 4x2000 ml | 29,1227 | 116,49 | | 5% |
| B05BA10 064 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Baxter d.o.o. | Baxter S.A. | OliClinomel N7-1000E | emulz. za inf., vreć. plast. 6x1000 ml | 22,4660 | 134,80 | | 5% |
| B05BA10 065 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Baxter d.o.o. | Baxter S.A. | OliClinomel N7-1000E | emulz. za inf., vreć. plast. 4x2000 ml | 33,6482 | 134,59 | | 5% |
| B05BA10 066 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Kabiven | vreć. plast. 4x1026 ml | 22,2765 | 89,11 | | 5% |
| B05BA10 067 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Kabiven | vreć. plast. 4x1540 ml | 24,6569 | 98,63 | | 5% |
| B05BA10 068 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Kabiven Peripheral | vreć. plast. 4x1440 ml | 24,4303 | 97,72 | | 5% |
| B05BA10 069 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Kabiven Peripheral | vreć. plast. 4x1920 ml | 25,8650 | 103,46 | | 5% |
| B05BA10 070 | DS | glukoza + otopina aminokiselina s elektrolitima + emulzija lipidaNB400 | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi AB | SmofKabiven extra Nitrogen | emulz. za inf., vreć. 4x1518 ml | 65,4111 | 261,64 | | 5% |
| B05BA10 075 | DS | infuzije aminokiselina | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Aminoven Infant 10% | boč. 10x250 ml | 7,3728 | 73,73 | | 5% |
| B05BA10 076 | DS | infuzije aminokiselina | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Aminosteril N hepa 8% | boca 10x500 ml | 9,2587 | 92,59 | | 5% |
| B05BA10 079 | DS | infuzije aminokiselina | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Aminoven 10% | boca 10x500 ml | 7,4789 | 74,79 | | 5% |
| B05BA10 080 | DS | glukoza + otopina aminokiselina s elektrolitima + emulzija lipidaNB400 | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi AB | SmofKabiven extra Nitrogen | emulz. za inf., vreć. 4x2025 ml | 88,8314 | 355,33 | | 5% |
| B05BA10 084 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Baxter d.o.o. | Baxter S.A. | Periolimel N4E | emulz. za inf., vreć. plast. 6x1000 ml | 37,8260 | 226,96 | | 5% |
| B05BA10 085 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Baxter d.o.o. | Baxter S.A. | Periolimel N4E | emulz. za inf., vreć. plast. 4x2000 ml | 48,7504 | 195,00 | | 5% |
| B05BA10 086 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Baxter d.o.o. | Baxter S.A. | Olimel N7E | emulz. za inf., vreć. plast. 4x2000 ml | 50,4347 | 201,74 | | 5% |
| B05BA10 087 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Baxter d.o.o. | Baxter S.A. | Olimel N9E | emulz. za inf., vreć. plast. 6x1000 ml | 43,8680 | 263,21 | | 5% |
| B05BA10 088 | DS | emulzija lipida + aminokiselina + glukoza + kalcij- klorid | | | P | Baxter d.o.o. | Baxter S.A. | Olimel N9E | emulz. za inf., vreć. plast. 4x2000 ml | 54,6420 | 218,57 | | 5% |
| B05BA10 089 | DS | glukoza + otopina aminokiselina s elektrolitima + emulzija lipida | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi AB | SmofKabiven Low Osmo Peripheral | emulz. za inf., vreć. 4x1400 ml | 52,9564 | 211,83 | | 5% |
| B05BA10 090 | DS | glukoza + otopina aminokiselina + emulzija lipidaNB400 | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi AB | SmofKabiven extra Nitrogen bez elektrolita | emulz. za inf., vreć. 4x1518 ml | 64,7687 | 259,07 | | 5% |
| B05BA10 092 | DS | glukoza + otopina aminokiselina s elektrolitima + masna emulzija | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven Peripheral | emulzija za infuziju, vreć. 4x1206 ml | 28,0510 | 112,20 | | 5% |
| B05BA10 093 | DS | glukoza + otopina aminokiselina s elektrolitima + masna emulzija | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven Peripheral | emulzija za infuziju, vreć. 4x1448 ml | 30,1798 | 120,72 | | 5% |
| B05BA10 094 | DS | glukoza + otopina aminokiselina s elektrolitima + masna emulzija | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven Peripheral | emulzija za infuziju, vreć. 4x1904 ml | 32,8834 | 131,53 | | 5% |
| B05BA10 095 | DS | emulzija lipida + aminokiselina + glukoza | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven bez elektrolita | emulz. za inf., plast. vreć. (Excel) 4x986 ml | 24,5059 | 98,02 | | 5% |
| B05BA10 096 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven | emulz. za inf., plast. vreć. (Excel) 4x986 ml | 24,5059 | 98,02 | | 5% |
| B05BA10 097 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven | emulz. za inf., plast. vreć. (Excel) 4x1477 ml | 30,8979 | 123,59 | | 5% |
| B05BA10 098 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven | emulz. za inf., plast. vreć. (Excel) 4x1970 ml | 38,6184 | 154,47 | | 5% |
| B05BA10 099 | DS | emulzija lipida + aminokiselina + glukoza + kalcij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | SmofKabiven | emulz. za inf., plast. vreć. (Excel) 3x2463 ml | 44,8815 | 134,64 | | 5% |
| B05BB01 014 | PO | natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrijev klorid HZTM 9 mg/ml (0,9%) otopina za infuziju | otop. za inf., boca stakl. 10x500 ml (9 mg/ml) | 1,0087 | 10,09 | | 5% |
| B05BB01 018 | PO | natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrijev klorid HZTM 9 mg/ml (0,9%) otopina za infuziju | otop. za inf., boca stakl. 10x250 ml (9 mg/ml) | 0,8760 | 8,76 | | 5% |
| B05BB01 029 | PO | natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrijev klorid HZTM 9 mg/ml (0,9%) otopina za infuziju | otop. za inf., boca polietil. 20x500 ml (9 mg/ml) | 1,0114 | 20,23 | | 5% |
| B05BB01 031 | PO | natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrijev klorid HZTM 9 mg/ml (0,9%) otopina za infuziju | otop. za inf., boč. stakl. 20x100 ml (9 mg/ml) | 0,8494 | 16,99 | | 5% |
| B05BB01 032 | DS | natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrijev klorid HZTM 10% koncentrat za otopinu za infuziju | konc. za otop. za inf. 10%, boč. stakl. 40x50 ml (100 mg/ml) | 0,9397 | 37,59 | | 5% |
| B05BB01 033 | DS | natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrijev klorid HZTM 9 mg/ml (0,9%) otopina za infuziju | otop. za inf. 0,9%, vreć. PP 12x1000 ml | 1,6458 | 19,75 | | 5% |
| B05BB01 034 | DS | natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Natrijev klorid HZTM 9 mg/ml (0,9%) otopina za infuziju | otop. za inf. 0,9%, vreć. PP 6x2000 ml | 2,6319 | 15,79 | | 5% |
| B05BB01 042 | PO | natrij-klorid | | | P | Baxter d.o.o. | Baxter/Bieffe Medital | Natrijev klorid Viaflo 9 mg/ml | otop. za inf., 9 mg/ml, vreć. plast. 30x250 ml | 0,8826 | 26,48 | | 5% |
| B05BB01 043 | PO | natrij-klorid | | | P | Baxter d.o.o. | Baxter/Bieffe Medital | Natrijev klorid Viaflo 9 mg/ml | otop. za inf., 9 mg/ml, vreć. plast. 20x500 ml | 1,0153 | 20,31 | | 5% |
| B05BB01 044 | DS | natrij-klorid | | | P | Baxter d.o.o. | Baxter/Bieffe Medital | Natrijev klorid Viaflo 9 mg/ml | otop. za inf., 9 mg/ml, vreć. plast. 10x1000 ml | 1,8289 | 18,29 | | 5% |
| B05BB01 046 | PO | natrij-klorid | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Natrijev klorid Viaflo 9 mg/ml | otop. za inf., 9 mg/ml, vreć. plast. 60x100 ml | 0,7287 | 43,72 | | 5% |
| B05BB01 047 | PO | natrij-klorid | | | P | Alkaloid-INT d.o.o. | Alkaloid – INT d.o.o. | Natrijev klorid Alkaloid 9 mg/ml | otop. za inf., boca plast. 20x500 ml (9 mg/ml) | 0,8687 | 17,37 | | 5% |
| B05BB01 051 | DS | natrij-klorid | | | P | | | | amp. 10%, 1x10 ml | | | | 5% |
| B05BB01 052 | DS | natrij-klorid + kalcij-klorid + kalij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Ringerova otopina HZTM otopina za infuziju | otop. za inf., boca stakl. 10x500 ml (8,6 mg/ml+0,34 mg/ml+0,30 mg/ml) | 1,0114 | 10,11 | | 5% |
| B05BB01 053 | DS | natrij-klorid + natrij-acetat + natrij-laktat + kalcij-klorid + kalij-klorid + magnezij klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Infusol | otop. za inf., boca stakl. 10x500 ml (5,723 mg/ml+5,305 mg/ml+0,56 mg/ml+0,294 mg/ml+0,372 mg/ml+0,305 mg/ml)) | 1,1481 | 11,48 | | 5% |
| B05BB01 054 | DS | natrij-klorid + kalcij-klorid + kalij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Ringerova otopina | otop. za inf., boca stakl. 10x500 ml (8,6 mg/ml+0,33 mg/ml+0,30 mg/ml) | 1,0114 | 10,11 | | 5% |
| B05BB01 055 | DS | natrij-klorid + kalcij-klorid + kalij-klorid | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Ringerova otopina Viaflo | otop. za inf., vreć. plast. 20x500 ml | 1,0153 | 20,31 | | 5% |
| B05BB01 056 | DS | natrij-klorid + kalcij-klorid + kalij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Ringerova otopina B. Braun | otop. za inf., polietil. Ecoflac plus boca, 10x500 ml | 1,0153 | 10,15 | | 5% |
| B05BB01 057 | DS | natrij-klorid + kalcij-klorid + kalij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Ringerova otopina B.Braun | otop. za inf., polietil. Ecoflac plus boca, 10x1000 ml | 1,5728 | 15,73 | | 5% |
| B05BB01 058 | DS | natrij-klorid + kalij-klorid + kalcij-klorid-dihidrat + natrij-laktat | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Slož. otop. natrijevog laktata (Hartmannova otopina) | otop. za inf., polietil. Ecoflac plus boca, 10x500 ml | 0,9004 | 9,00 | | 5% |
| B05BB01 059 | DS | natrij-klorid + kalij-klorid + kalcij-klorid-dihidrat + natrij-laktat | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Slož. otop. natrijevog laktata (Hartmannova otopina) otopina za infuziju | otop. za inf., polietil. Ecoflac plus boca, 10x1000 ml | 1,2572 | 12,57 | | 5% |
| B05BB01 060 | DS | natrij-klorid + kalij- klorid + kalcij-klorid-dihidrat + natrij-laktat | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Ringerov laktat Fresenius Kabi | otop. za inf., boca plast. 10x500 ml | 0,8096 | 8,10 | | 5% |
| B05BB01 068 | DS | natrij-klorid + kalcij-klorid + kalij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Ringerova otopina Fresenius Kabi | otop. za inf., boca plast. 10x500 ml | 0,9138 | 9,14 | | 5% |
| B05BB01 071 | PO | natrij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Natrijev klorid B. Braun 9 mg/ml | otop. za inf., 9 mg/ml, polietil. Ecoflac plus boca, 20x100 ml | 0,8534 | 17,07 | | 5% |
| B05BB01 072 | PO | natrij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Natrijev klorid B. Braun 9 mg/ml | otop. za inf., 9 mg/ml, polietil. Ecoflac plus boca, 10x250 ml | 0,8826 | 8,83 | | 5% |
| B05BB01 073 | PO | natrij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Natrijev klorid B. Braun 9 mg/ml | otop. za inf., 9 mg/ml, polietil. Ecoflac plus boca, 10x500 ml | 1,0153 | 10,15 | | 5% |
| B05BB01 074 | DS | natrij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Natrijev klorid B. Braun 9 mg/ml | otop. za inf., 9 mg/ml, polietil. Ecoflac plus boca, 10x1000 ml | 1,8289 | 18,29 | | 5% |
| B05BB01 077 | DS | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., PE boca, 10x1000 ml (9 mg/ml) | 1,6458 | 16,46 | | 5% |
| B05BB01 078 | PO | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., vreć. plast. 50x100 ml (9 mg/ml) | 0,7681 | 38,40 | | 5% |
| B05BB01 079 | PO | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., vreć. plast. 30x250 ml (9 mg/ml) | 0,7944 | 23,83 | | 5% |
| B05BB01 085 | DS | natrij-klorid + kalij-klorid + magnezij-klorid heksahidrat + kalcij-klorid dihidrat + natrij-acetat trihidrat + L-malatna kiselina | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Sterofundin Iso B. Braun | otop. za inf., polietil. Ecoflac plus boca, 10x500 ml | 1,3525 | 13,52 | | 5% |
| B05BB01 086 | DS | natrij-klorid + kalij-klorid + magnezij-klorid heksahidrat + kalcij-klorid dihidrat + natrij-acetat trihidrat + L-malatna kiselina | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Sterofundin Iso B. Braun | otop. za inf., polietil. Ecoflac plus boca, 10x1000 ml | 1,6645 | 16,64 | | 5% |
| B05BB01 087 | DS | natrij-klorid + kalij-klorid + magnezij-klorid heksahidrat + natrij-acetat trihidrat | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Ionolyte | otop. za inf., vreć. plast. 20x500 ml | 1,2172 | 24,34 | | 5% |
| B05BB01 088 | DS | natrij-klorid + kalij-klorid + magnezij-klorid heksahidrat + natrij-acetat trihidrat | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Ionolyte | otop. za inf., vreć. plast. 10x1000 ml | 1,4980 | 14,98 | | 5% |
| B05BB01 091 | DS | natrij-klorid + kalij-klorid + magnezij-klorid heksahidrat + natrij-acetat-trihidrat + natrij-glukonat | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Plasma-Lyte 148 Viaflo | otop. za inf., vreć. plast. 20x500 ml | 1,5038 | 30,07 | | 5% |
| B05BB01 092 | DS | natrij-klorid + kalij-klorid + magnezij-klorid heksahidrat + natrij-acetat-trihidrat + natrij-glukonat | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Plasma-Lyte 148 Viaflo | otop. za inf., vreć. plast. 10x1000 ml | 1,8502 | 18,50 | | 5% |
| B05BB01 093 | PO | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., vreć. plast. 20x500 ml (9 mg/ml) | 0,9138 | 18,28 | | 5% |
| B05BB01 094 | DS | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., vreć. plast. 60x50 ml (9 mg/ml) | 0,6928 | 41,57 | | 5% |
| B05BB01 095 | PO | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., boca plast. 40x100 ml (9 mg/ml) | 0,7681 | 30,72 | | 5% |
| B05BB01 096 | PO | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., boca plast. 20x250 ml (9 mg/ml) | 0,7944 | 15,89 | | 5% |
| B05BB01 097 | PO | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., boca plast. 10x500 ml (9 mg/ml) | 0,9138 | 9,14 | | 5% |
| B05BB01 098 | DS | natrij-klorid | | | P | Fresenius Kabi d.o.o. | Fresenius Kabi | Natrijev klorid Fresenius Kabi 9 mg/ml | otop. za inf., vreć. plast. 10x1000 ml (9 mg/ml) | 1,4812 | 14,81 | | 5% |
| B05BB01 099 | DS | natrij-klorid | | | P | Baxter d.o.o. | Baxter, Bieffe Medital | Natrijev klorid Viaflo 9 mg/ml | otop. za inf. 9 mg/ml, vreć. plast. 75x50 ml | 0,6928 | 51,96 | | 5% |
| B05BB02 021 | DS | glukoza + natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukosalina I 50 mg/ml + 9 mg/ml otopina za infuziju | otop. za inf., boca stakl. 10x500 ml (50 mg/ml+9 mg/ml) | 1,1627 | 11,63 | | 5% |
| B05BB02 022 | DS | glukoza + natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukosalina I 50 mg/ml + 9 mg/ml otopina za infuziju | otop. za inf., boca stakl. 10x250 ml (50 mg/ml+9 mg/ml) | 1,0273 | 10,27 | | 5% |
| B05BB02 024 | DS | glukoza + natrij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Glukosalina III 25 mg/ml + 4,5 mg/ml otopina za infuziju | otop. za inf., boca stakl. 10x500 ml (25 mg/ml+4,5 mg/ml) | 1,2211 | 12,21 | | 5% |
| B05BB02 061 | DS | glukoza + natrij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Natrijev klorid 9 mg/ml + Glukoza 50 mg/ml B. Braun | otop. za inf., (9 mg/ml+50 mg/ml), polietil. Ecoflac plus boca, 10x500 ml | 1,0459 | 10,46 | | 5% |
| B05BB02 062 | DS | glukoza + natrij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG, B. Braun Medical S.A. | Natrijev klorid 9 mg/ml + Glukoza 50 mg/ml B. Braun | otop. za inf., (9 mg/ml+50 mg/ml), polietil. Ecoflac plus boca, 10x1000 ml | 1,8249 | 18,25 | | 5% |
| B05BB02 071 | DS | glukoza (kao hidrat) + natrij-klorid + natrij-acetat-trihidrat + kalij-klorid + magnezij-klorid heksahidrat | | | P | Baxter d.o.o. | Bieffe Medital S.A. | GNAK 50 mg/ml | otop. za inf., vreć. plast. 10x1000 ml | 1,7573 | 17,57 | | 5% |
| B05BC01 006 | DS | manitol + natrij-klorid + natrij-acetat | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Manitol 10% + elektroliti HZTM otopina za infuziju | otop. za inf., boca stakl. 10x500 ml (100 mg/ml+2,6 mg/ml+2,7 mg/ml) | 1,7942 | 17,94 | | 5% |
| B05BC01 007 | DS | manitol | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Manitol HZTM 20% otopina za infuziju | otop. za inf., boca stakl. 10x250 ml (200 mg/ml) | 1,7559 | 17,56 | | 5% |
| B05CX10 961 | DS | otopine za ispiranje mokraćnog mjehura | | | L | Fresenius Kabi d.o.o. | Fresenius Kabi | Purisole SM | vreć. plast. 1x3000 ml | 7,4046 | 7,40 | | 5% |
| B05CX10 963 | DS | otopina za ispiranje kod endoskopskih pretraga i operativnih zahvata | | | L | B. Braun Adria d.o.o. | B.Braun | Sorbitol/Manitol 3% B. Braun | ecobag/ecobag Click 4x3.000 ml | 6,6640 | 26,66 | | 5% |
| B05CX10 964 | DS | otopina za ispiranje | | | L | Agmar d.o.o. | Baxter, Bieffe Medital | Manitol i sorbitol | otop. za ispir., vreć. Clear-Flex 4x3.000 ml | 5,9964 | 23,99 | | 5% |
| B05XA01 027 | DS | kalij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | 1 M Kalijev klorid HZTM 7,45% koncentrat za otopinu za infuziju | konc. za otop. za inf., boč. stakl. 40x50 ml (74,5 mg/ml) | 0,9012 | 36,05 | | 5% |
| B05XA01 061 | DS | kalij-klorid | | | P | B. Braun Adria d.o.o. | B. Braun Melsungen AG | Kalijev klorid B. Braun 74,5 mg/ml | konc. za otop. za inf., 74,5 mg/ml, boca stakl. 20x100 ml | 1,4679 | 29,36 | | 5% |
| B05XA02 052 | DS | natrij-hidrogenkarbonat | | | P | | | | | | | | 5% |
| B05XA05 051 | DS | magnezij-sulfat | | | P | | | | | | | | 5% |
| B05XA07 017 | DS | kalcij-klorid | | | P | Hrvatski zavod za transfuzijsku medicinu | Hrvatski zavod za transf. med. | Kalcijev klorid 100 mg/ml (10%) HZTM otopina za injekciju | otop. za inj., boč. stakl. 40x30 ml (100 mg/ml) | 1,0644 | 42,58 | | 5% |
| B06AC02 001 | DS | ikatibantNB509 | 30 mg | 1.092,7613 | P | Teva B.V. | Merckle GmbH | Ikatibant Teva | štrc. napunj. 1x30 mg | 1.092,7613 | 1.092,76 | | 5% |
| B06AC02 041 | DS | ikatibantNB509 | 30 mg | 1.092,7613 | P | Accord Healthcare S.L.U. | Accord Healthcare Polska Sp.z.o.o., Accord Healthcare B.V. | Icatibant Accord | štrc. napunj. 1x30 mg | 1.092,7613 | 1.092,76 | | 5% |
| B06AC02 061 | DS | ikatibantNB509 | 30 mg | 1.216,8239 | P | Takeda Pharmaceuticals International AG Ireland Branch | Shire Pharmaceuticals Ireland Limited | Firazyr | štrc. napunj. 1x30 mg | 1.216,8239 | 1.216,82 | | 5% |
| B06AC02 071 | DS | ikatibantNB509 | 30 mg | 1.038,1233 | P | Fresenius Kabi d.o.o. | Fresenius Kabi Austria GmbH | Ikatibant Fresenius | štrc. napunj. 1x30 mg | 1.038,1233 | 1.038,12 | | 5% |
| B06AC04 061 | DS | konestat alfaNB509 | 3500 U | 1.238,7462 | P | Pharming Group N.V. | Pharming Technologies B.V. | Ruconest | praš. za otop. za inj., boč. stakl. 1x2100 U | 743,2477 | 743,25 | | 5% |
| C01AA08 051 | PR | metildigoksin | 0,2 mg | | P | | | | | | | | 5% |
| C01AA08 101 | | metildigoksin | 0,2 mg | 0,1314 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Lanitop | tbl. 50x0,1 mg | 0,0657 | 3,28 | R | 5% |
| C01BB01 051 | PR | lidokain | 3 g | | P | | | | | | | | 5% |
| C01BC03 073 | PR | propafenon | 0,3 g | 5,2346 | P | Mylan Hrvatska d.o.o. | Famar Health Care Services Madrid S.A.U. | Rytmonorm | amp. 5x70 mg/20 ml | 1,0469 | 5,23 | | 5% |
| C01BC03 142 | | propafenon | 0,3 g | 0,1311 | O | Alkaloid d.o.o. | Alkaloid | Propafenon Alkaloid | tbl. 50x150 mg | 0,0656 | 3,28 | R | 5% |
| C01BD01 022 | DS | amjodaron | 0,2 g | 1,5691 | P | sanofi-aventis groupe | Sanofi Winthrop Ambares | Cordarone | amp. 6x150 mg/3 ml | 1,1768 | 7,06 | | 5% |
| C01BD01 061 | DS | amjodaron | 0,2 g | 1,0988 | P | hameln pharma gmbh | HBM Pharma s.r.o. | Amiodaronklorid Hameln | amp. 10x150 mg/3 ml | 0,8241 | 8,24 | | 5% |
| C01BD01 112 | | amjodaron | 0,2 g | 0,1619 | O | Belupo d.d. | Belupo | Amiodaronklorid Belupo | tbl. 60x200 mg | 0,1619 | 9,72 | R | 5% |
| C01BD01 121 | | amjodaron | 0,2 g | 0,1619 | O | sanofi-aventis groupe | Sanofi Winthrop Ambares | Cordarone | tbl. 60x200 mg | 0,1619 | 9,72 | R | 5% |
| C01BD01 133 | | amjodaron | 0,2 g | 0,1619 | O | KRKA-FARMA d.o.o. | Krka d.d. | Amiokordin | tbl. 60x200 mg | 0,1619 | 9,72 | R | 5% |
| C01CA01 052 | DS | etiladrianolNC101 | 50 mg | | P | | | | | | | | 5% |
| C01CA03 071 | PR | norepinefrin | 6 mg | 6,2272 | P | Sintetica GmbH | Sirton Pharmaceuticals S.p.A., Sintetica GmbH | Sinora | konc. za otop. za inf., 1 mg/ml, amp. 10x1 ml | 1,0379 | 10,38 | | 5% |
| C01CA03 072 | PR | norepinefrin | 6 mg | 2,1445 | P | Sintetica GmbH | Sirton Pharmaceuticals S.p.A., Sintetica GmbH | Sinora | konc. za otop. za inf., 1 mg/ml, amp. 10x10 ml | 3,5742 | 35,74 | | 5% |
| C01CA03 073 | PR | norepinefrin | 6 mg | 2,0374 | P | Sintetica GmbH | Sirton Pharmaceuticals S.p.A., Sintetica GmbH | Sinora | konc. za otop. za inf., 1 mg/ml, amp. 10x5 ml | 1,6978 | 16,98 | | 5% |
| C01CA03 081 | PR | norepinefrin | 6 mg | 2,3039 | P | Ligula Pharma d.o.o. | Laboratorios Normon S.A. | Noradrenalin Ligula Pharma | konc. za otop. za inf., 0,5 mg/ml, amp. 100x10 ml | 1,9199 | 191,99 | | 5% |
| C01CA04 061 | DS | dopamin | 0,5 g | 9,8825 | P | Medicuspharma d.o.o. | Wuelfing Pharma | Dopamin Admeda | amp. 5x50 mg/5 ml | 0,9883 | 4,94 | | 5% |
| C01CA07 061 | DS | dobutamin | 0,5 g | 7,6979 | P | Panpharma | Panpharma GmbH | Dobutamin Panpharma | konc. za otop. za inf., boč. stakl. 10x250 mg/20 ml | 3,8490 | 38,49 | | 5% |
| C01CA07 071 | DS | dobutamin | 0,5 g | 8,4279 | P | Medicuspharma d.o.o. | Haupt Pharma Wülfing GmbH | Dobutamin Admeda | otop. za inf., amp. 1x250 mg/50 ml | 4,2140 | 4,21 | | 5% |
| C01CA07 082 | DS | dobutamin | 0,5 g | 8,0058 | P | hameln pharma gmbh | Siegfried Hameln GmbH, Hameln rds | Dobutamin Hameln | otop. za inf., boč. 1x250 mg/50 ml | 4,0029 | 4,00 | | 5% |
| C01CA07 083 | DS | dobutamin | 0,5 g | 8,0058 | P | hameln pharma gmbh | Siegfried Hameln GmbH, Hameln rds | Dobutamin Hameln | konc. za otop. za inf., amp. 5x250 mg/20 ml | 4,0029 | 20,01 | | 5% |
| C01CA24 051 | PR | adrenalin (epinefrin) | 0,5 mg | | P | | | | | | | | 5% |
| C01CA24 071 | | adrenalin (epinefrin) | 0,5 mg | 17,2633 | P | Mylan Hrvatska d.o.o. | Meda Pharma GmbH | EpiPen Jr | otop. za inj., autoinjektor 1x1 mg/2 ml (doza 0,15 mg/0,3 ml) | 34,5265 | 34,53 | RSRC09 | 5% |
| C01CA24 072 | | adrenalin (epinefrin) | 0,5 mg | 8,6316 | P | Mylan Hrvatska d.o.o. | Meda Pharma GmbH | EpiPen | otop. za inj., autoinjektor 1x2 mg/2 ml (doza 0,3 mg/0,3 ml) | 34,5265 | 34,53 | RSRC09 | 5% |
| C01CX08 061 | DS | levosimendanNC102 | 11 mg | 657,6927 | P | Orion Corporation | Orion | Simdax | konc. otop. za inf., boč. stak. 1x5ml (2,5mg/1ml) | 747,4020 | 747,40 | | 5% |
| C01CX08 071 | DS | levosimendanNC102 | 11 mg | 472,8898 | P | ALPHA-MEDICAL d.o.o. | Sabiedriba Ar Ierobezotu Atbildibu »Pharmidea« | Levosimendan Alpha-Medical | konc. otop. za inf., boč. stak. 1x5ml (2,5mg/1ml) | 537,3920 | 537,39 | | 5% |
| C01DA02 764 | | gliceriltrinitrat | 2,5 mg | 0,1523 | O | Medis Adria d.o.o. | G. Pohl-Boskamp | Nitrolingual | rasprš. oral. boč. 1x14,4 ml (0,4 mg/doza, 200 doza) | 4,8749 | 4,87 | R | 5% |
| C01DA08 101 | | izosorbid-dinitrat | 20 mg | 0,0909 | SL | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Tinidil | tbl. sublingv. 40x5 mg | 0,0227 | 0,91 | R | 5% |
| C01DA14 111 | | izosorbid-5-mononitrat | 40 mg | 0,0796 | O | Mylan Hrvatska d.o.o. | Temmler Pharma | Olicard 40 | caps. retard 50x40 mg | 0,0796 | 3,98 | R | 5% |
| C01DA14 112 | | izosorbid-5-mononitrat | 40 mg | 0,0840 | O | Mylan Hrvatska d.o.o. | Temmler Pharma | Olicard 60 | caps. retard 50x60 mg | 0,1260 | 6,30 | R | 5% |
| C01DA14 113 | | izosorbid-5-mononitrat | 40 mg | 0,0796 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Cardox retard | tbl. retard 50x40 mg | 0,0796 | 3,98 | R | 5% |
| C01DA14 115 | | izosorbid mononitrat | 40 mg | 0,0796 | O | Belupo d.d. | Belupo | Isocard 40 mg | tbl. s prod. oslob. 50x40 mg | 0,0796 | 3,98 | R | 5% |
| C01DA14 116 | | izosorbid mononitrat | 40 mg | 0,0840 | O | Belupo d.d. | Belupo | Isocard 60 mg | tbl. s prod. osl. 50x60 mg | 0,1260 | 6,30 | R | 5% |
| C01DA14 121 | | izosorbid-5-mononitrat | 40 mg | 0,0841 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | ISMN Jadran 20 | tbl. 60x20 mg | 0,0421 | 2,52 | R | 5% |
| C01DA14 122 | | izosorbid-5-mononitrat | 40 mg | 0,0796 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | ISMN Jadran 40 | tbl. 60x40 mg | 0,0796 | 4,78 | R | 5% |
| C01DA14 161 | | izosorbid-5-mononitrat | 40 mg | 0,0841 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | ISMN Genericon | tbl. 60x20 mg | 0,0421 | 2,52 | R | 5% |
| C01DA14 162 | | izosorbid-5-mononitrat | 40 mg | 0,0796 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | ISMN Genericon | tbl. 60x40 mg | 0,0796 | 4,78 | R | 5% |
| C01EA01 061 | DS | alprostadilNC103 | 0,5 mg | 20,1923 | P | Pfizer Croatia d.o.o. | Pfizer | Prostin VR | amp. 5x1 ml (0,5 mg/ml) | 40,3846 | 201,92 | | 5% |
| C01EB15 145 | | trimetazidin | 40 mg | 0,0638 | O | PharmaS d.o.o. | PharmaS d.o.o. | Trimetazidin PharmaS | tbl. s prilag. oslob. 60x35 mg | 0,0558 | 3,35 | RS | 5% |
| C02AB01 151 | | l-metildopa | 1g | | O | | | | | | | R | 5% |
| C02AC05 112 | | moksonidin | 0,3 mg | 0,1863 | O | Belupo d.d. | Belupo d.d. | Moksonidin Belupo | tbl. film obl. 28x0,2 mg | 0,1242 | 3,48 | RRC07 | 5% |
| C02AC05 113 | | moksonidin | 0,3 mg | 0,1642 | O | Belupo d.d. | Belupo d.d. | Moksonidin Belupo | tbl. film obl. 28x0,4 mg | 0,2190 | 6,13 | RRC07 | 5% |
| C02AC05 121 | | moksonidin | 0,3 mg | 0,1863 | O | Sandoz d.o.o. | Sandoz-Salutas | Moxaviv | tbl. film obl. 28x0,2 mg | 0,1242 | 3,48 | RRC07 | 5% |
| C02AC05 122 | | moksonidin | 0,3 mg | 0,1642 | O | Sandoz d.o.o. | Sandoz-Salutas | Moxaviv | tbl. film obl. 28x0,4 mg | 0,2190 | 6,13 | RRC07 | 5% |
| C02AC05 123 | | moksonidin | 0,3 mg | 0,1681 | O | Sandoz d.o.o. | Salutas Pharma | Moxaviv | tbl. film obl. 60x0,2 mg | 0,1121 | 6,72 | RRC07 | 5% |
| C02AC05 124 | | moksonidin | 0,3 mg | 0,1482 | O | Sandoz d.o.o. | Salutas Pharma | Moxaviv | tbl. film obl. 60x0,4 mg | 0,1977 | 11,86 | RRC07 | 5% |
| C02AC05 162 | | moksonidin | 0,3 mg | 0,1642 | O | Mylan Hrvatska d.o.o. | Mylan Laboratories SAS | Physiotens | tbl. film obl. 28x0,4 mg | 0,2190 | 6,13 | RRC07 | 5% |
| C02AC05 163 | | moksonidin | 0,3 mg | 0,1652 | O | Mylan Hrvatska d.o.o. | Mylan Laboratories SAS | Cynt | tbl. film obl. 28x0,2 mg | 0,1102 | 3,08 | RRC07 | 5% |
| C02AC05 164 | | moksonidin | 0,3 mg | 0,1473 | O | Mylan Hrvatska d.o.o. | Mylan Laboratories SAS | Cynt | tbl. film obl. 28x0,4 mg | 0,1964 | 5,50 | RRC07 | 5% |
| C02CA04 111 | | doksazosin | 4 mg | 0,1991 | O | Belupo d.d. | Belupo | Doxa | tbl. 20x2 mg | 0,0995 | 1,99 | R | 5% |
| C02CA04 112 | | doksazosin | 4 mg | 0,1739 | O | Belupo d.d. | Belupo | Doxa | tbl. 20x4 mg | 0,1739 | 3,48 | R | 5% |
| C02CA04 123 | | doksazosin | 4 mg | 0,1991 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Doxazin | tbl. 30x2 mg | 0,0995 | 2,99 | R | 5% |
| C02CA04 124 | | doksazosin | 4 mg | 0,1739 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Doxazin | tbl. 30x4 mg | 0,1739 | 5,22 | R | 5% |
| C02CA04 131 | | doksazosin | 4 mg | 0,1991 | O | KRKA-FARMA d.o.o. | Krka d.d. | Kamiren | tbl. 20x2 mg | 0,0995 | 1,99 | R | 5% |
| C02CA04 134 | | doksazosin | 4 mg | 0,1739 | O | KRKA-FARMA d.o.o. | Krka d.d. | Kamiren | tbl. 20x4 mg | 0,1739 | 3,48 | R | 5% |
| C02CA04 137 | | doksazosin | 4 mg | 0,1739 | O | KRKA-FARMA d.o.o. | Krka d.d. | Kamiren XL | tbl. s prilag. osl. 30x4 mg | 0,1739 | 5,22 | R | 5% |
| C02CA04 138 | | doksazosin | 4 mg | 0,1756 | O | KRKA-FARMA d.o.o. | Krka d.d. | Kamiren XL | tbl. s prilag. osl. 60x4 mg | 0,1756 | 10,54 | R | 5% |
| C02CA06 064 | PO | urapidil | 50 mg | 4,4537 | P | Cheplapharm Arzneimittel GmbH | Takeda | Ebrantil | amp. 5x50 mg/10 ml | 4,4537 | 22,27 | | 5% |
| C02CA06 065 | PO | urapidil | 50 mg | 6,1291 | P | Cheplapharm Arzneimittel GmbH | Takeda | Ebrantil | amp. 5x25 mg/5 ml | 3,0646 | 15,32 | | 5% |
| C02DA01 051 | DS | diazoksid | 0,3g | | P | | | | | | | | 5% |
| C02DC01 151 | DS | minoksidilNC991 | 20 mg | | O | | | | | | | RSRC91 | 5% |
| C02DD01 051 | DS | nitroprusid-natrij | 50 mg | | P | | | | | | | | 5% |
| C02KX01 131 | KS | bosentanNC201 | 0,25 g | 45,7734 | O | Makpharm d.o.o. | Pharmascience International Limited, Kern Pharma S.L. | Bosentan Makpharm | tbl. film obl. 56x62,5 mg | 11,4434 | 640,83 | | 5% |
| C02KX01 132 | KS | bosentanNC201 | 0,25 g | 31,5447 | O | Makpharm d.o.o. | Pharmascience International Limited, Kern Pharma S.L. | Bosentan Makpharm | tbl. film obl. 56x125 mg | 15,7723 | 883,25 | | 5% |
| C02KX01 141 | KS | bosentanNC201 | 0,25 g | 45,7734 | O | Cipla Europe NV | Cipla (EU) Limited, Cipla Europe NV | Bosentan Cipla | tbl. film obl. 56x62,5 mg | 11,4434 | 640,83 | | 5% |
| C02KX01 142 | KS | bosentanNC201 | 0,25 g | 31,5447 | O | Cipla Europe NV | Cipla (EU) Limited, Cipla Europe NV | Bosentan Cipla | tbl. film obl. 56x125 mg | 15,7723 | 883,25 | | 5% |
| C02KX01 181 | KS | bosentanNC201 | 0,25 g | 45,7734 | O | ALPHA-MEDICAL d.o.o. | Pharmadox Healthcare Limited | Phan | tbl. film obl. 56x62,5 mg | 11,4434 | 640,83 | | 5% |
| C02KX01 182 | KS | bosentanNC201 | 0,25 g | 31,5447 | O | ALPHA-MEDICAL d.o.o. | Pharmadox Healthcare Limited | Phan | tbl. film obl. 56x125 mg | 15,7723 | 883,25 | | 5% |
| C02KX02 061 | KS | ambrisentanNC201 | 7,5 mg | 69,5979 | O | GlaxoSmithKline (Ireland) Limited | Aspen Bad Oldesloe, GlaxoSmithKline Trading Services Limited | Volibris | tbl. film obl. 30x5 mg | 46,3986 | 1.391,96 | | 5% |
| C02KX02 062 | KS | ambrisentanNC201 | 7,5 mg | 27,7988 | O | GlaxoSmithKline (Ireland) Limited | Aspen Bad Oldesloe, GlaxoSmithKline Trading Services Limited | Volibris | tbl. film obl. 30x10 mg | 37,0651 | 1.111,95 | | 5% |
| C02KX02 101 | KS | ambrisentanNC201 | 7,5 mg | 69,5979 | O | Teva B.V. | Teva UK Ltd. | Ambrisentan Teva | tbl. film obl. 30x5 mg | 46,3986 | 1.391,96 | | 5% |
| C02KX02 102 | KS | ambrisentanNC201 | 7,5 mg | 27,7988 | O | Teva B.V. | Teva UK Ltd. | Ambrisentan Teva | tbl. film obl. 30x10 mg | 37,0651 | 1.111,95 | | 5% |
| C03BA04 151 | | klortalidon | 25 mg | | O | | | | | | | R | 5% |
| C03BA11 101 | | indapamid | 2,5 mg | 0,1505 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Indapamid SR Pliva | drag. 30x1,5 mg | 0,0903 | 2,71 | R | 5% |
| C03BA11 111 | | indapamid | 2,5 mg | 0,1505 | O | Belupo d.d. | Belupo | Indamid SR | drag. 30x1,5 mg | 0,0903 | 2,71 | R | 5% |
| C03BA11 131 | | indapamid | 2,5 mg | 0,1505 | O | KRKA-FARMA d.o.o. | Krka d.d. | Rawel SR | tbl. film obl. 30x1,5 mg | 0,0903 | 2,71 | R | 5% |
| C03BA11 132 | | indapamid | 2,5 mg | 0,1505 | O | KRKA-FARMA d.o.o. | Krka d.d. | Rawel SR | tbl. film obl. 60x1,5 mg | 0,0903 | 5,42 | R | 5% |
| C03BA11 145 | | indapamid | 2,5 mg | 0,1203 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Dipam retard | tbl. s prod. oslob. 30x1,5 mg | 0,0722 | 2,16 | R | 5% |
| C03BA11 172 | | indapamid | 2,5 mg | 0,1505 | O | Servier Pharma d.o.o. | LLS, SII, Anpharm | Tertensif SR | tbl. 30x1,5 mg | 0,0903 | 2,71 | R | 5% |
| C03CA01 014 | PR | furosemid | 40 mg | 0,7130 | P | Belupo d.d. | Belupo | Fursemid | amp. 5x20 mg/2 ml | 0,3565 | 1,78 | | 5% |
| C03CA01 023 | PR | furosemid | 40 mg | 0,5423 | P | Sandoz d.o.o. | Sandoz-Salutas | Edemid | otop. za inj., amp. 5x40 mg/4 ml | 0,5423 | 2,71 | | 5% |
| C03CA01 061 | PR | furosemid | 40 mg | 0,6774 | P | hameln pharma gmbh | Hameln rds, Siegfried Hameln GmbH | Furosemid Hameln | amp. 10x20 mg/2 ml | 0,3387 | 3,39 | | 5% |
| C03CA01 112 | | furosemid | 40 mg | 0,0297 | O | Belupo d.d. | Belupo | Fursemid forte | tbl. 20x500 mg | 0,3715 | 7,43 | R | 5% |
| C03CA01 122 | | furosemid | 40 mg | 0,0297 | O | Sandoz d.o.o. | Sandoz-Lek | Edemid forte | tbl. 30x500 mg | 0,3715 | 11,14 | R | 5% |
| C03CA01 171 | | furosemid | 40 mg | 0,0584 | O | sanofi-aventis groupe | Sanofi Winthrop Industrie | Lasix | tbl. 20x40 mg | 0,0584 | 1,17 | R | 5% |
| C04AB01 051 | DS | fentolamin | 1 mg | | P | | | | | | | | 5% |
| C05BA01 404 | DS | heparin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Heparin krema | krema 30g (250 i.j./g) | 3,7242 | 3,72 | | 5% |
| C07AA05 121 | | propranolol | 0,16 g | 0,2218 | O | Sandoz d.o.o. | Sandoz-Lek | Propranolol Sandoz | tbl. 50x40 mg | 0,0555 | 2,77 | R | 5% |
| C07AA05 270 | | propranolol | 0,16 g | 60,8147 | O | Pierre Fabre Dermatologie | Farmea, PIERRE FABRE MEDICAMENT PRODUCTION – CHATEAURENARD | Hemangiol | oral. otop., boca 1x120 ml (3,75 mg/ml) | 171,0412 | 171,04 | RSRC10 | 5% |
| C07AB03 101 | | atenolol | 75 mg | 0,0859 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atenolol | tbl. 30x50 mg | 0,0573 | 1,72 | R | 5% |
| C07AB03 112 | | atenolol | 75 mg | 0,0859 | O | Belupo d.d. | Belupo | Ormidol | tbl. 30x50 mg | 0,0573 | 1,72 | R | 5% |
| C07AB03 113 | | atenolol | 75 mg | 0,0859 | O | Belupo d.d. | Belupo | Ormidol | tbl. 28x100 mg | 0,1145 | 3,21 | R | 5% |
| C07AB07 101 | | bisoprolol | 10 mg | 0,2336 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Kordobis | tbl. 20x1,25 mg | 0,0292 | 0,58 | R | 5% |
| C07AB07 102 | | bisoprolol | 10 mg | 0,2005 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Kordobis | tbl. 30x2,5 mg | 0,0501 | 1,50 | R | 5% |
| C07AB07 103 | | bisoprolol | 10 mg | 0,1099 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Kordobis | tbl. 30x5 mg | 0,0550 | 1,65 | R | 5% |
| C07AB07 111 | | bisoprolol | 10 mg | 0,1099 | O | Belupo d.d. | Belupo | Bisobel | tbl. 30x5 mg | 0,0550 | 1,65 | R | 5% |
| C07AB07 112 | | bisoprolol | 10 mg | 0,0717 | O | Belupo d.d. | Belupo | Bisobel | tbl. 30x10 mg | 0,0717 | 2,15 | R | 5% |
| C07AB07 114 | | bisoprolol | 10 mg | 0,1099 | O | Belupo d.d. | Belupo | Bisobel | tbl. 60x5 mg | 0,0550 | 3,30 | R | 5% |
| C07AB07 115 | | bisoprolol | 10 mg | 0,1099 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Biprol | tbl. 30x5 mg | 0,0550 | 1,65 | R | 5% |
| C07AB07 117 | | bisoprolol | 10 mg | 0,2005 | O | Belupo d.d. | Belupo | Bisobel | tbl. 30x2,5 mg | 0,0501 | 1,50 | R | 5% |
| C07AB07 118 | | bisoprolol | 10 mg | 0,2005 | O | Belupo d.d. | Belupo | Bisobel | tbl. 60x2,5 mg | 0,0501 | 3,01 | R | 5% |
| C07AB07 119 | | bisoprolol | 10 mg | 0,2005 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Biprol | tbl. 30x2,5 mg | 0,0501 | 1,50 | R | 5% |
| C07AB07 121 | | bisoprolol | 10 mg | 0,1099 | O | Sandoz d.o.o. | Sandoz-Salutas | Byol | tbl. film obl. 30x5 mg | 0,0550 | 1,65 | R | 5% |
| C07AB07 122 | | bisoprolol | 10 mg | 0,0717 | O | Sandoz d.o.o. | Sandoz-Salutas | Byol | tbl. film obl. 30x10 mg | 0,0717 | 2,15 | R | 5% |
| C07AB07 125 | | bisoprolol | 10 mg | 0,2005 | O | Sandoz d.o.o. | Sandoz-Salutas | Byol Cor | tbl. film obl. 30x2,5 mg | 0,0501 | 1,50 | R | 5% |
| C07AB07 126 | | bisoprolol | 10 mg | 0,2005 | O | Sandoz d.o.o. | Sandoz-Salutas | Byol Cor | tbl. film obl. 50x2,5 mg | 0,0501 | 2,51 | R | 5% |
| C07AB07 127 | | bisoprolol | 10 mg | 0,2336 | O | Sandoz d.o.o. | Sandoz-Salutas | Byol Cor | tbl. film obl. 30x1,25 mg | 0,0292 | 0,88 | R | 5% |
| C07AB07 128 | | bisoprolol | 10 mg | 0,1099 | O | Sandoz d.o.o. | Sandoz-Salutas | Byol | tbl. film obl. 60x5 mg | 0,0550 | 3,30 | R | 5% |
| C07AB07 136 | | bisoprolol | 10 mg | 0,2005 | O | Alkaloid d.o.o. | Alkaloid | Tyrez | tbl. film obl. 30x2,5 mg | 0,0501 | 1,50 | R | 5% |
| C07AB07 137 | | bisoprolol | 10 mg | 0,1099 | O | Alkaloid d.o.o. | Alkaloid | Tyrez | tbl. film obl. 30x5 mg | 0,0550 | 1,65 | R | 5% |
| C07AB07 138 | | bisoprolol | 10 mg | 0,0717 | O | Alkaloid d.o.o. | Alkaloid | Tyrez | tbl. film obl. 30x10 mg | 0,0717 | 2,15 | R | 5% |
| C07AB07 141 | | bisoprolol | 10 mg | 0,2336 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Lybrol | tbl. 20x1,25 mg | 0,0292 | 0,58 | R | 5% |
| C07AB07 142 | | bisoprolol | 10 mg | 0,2005 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Lybrol | tbl. 30x2,5 mg | 0,0501 | 1,50 | R | 5% |
| C07AB07 144 | | bisoprolol | 10 mg | 0,1099 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Lybrol | tbl. 30x5 mg | 0,0550 | 1,65 | R | 5% |
| C07AB07 163 | | bisoprolol | 10 mg | 0,1230 | O | MERCK d.o.o. | Merck | Concor | tbl. 30x10 mg | 0,1230 | 3,69 | R | 5% |
| C07AB07 181 | | bisoprolol | 10 mg | 0,2005 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Sobycor | tbl. film obl. 30x2,5 mg | 0,0501 | 1,50 | R | 5% |
| C07AB07 182 | | bisoprolol | 10 mg | 0,1099 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Sobycor | tbl. film obl. 30x5 mg | 0,0550 | 1,65 | R | 5% |
| C07AB07 183 | | bisoprolol | 10 mg | 0,0717 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Sobycor | tbl. film obl. 30x10 mg | 0,0717 | 2,15 | R | 5% |
| C07AB07 184 | | bisoprolol | 10 mg | 0,1804 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Sobycor | tbl. film obl. 60x2,5 mg | 0,0451 | 2,71 | R | 5% |
| C07AB07 185 | | bisoprolol | 10 mg | 0,0989 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Sobycor | tbl. film obl. 60x5 mg | 0,0495 | 2,97 | R | 5% |
| C07AB07 186 | | bisoprolol | 10 mg | 0,0645 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Sobycor | tbl. film obl. 60x10 mg | 0,0645 | 3,87 | R | 5% |
| C07AB12 101 | | nebivolol | 5 mg | 0,1234 | O | PLIVA HRVATSKA d.o.o. | Balkanpharma – Dupnitsa AD, Actavis Limited | Nebivolol Pliva | tbl. 28x5 mg | 0,1234 | 3,46 | R | 5% |
| C07AB12 111 | | nebivolol | 5 mg | 0,1190 | O | Belupo d.d. | Belupo | Nibel | tbl. 14x5 mg | 0,1190 | 1,67 | R | 5% |
| C07AB12 112 | | nebivolol | 5 mg | 0,1234 | O | Belupo d.d. | Belupo | Nibel | tbl. 28x5 mg | 0,1234 | 3,46 | R | 5% |
| C07AB12 121 | | nebivolol | 5 mg | 0,1234 | O | Sandoz d.o.o. | Sandoz-Salutas | Nebyol | tbl. 30x5 mg | 0,1234 | 3,70 | R | 5% |
| C07AB12 122 | | nebivolol | 5 mg | 0,1118 | O | Sandoz d.o.o. | Sandoz-Salutas | Nebyol | tbl. 60x5 mg | 0,1118 | 6,71 | R | 5% |
| C07AB12 141 | | nebivolol | 5 mg | 0,1111 | O | Alkaloid-INT d.o.o. | Alkaloid – int d.o.o. | Massido | tbl. 28x5 mg | 0,1111 | 3,11 | R | 5% |
| C07AG02 101 | | karvedilol | 37,5 mg | 0,1863 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Carvetrend | tbl. 28x25 mg | 0,1242 | 3,48 | R | 5% |
| C07AG02 102 | | karvedilol | 37,5 mg | 0,2483 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Carvetrend | tbl. 28x12,5mg | 0,0828 | 2,32 | R | 5% |
| C07AG02 103 | | karvedilol | 37,5 mg | 0,4582 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Carvetrend | tbl. 28x6,25 mg | 0,0764 | 2,14 | R | 5% |
| C07AG02 104 | | karvedilol | 37,5 mg | 0,4778 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Carvetrend | tbl. 28x3,125 mg | 0,0398 | 1,11 | R | 5% |
| C07AG02 114 | | karvedilol | 37,5 mg | 0,4778 | O | Belupo d.d. | Belupo | Carvelol | tbl. 30x3,125 mg | 0,0398 | 1,19 | R | 5% |
| C07AG02 115 | | karvedilol | 37,5 mg | 0,4582 | O | Belupo d.d. | Belupo | Carvelol | tbl. 30x6,25 mg | 0,0764 | 2,29 | R | 5% |
| C07AG02 116 | | karvedilol | 37,5 mg | 0,2483 | O | Belupo d.d. | Belupo | Carvelol | tbl. 30x12,5 mg | 0,0828 | 2,48 | R | 5% |
| C07AG02 117 | | karvedilol | 37,5 mg | 0,1863 | O | Belupo d.d. | Belupo | Carvelol | tbl. 30x25 mg | 0,1242 | 3,73 | R | 5% |
| C07AG02 131 | | karvedilol | 37,5 mg | 0,4778 | O | KRKA-FARMA d.o.o. | Krka d.d. | Coryol | tbl. 28x3,125 mg | 0,0398 | 1,11 | R | 5% |
| C07AG02 132 | | karvedilol | 37,5 mg | 0,4582 | O | KRKA-FARMA d.o.o. | Krka d.d. | Coryol | tbl. 28x6,25 mg | 0,0764 | 2,14 | R | 5% |
| C07AG02 133 | | karvedilol | 37,5 mg | 0,2483 | O | KRKA-FARMA d.o.o. | Krka d.d. | Coryol | tbl. 28x12,5 mg | 0,0828 | 2,32 | R | 5% |
| C07AG02 134 | | karvedilol | 37,5 mg | 0,1863 | O | KRKA-FARMA d.o.o. | Krka d.d. | Coryol | tbl. 28x25 mg | 0,1242 | 3,48 | R | 5% |
| C08CA01 101 | | amlodipin | 5 mg | 0,0643 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Vilpin | tbl. 30x5 mg | 0,0643 | 1,93 | R | 5% |
| C08CA01 102 | | amlodipin | 5 mg | 0,0382 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Vilpin | tbl. 30x10 mg | 0,0764 | 2,29 | R | 5% |
| C08CA01 111 | | amlodipin | 5 mg | 0,0643 | O | Belupo d.d. | Belupo | Amonex | tbl. 30x5 mg | 0,0643 | 1,93 | R | 5% |
| C08CA01 112 | | amlodipin | 5 mg | 0,0382 | O | Belupo d.d. | Belupo | Amonex | tbl. 30x10 mg | 0,0764 | 2,29 | R | 5% |
| C08CA01 113 | | amlodipin | 5 mg | 0,0478 | O | Belupo d.d. | Belupo | Amonex | tbl. 60x5 mg | 0,0478 | 2,87 | R | 5% |
| C08CA01 114 | | amlodipin | 5 mg | 0,0478 | O | Belupo d.d. | Belupo | Amonex | tbl. 90x5 mg | 0,0478 | 4,30 | R | 5% |
| C08CA01 115 | | amlodipin | 5 mg | 0,0358 | O | Belupo d.d. | Belupo | Amonex | tbl. 60x10 mg | 0,0717 | 4,30 | R | 5% |
| C08CA01 116 | | amlodipin | 5 mg | 0,0358 | O | Belupo d.d. | Belupo | Amonex | tbl. 90x10 mg | 0,0717 | 6,45 | R | 5% |
| C08CA01 123 | | amlodipin | 5 mg | 0,0643 | O | Sandoz d.o.o. | Sandoz-Lek | Amlopin | tbl. 30x5 mg | 0,0643 | 1,93 | R | 5% |
| C08CA01 124 | | amlodipin | 5 mg | 0,0478 | O | Sandoz d.o.o. | Sandoz-Lek | Amlopin | tbl. 60x5 mg | 0,0478 | 2,87 | R | 5% |
| C08CA01 125 | | amlodipin | 5 mg | 0,0478 | O | Sandoz d.o.o. | Sandoz-Lek | Amlopin | tbl. 90x5 mg | 0,0478 | 4,30 | R | 5% |
| C08CA01 126 | | amlodipin | 5 mg | 0,0382 | O | Sandoz d.o.o. | Sandoz-Lek | Amlopin | tbl. 30x10 mg | 0,0764 | 2,29 | R | 5% |
| C08CA01 127 | | amlodipin | 5 mg | 0,0358 | O | Sandoz d.o.o. | Sandoz-Lek | Amlopin | tbl. 60x10 mg | 0,0717 | 4,30 | R | 5% |
| C08CA01 128 | | amlodipin | 5 mg | 0,0358 | O | Sandoz d.o.o. | Sandoz-Lek | Amlopin | tbl. 90x10 mg | 0,0717 | 6,45 | R | 5% |
| C08CA01 131 | | amlodipin | 5 mg | 0,0643 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Tenox | tbl. 30x5 mg | 0,0643 | 1,93 | R | 5% |
| C08CA01 132 | | amlodipin | 5 mg | 0,0382 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Tenox | tbl. 30x10 mg | 0,0764 | 2,29 | R | 5% |
| C08CA01 133 | | amlodipin | 5 mg | 0,0478 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Tenox | tbl. 60x5 mg | 0,0478 | 2,87 | R | 5% |
| C08CA01 134 | | amlodipin | 5 mg | 0,0358 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Tenox | tbl. 60x10 mg | 0,0717 | 4,30 | R | 5% |
| C08CA01 141 | | amlodipin | 5 mg | 0,0643 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Lopin | tbl. 30x5 mg | 0,0643 | 1,93 | R | 5% |
| C08CA01 142 | | amlodipin | 5 mg | 0,0382 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Lopin | tbl. 30x10 mg | 0,0764 | 2,29 | R | 5% |
| C08CA01 143 | | amlodipin | 5 mg | 0,0358 | O | PharmaS d.o.o. | PharmaS d.o.o. | Amlodipin PharmaS | tbl. 30x10 mg | 0,0716 | 2,15 | R | 5% |
| C08CA01 145 | | amlodipin | 5 mg | 0,0597 | O | PharmaS d.o.o. | PharmaS d.o.o. | Amlodipin PharmaS | tbl. 30x5 mg | 0,0597 | 1,79 | R | 5% |
| C08CA01 146 | | amlodipin | 5 mg | 0,0460 | O | PharmaS d.o.o. | PharmaS d.o.o. | Amlodipin PharmaS | tbl. 60x5 mg | 0,0460 | 2,76 | R | 5% |
| C08CA01 147 | | amlodipin | 5 mg | 0,0643 | O | Alkaloid d.o.o. | Alkaloid | Caprez | tbl. 30x5 mg | 0,0643 | 1,93 | R | 5% |
| C08CA01 148 | | amlodipin | 5 mg | 0,0382 | O | Alkaloid d.o.o. | Alkaloid | Caprez | tbl. 30x10 mg | 0,0764 | 2,29 | R | 5% |
| C08CA01 149 | | amlodipin | 5 mg | 0,0323 | O | PharmaS d.o.o. | PharmaS d.o.o. | Amlodipin PharmaS | tbl. 60x10 mg | 0,0646 | 3,88 | R | 5% |
| C08CA01 171 | | amlodipin | 5 mg | 0,0643 | O | Upjohn EESV | Heinrich Mack | Norvasc | tbl. 30x5 mg | 0,0643 | 1,93 | R | 5% |
| C08CA01 172 | | amlodipin | 5 mg | 0,0382 | O | Upjohn EESV | Heinrich Mack | Norvasc | tbl. 30x10 mg | 0,0764 | 2,29 | R | 5% |
| C08CA01 181 | | amlodipin | 5 mg | 0,0575 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Amlodipin Genericon | tbl. 30x5 mg | 0,0575 | 1,73 | R | 5% |
| C08CA01 182 | | amlodipin | 5 mg | 0,0337 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Amlodipin Genericon | tbl. 30x10 mg | 0,0675 | 2,02 | R | 5% |
| C08CA01 183 | | amlodipin | 5 mg | 0,0430 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Amlodipin Genericon | tbl. 90x5 mg | 0,0430 | 3,87 | R | 5% |
| C08CA05 132 | | nifedipin dugodjelujući | 30 mg | 0,1125 | O | KRKA-FARMA d.o.o. | Krka d.d. | Cordipin XL | tbl. 20x40 mg | 0,1500 | 3,00 | R | 5% |
| C08CA06 041 | DS | nimodipinNC801 | 50 mg | 56,7523 | P | Bayer d.o.o. | Bayer AG | Nimotop S | boč. inf. 1x10 mg/50 ml | 11,3505 | 11,35 | | 5% |
| C08CA13 111 | | lerkanidipin | 10 mg | 0,0643 | O | Belupo d.d. | Belupo | Pinox | tbl. film obl. 28x10 mg | 0,0643 | 1,80 | R | 5% |
| C08CA13 112 | | lerkanidipin | 10 mg | 0,0478 | O | Belupo d.d. | Belupo | Pinox | tbl. film obl. 56x10 mg | 0,0478 | 2,68 | R | 5% |
| C08DA01 105 | | verapamil | 0,24 g | 0,1863 | O | Mylan Hrvatska d.o.o. | AbbVie Deutschland GmbH & Co.KG | Isoptin RR | tbl. s prod. oslob. 30x240 mg | 0,1863 | 5,59 | R | 5% |
| C09AA02 131 | | enalapril | 10 mg | 0,0531 | O | KRKA-FARMA d.o.o. | Krka d.d. | Enap | tbl. 20x5 mg | 0,0265 | 0,53 | R | 5% |
| C09AA02 132 | | enalapril | 10 mg | 0,0465 | O | KRKA-FARMA d.o.o. | Krka d.d. | Enap | tbl. 20x10 mg | 0,0465 | 0,93 | R | 5% |
| C09AA03 101 | | lizinopril | 10 mg | 0,0504 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Optimon | tbl. 30x5 mg | 0,0252 | 0,76 | R | 5% |
| C09AA03 102 | | lizinopril | 10 mg | 0,0385 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Optimon | tbl. 30x10 mg | 0,0385 | 1,15 | R | 5% |
| C09AA03 103 | | lizinopril | 10 mg | 0,0420 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Optimon | tbl. 30x20 mg | 0,0841 | 2,52 | R | 5% |
| C09AA03 104 | | lizinopril | 10 mg | 0,0531 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Amicor | tbl. 30x5 mg | 0,0265 | 0,80 | R | 5% |
| C09AA03 113 | | lizinopril | 10 mg | 0,0531 | O | Belupo d.d. | Belupo | Irumed | tbl. 60x5 mg | 0,0265 | 1,59 | R | 5% |
| C09AA03 114 | | lizinopril | 10 mg | 0,0531 | O | Belupo d.d. | Belupo | Irumed | tbl. 30x5 mg | 0,0265 | 0,80 | R | 5% |
| C09AA03 115 | | lizinopril | 10 mg | 0,0465 | O | Belupo d.d. | Belupo | Irumed | tbl. 30x10 mg | 0,0465 | 1,39 | R | 5% |
| C09AA03 116 | | lizinopril | 10 mg | 0,0420 | O | Belupo d.d. | Belupo | Irumed | tbl. 30x20 mg | 0,0841 | 2,52 | R | 5% |
| C09AA03 124 | | lizinopril | 10 mg | 0,0465 | O | Belupo d.d. | Belupo | Irumed | tbl. 60x10 mg | 0,0465 | 2,79 | R | 5% |
| C09AA03 125 | | lizinopril | 10 mg | 0,0332 | O | Belupo d.d. | Belupo | Irumed | tbl. 60x20 mg | 0,0664 | 3,98 | R | 5% |
| C09AA03 127 | | lizinopril | 10 mg | 0,0465 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Amicor | tbl. 30x10 mg | 0,0465 | 1,39 | R | 5% |
| C09AA03 129 | | lizinopril | 10 mg | 0,0420 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Amicor | tbl. 30x20 mg | 0,0841 | 2,52 | R | 5% |
| C09AA03 130 | | lizinopril | 10 mg | 0,0332 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Amicor | tbl. 60x20 mg | 0,0664 | 3,98 | R | 5% |
| C09AA03 143 | | lizinopril | 10 mg | 0,0385 | O | Alkaloid d.o.o. | Alkaloid | Skopryl | tbl. 30x10 mg | 0,0385 | 1,15 | R | 5% |
| C09AA03 144 | | lizinopril | 10 mg | 0,0420 | O | Alkaloid d.o.o. | Alkaloid | Skopryl | tbl. 30x20 mg | 0,0841 | 2,52 | R | 5% |
| C09AA04 130 | | perindopril | 4 mg | 0,0531 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Perineva | tbl. 30x2 mg | 0,0265 | 0,80 | R | 5% |
| C09AA04 131 | | perindopril | 4 mg | 0,0465 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Perineva | tbl. 30x4 mg | 0,0465 | 1,39 | R | 5% |
| C09AA04 132 | | perindopril | 4 mg | 0,0465 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Perineva | tbl. 60x4 mg | 0,0465 | 2,79 | R | 5% |
| C09AA04 133 | | perindopril | 4 mg | 0,0420 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Perineva | tbl. 30x8 mg | 0,0841 | 2,52 | R | 5% |
| C09AA05 104 | | ramipril | 2,5 mg | 0,0465 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen | tbl. 30x2,5 mg | 0,0465 | 1,39 | R | 5% |
| C09AA05 105 | | ramipril | 2,5 mg | 0,0420 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen | tbl. 30x5 mg | 0,0841 | 2,52 | R | 5% |
| C09AA05 106 | | ramipril | 2,5 mg | 0,0322 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen | tbl. 30x10 mg | 0,1287 | 3,86 | R | 5% |
| C09AA05 107 | | ramipril | 2,5 mg | 0,0465 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen | tbl. 60x2,5 mg | 0,0465 | 2,79 | R | 5% |
| C09AA05 108 | | ramipril | 2,5 mg | 0,0332 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen | tbl. 60x5 mg | 0,0664 | 3,98 | R | 5% |
| C09AA05 109 | | ramipril | 2,5 mg | 0,0322 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen | tbl. 60x10 mg | 0,1287 | 7,72 | R | 5% |
| C09AA05 111 | | ramipril | 2,5 mg | 0,0531 | O | Belupo d.d. | Belupo | Ramed | tbl. 28x1,25 mg | 0,0265 | 0,74 | R | 5% |
| C09AA05 112 | | ramipril | 2,5 mg | 0,0465 | O | Belupo d.d. | Belupo | Ramed | tbl. 28x2,5 mg | 0,0465 | 1,30 | R | 5% |
| C09AA05 113 | | ramipril | 2,5 mg | 0,0420 | O | Belupo d.d. | Belupo | Ramed | tbl. 28x5 mg | 0,0840 | 2,35 | R | 5% |
| C09AA05 114 | | ramipril | 2,5 mg | 0,0322 | O | Belupo d.d. | Belupo | Ramed | tbl. 28x10 mg | 0,1287 | 3,60 | R | 5% |
| C09AA05 115 | | ramipril | 2,5 mg | 0,0465 | O | Belupo d.d. | Belupo | Ramed | tbl. 56x2,5 mg | 0,0465 | 2,60 | R | 5% |
| C09AA05 116 | | ramipril | 2,5 mg | 0,0332 | O | Belupo d.d. | Belupo | Ramed | tbl. 56x5 mg | 0,0664 | 3,72 | R | 5% |
| C09AA05 117 | | ramipril | 2,5 mg | 0,0465 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Blocar | tbl. 28x2,5 mg | 0,0465 | 1,30 | R | 5% |
| C09AA05 118 | | ramipril | 2,5 mg | 0,0420 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Blocar | tbl. 28x5 mg | 0,0840 | 2,35 | R | 5% |
| C09AA05 119 | | ramipril | 2,5 mg | 0,0322 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Blocar | tbl. 28x10 mg | 0,1287 | 3,60 | R | 5% |
| C09AA05 121 | | ramipril | 2,5 mg | 0,0531 | O | Sandoz d.o.o. | Sandoz-Lek | Piramil | tbl. 28x1,25 mg | 0,0265 | 0,74 | R | 5% |
| C09AA05 122 | | ramipril | 2,5 mg | 0,0465 | O | Sandoz d.o.o. | Sandoz-Lek | Piramil | tbl. 28x2,5 mg | 0,0465 | 1,30 | R | 5% |
| C09AA05 123 | | ramipril | 2,5 mg | 0,0465 | O | Sandoz d.o.o. | Sandoz-Lek | Piramil | tbl. 50x2,5 mg | 0,0465 | 2,32 | R | 5% |
| C09AA05 124 | | ramipril | 2,5 mg | 0,0420 | O | Sandoz d.o.o. | Sandoz-Lek | Piramil | tbl. 28x5 mg | 0,0840 | 2,35 | R | 5% |
| C09AA05 125 | | ramipril | 2,5 mg | 0,0332 | O | Sandoz d.o.o. | Sandoz-Lek | Piramil | tbl. 50x5 mg | 0,0664 | 3,32 | R | 5% |
| C09AA05 126 | | ramipril | 2,5 mg | 0,0322 | O | Sandoz d.o.o. | Sandoz-Lek | Piramil | tbl. 28x10 mg | 0,1287 | 3,60 | R | 5% |
| C09AA05 127 | | ramipril | 2,5 mg | 0,0322 | O | Sandoz d.o.o. | Sandoz-Lek | Piramil | tbl. 50x10 mg | 0,1287 | 6,44 | R | 5% |
| C09AA05 131 | | ramipril | 2,5 mg | 0,0531 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril | tbl. 30x1,25 mg | 0,0265 | 0,80 | R | 5% |
| C09AA05 133 | | ramipril | 2,5 mg | 0,0465 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril | tbl. 30x2,5 mg | 0,0465 | 1,39 | R | 5% |
| C09AA05 134 | | ramipril | 2,5 mg | 0,0465 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril | tbl. 60x2,5 mg | 0,0465 | 2,79 | R | 5% |
| C09AA05 135 | | ramipril | 2,5 mg | 0,0420 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril | tbl. 30x5 mg | 0,0841 | 2,52 | R | 5% |
| C09AA05 136 | | ramipril | 2,5 mg | 0,0332 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril | tbl. 60x5 mg | 0,0664 | 3,98 | R | 5% |
| C09AA05 137 | | ramipril | 2,5 mg | 0,0322 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril | tbl. 30x10 mg | 0,1287 | 3,86 | R | 5% |
| C09AA05 138 | | ramipril | 2,5 mg | 0,0322 | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril | tbl. 60x10 mg | 0,1287 | 7,72 | R | 5% |
| C09AA05 141 | | ramipril | 2,5 mg | 0,0465 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH | Ramipril Mibe | tbl. 28x2,5 mg | 0,0465 | 1,30 | R | 5% |
| C09AA05 142 | | ramipril | 2,5 mg | 0,0420 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH | Ramipril Mibe | tbl. 28x5 mg | 0,0840 | 2,35 | R | 5% |
| C09AA05 143 | | ramipril | 2,5 mg | 0,0322 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH | Ramipril Mibe | tbl. 28x10 mg | 0,1287 | 3,60 | R | 5% |
| C09AA05 161 | | ramipril | 2,5 mg | 0,0420 | O | sanofi-aventis groupe | Sanofi-Aventis S.p.A., Sanofi-Aventis GmbH, Sanofi Winthrop Quetigny | Tritace | tbl. 28x5 mg | 0,0840 | 2,35 | R | 5% |
| C09AA05 164 | | ramipril | 2,5 mg | 0,0322 | O | sanofi-aventis groupe | Sanofi-Aventis S.p.A., Sanofi-Aventis GmbH, Sanofi Winthrop Quetigny | Tritace | tbl. 28x10 mg | 0,1287 | 3,60 | R | 5% |
| C09AA05 171 | | ramipril | 2,5 mg | 0,0465 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Ramipril Genericon | tbl. 30x2,5 mg | 0,0465 | 1,39 | R | 5% |
| C09AA05 172 | | ramipril | 2,5 mg | 0,0420 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Ramipril Genericon | tbl. 30x5 mg | 0,0841 | 2,52 | R | 5% |
| C09AA05 173 | | ramipril | 2,5 mg | 0,0322 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Ramipril Genericon | tbl. 30x10 mg | 0,1287 | 3,86 | R | 5% |
| C09AA05 175 | | ramipril | 2,5 mg | 0,0332 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Ramipril Genericon | tbl. 90x5 mg | 0,0664 | 5,97 | R | 5% |
| C09BA02 132 | | enalapril + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Enap H | tbl. 20x(10 mg +25 mg) | 0,0790 | 1,58 | R | 5% |
| C09BA02 134 | | enalapril + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Enap HL 20 | tbl. 30x(20 mg +12,5 mg) | 0,1186 | 3,56 | R | 5% |
| C09BA02 135 | | enalapril + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Enap HL 20 | tbl. 60x(20 mg +12,5 mg) | 0,1119 | 6,72 | R | 5% |
| C09BA03 101 | | lizinopril + hidroklorotiazid | | | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Optimon Plus | tbl. 30x(20 mg +12,5 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA03 112 | | lizinopril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Iruzid | tbl. 30x(20 mg +12,5 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA03 113 | | lizinopril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Iruzid | tbl. 60x(20 mg +12,5 mg) | 0,1230 | 7,38 | R | 5% |
| C09BA03 114 | | lizinopril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Iruzid | tbl. 30x(10 mg +12,5 mg) | 0,0845 | 2,54 | R | 5% |
| C09BA03 115 | | lizinopril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Iruzid | tbl. 60x(10 mg +12,5 mg) | 0,0845 | 5,07 | R | 5% |
| C09BA03 116 | | lizinopril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Iruzid | tbl. 30x(20 mg +25 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA03 117 | | lizinopril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Iruzid | tbl. 60x(20 mg +25 mg) | 0,1110 | 6,66 | R | 5% |
| C09BA03 122 | | lizinopril + hidroklorotiazid | | | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Amicor H | tbl. 20x(20 mg +12,5 mg) | 0,1230 | 2,46 | R | 5% |
| C09BA03 123 | | lizinopril + hidroklorotiazid | | | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Amicor H | tbl. 30x(10 mg +12,5 mg) | 0,0845 | 2,54 | R | 5% |
| C09BA03 124 | | lizinopril + hidroklorotiazid | | | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Amicor H | tbl. 30x(20 mg +12,5 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA03 141 | | lizinopril + hidroklorotiazid | | | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH | Lizinopril H Mibe | tbl. 30x(10 mg +12,5 mg) | 0,0845 | 2,54 | R | 5% |
| C09BA03 142 | | lizinopril + hidroklorotiazid | | | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH | Lizinopril H Mibe | tbl. 30x(20 mg +12,5 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA03 145 | | lizinopril + hidroklorotiazid | | | O | Alkaloid d.o.o. | Alkaloid | Skopryl Plus | tbl. 30x(20 mg +12,5 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA03 146 | | lizinopril + hidroklorotiazid | | | O | Alkaloid d.o.o. | Alkaloid | Skopryl Plus | tbl. 60x(20 mg +12,5 mg) | 0,1150 | 6,90 | R | 5% |
| C09BA04 102 | | perindopril + indapamid | | | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o | Co-Articel | tbl. film obl. 30x(5 mg + 1,25 mg) | 0,0894 | 2,68 | R | 5% |
| C09BA04 131 | | perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Co-Perineva | tbl. 60x(2 mg +0,625 mg) | 0,0447 | 2,68 | R | 5% |
| C09BA04 132 | | perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Co-Perineva | tbl. 30x(4 mg +1,25 mg) | 0,0894 | 2,68 | R | 5% |
| C09BA04 134 | | perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Co-Perineva | tbl. 30x(8 mg +2,5 mg) | 0,1449 | 4,35 | R | 5% |
| C09BA04 136 | | perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Co-Perineva | tbl. 30x(2 mg +0,625 mg) | 0,0447 | 1,34 | R | 5% |
| C09BA05 103 | | ramipril + hidroklorotiazid | | | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen Plus | tbl. 30x(2,5 mg +12,5 mg) | 0,0845 | 2,54 | R | 5% |
| C09BA05 104 | | ramipril + hidroklorotiazid | | | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen Plus | tbl. 30x(5 mg +25 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA05 105 | | ramipril + hidroklorotiazid | | | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen Plus | tbl. 60x(2,5 mg +12,5 mg) | 0,0845 | 5,07 | R | 5% |
| C09BA05 106 | | ramipril + hidroklorotiazid | | | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Prilen Plus | tbl. 60x(5 mg +25 mg) | 0,1110 | 6,66 | R | 5% |
| C09BA05 111 | | ramipril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Ramzid | tbl. 28x(2,5mg +12,5 mg) | 0,0845 | 2,37 | R | 5% |
| C09BA05 112 | | ramipril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Ramzid | tbl. 28x(5 mg +25 mg) | 0,1230 | 3,44 | R | 5% |
| C09BA05 113 | | ramipril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Ramzid | tbl. 56x(2,5 mg +12,5 mg) | 0,0845 | 4,73 | R | 5% |
| C09BA05 114 | | ramipril + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Ramzid | tbl. 56x(5 mg +25 mg) mg | 0,1110 | 6,22 | R | 5% |
| C09BA05 121 | | ramipril + hidroklorotiazid | | | O | Sandoz d.o.o. | Sandoz-Salutas | Piramil HL | tbl. 28x(2,5 mg +12,5 mg) | 0,0845 | 2,37 | R | 5% |
| C09BA05 123 | | ramipril + hidroklorotiazid | | | O | Sandoz d.o.o. | Sandoz-Salutas | Piramil H | tbl. 28x(5mg +25 mg) | 0,1230 | 3,44 | R | 5% |
| C09BA05 128 | | ramipril + hidroklorotiazid | | | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Blocar Plus | tbl. 28x(2,5mg +12,5 mg) | 0,0740 | 2,07 | R | 5% |
| C09BA05 129 | | ramipril + hidroklorotiazid | | | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Blocar Plus | tbl. 28x(5 mg +25 mg) | 0,1206 | 3,38 | R | 5% |
| C09BA05 131 | | ramipril + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril HL | tbl. 30x(2,5 mg +12,5 mg) | 0,0845 | 2,54 | R | 5% |
| C09BA05 132 | | ramipril + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril HL | tbl. 60x(2,5 mg +12,5 mg) | 0,0845 | 5,07 | R | 5% |
| C09BA05 133 | | ramipril + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril HD | tbl. 30x(5 mg +25 mg) | 0,1230 | 3,69 | R | 5% |
| C09BA05 134 | | ramipril + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Ampril HD | tbl. 60x(5 mg +25 mg) | 0,1110 | 6,66 | R | 5% |
| C09BA05 141 | | ramipril + hidroklorotiazid | | | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH | Ramipril H Mibe | tbl. 28x(2,5 mg +12,5 mg) | 0,0845 | 2,37 | R | 5% |
| C09BA05 142 | | ramipril + hidroklorotiazid | | | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH | Ramipril H Mibe | tbl. 28x(5 mg +25 mg) | 0,1230 | 3,44 | R | 5% |
| C09BA05 161 | | ramipril + hidroklorotiazid | | | O | sanofi-aventis groupe | Aventis Pharma S.p.A | Tritazide | tbl. 28x(2,5 mg +12,5 mg) | 0,0845 | 2,37 | R | 5% |
| C09BA05 171 | | ramipril + hidroklorotiazid | | | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Ramicomp Genericon 2,5 mg/12,5 mg | tbl. 30x(2,5 mg +12,5 mg) | 0,0823 | 2,47 | R | 5% |
| C09BA05 172 | | ramipril + hidroklorotiazid | | | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Ramicomp Genericon 5 mg/25 mg | tbl. 30x(5 mg +25 mg) | 0,1230 | 3,69 | R | 5% |
| C09BB04 101 | | perindopril + amlodipin | | | O | PLIVA HRVATSKA d.o.o. | Teva Czech Industries s.r.o., Teva Pharma S.L.U., Teva UK Ltd., Teva Operations Poland Sp. z o.o., Teva Pharmaceuticals, Teva Pharma B.V. | Articel-Am | tbl. 30x(5 mg + 5 mg) | 0,0894 | 2,68 | R | 5% |
| C09BB04 111 | | perindopril + amlodipin | | | O | Jadran – Galenski Laboratorij d.d. | Adamed Pharma S.A., Jadran Galenski laboratorij d.d. | Almirincomb | tbl. 30x(4 mg+5 mg) | 0,0626 | 1,88 | R | 5% |
| C09BB04 112 | | perindopril + amlodipin | | | O | Jadran – Galenski Laboratorij d.d. | Adamed Pharma S.A., Jadran Galenski laboratorij d.d. | Almirincomb | tbl. 30x(4 mg+10 mg) | 0,0626 | 1,88 | R | 5% |
| C09BB04 113 | | perindopril + amlodipin | | | O | Jadran – Galenski Laboratorij d.d. | Adamed Pharma S.A., Jadran Galenski laboratorij d.d. | Almirincomb | tbl. 30x(8 mg+5 mg) | 0,1031 | 3,09 | R | 5% |
| C09BB04 114 | | perindopril + amlodipin | | | O | Jadran – Galenski Laboratorij d.d. | Adamed Pharma S.A., Jadran Galenski laboratorij d.d. | Almirincomb | tbl. 30x(8 mg+10 mg) | 0,1094 | 3,28 | R | 5% |
| C09BB04 131 | | perindopril + amlodipin | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Dalneva | tbl. 30x(4 mg +5 mg) | 0,0894 | 2,68 | R | 5% |
| C09BB04 132 | | perindopril + amlodipin | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Dalneva | tbl. 30x(4 mg +10 mg) | 0,0894 | 2,68 | R | 5% |
| C09BB04 133 | | perindopril + amlodipin | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Dalneva | tbl. 30x(8 mg +5 mg) | 0,1473 | 4,42 | R | 5% |
| C09BB04 134 | | perindopril + amlodipin | | | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Dalneva | tbl. 30x(8 mg +10 mg) | 0,1563 | 4,69 | R | 5% |
| C09BB04 135 | | perindopril + amlodipin | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Predalneva | tbl. 30x(2,85 mg +2,5 mg) | 0,0511 | 1,53 | R | 5% |
| C09BB07 101 | | ramipril + amlodipin | | | O | PLIVA HRVATSKA d.o.o. | Pliva-Hrvatska d.o.o. | Prilen-Am | caps. tvrda 30x(5 mg+5 mg) | 0,1266 | 3,80 | R | 5% |
| C09BB07 102 | | ramipril + amlodipin | | | O | PLIVA HRVATSKA d.o.o. | Pliva-Hrvatska d.o.o. | Prilen-Am | caps. tvrda 60x(5 mg+5 mg) | 0,1139 | 6,84 | R | 5% |
| C09BB07 103 | | ramipril + amlodipin | | | O | PLIVA HRVATSKA d.o.o. | Pliva-Hrvatska d.o.o. | Prilen-Am | caps. tvrda 30x(5 mg+10 mg) | 0,1266 | 3,80 | R | 5% |
| C09BB07 104 | | ramipril + amlodipin | | | O | PLIVA HRVATSKA d.o.o. | Pliva-Hrvatska d.o.o. | Prilen-Am | caps. tvrda 60x(5 mg+10 mg) | 0,1139 | 6,84 | R | 5% |
| C09BB07 105 | | ramipril + amlodipin | | | O | PLIVA HRVATSKA d.o.o. | Pliva-Hrvatska d.o.o. | Prilen-Am | caps. tvrda 30x(10 mg+5 mg) | 0,1502 | 4,51 | R | 5% |
| C09BB07 106 | | ramipril + amlodipin | | | O | PLIVA HRVATSKA d.o.o. | Pliva-Hrvatska d.o.o. | Prilen-Am | caps. tvrda 30x(10 mg+10 mg) | 0,1502 | 4,51 | R | 5% |
| C09BB07 110 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 60x(10 mg+10 mg) | 0,1352 | 8,11 | R | 5% |
| C09BB07 111 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 30x(2,5 mg+5 mg) | 0,0936 | 2,81 | R | 5% |
| C09BB07 112 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 60x(2,5 mg+5 mg) | 0,0842 | 5,05 | R | 5% |
| C09BB07 113 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 30x(5 mg+5 mg) | 0,1266 | 3,80 | R | 5% |
| C09BB07 114 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 60x(5 mg+5 mg) | 0,1139 | 6,84 | R | 5% |
| C09BB07 115 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 30x(5 mg+10 mg) | 0,1266 | 3,80 | R | 5% |
| C09BB07 116 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 60x(5 mg+10 mg) | 0,1139 | 6,84 | R | 5% |
| C09BB07 117 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 30x(10 mg+5 mg) | 0,1502 | 4,51 | R | 5% |
| C09BB07 118 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 60x(10 mg+5 mg) | 0,1352 | 8,11 | R | 5% |
| C09BB07 119 | | ramipril + amlodipin | | | O | Belupo d.d. | Belupo | Amora | caps. tvrda 30x(10 mg+10 mg) | 0,1502 | 4,51 | R | 5% |
| C09BB07 122 | | ramipril + amlodipin | | | O | Sandoz d.o.o. | Sandoz-Lek | Prylar | caps. tvrda 30x(5 mg+5 mg) | 0,1266 | 3,80 | R | 5% |
| C09BB07 123 | | ramipril + amlodipin | | | O | Sandoz d.o.o. | Sandoz-Lek | Prylar | caps. tvrda 30x(10 mg+5 mg) | 0,1502 | 4,51 | R | 5% |
| C09BB07 124 | | ramipril + amlodipin | | | O | Sandoz d.o.o. | Sandoz-Lek | Prylar | caps. tvrda 30x(5 mg+10 mg) | 0,1266 | 3,80 | R | 5% |
| C09BB07 125 | | ramipril + amlodipin | | | O | Sandoz d.o.o. | Sandoz-Lek | Prylar | caps. tvrda 30x(10 mg+10 mg) | 0,1502 | 4,51 | R | 5% |
| C09BB07 131 | | ramipril + amlodipin | | | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Rameam | caps. tvrda 30x(5 mg+5 mg) | 0,1266 | 3,80 | R | 5% |
| C09BB07 181 | | ramipril + amlodipin | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol | caps. tvrda 30x(5 mg+5 mg) | 0,1203 | 3,61 | R | 5% |
| C09BB07 182 | | ramipril + amlodipin | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol | caps. tvrda 30x(5 mg+10 mg) | 0,1203 | 3,61 | R | 5% |
| C09BB07 183 | | ramipril + amlodipin | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol | caps. tvrda 30x(10 mg+5 mg) | 0,1427 | 4,28 | R | 5% |
| C09BB07 184 | | ramipril + amlodipin | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol | caps. tvrda 30x(10 mg+10 mg) | 0,1427 | 4,28 | R | 5% |
| C09BX01 131 | | perindopril + indapamid + amlodipin | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Co-Dalneva | tbl. film obl. 30x(4 mg+1,25 mg+5 mg) | 0,1099 | 3,30 | R | 5% |
| C09BX01 132 | | perindopril + indapamid + amlodipin | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Co-Dalneva | tbl. film obl. 30x(4 mg+1,25 mg+10 mg) | 0,1172 | 3,52 | R | 5% |
| C09BX01 133 | | perindopril + indapamid + amlodipin | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Co-Dalneva | tbl. film obl. 30x(8 mg+2,5 mg+5 mg) | 0,2185 | 6,56 | R | 5% |
| C09BX01 134 | | perindopril + indapamid + amlodipin | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Co-Dalneva | tbl. film obl. 30x(8 mg+2,5 mg+10 mg) | 0,2259 | 6,78 | R | 5% |
| C09BX03 121 | | ramipril + amlodipin + hidroklorotiazid | | | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Prylar H | caps. tvrda 30x(5 mg+5 mg+12,5 mg) | 0,0991 | 2,97 | R | 5% |
| C09BX03 122 | | ramipril + amlodipin + hidroklorotiazid | | | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Prylar H | caps. tvrda 30x(5 mg+5 mg+25 mg) | 0,0991 | 2,97 | R | 5% |
| C09BX03 123 | | ramipril + amlodipin + hidroklorotiazid | | | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Prylar H | caps. tvrda 30x(10 mg+5 mg+25 mg) | 0,1322 | 3,97 | R | 5% |
| C09BX03 124 | | ramipril + amlodipin + hidroklorotiazid | | | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Prylar H | caps. tvrda 30x(10 mg+10 mg+25 mg) | 0,1392 | 4,18 | R | 5% |
| C09BX03 171 | | ramipril + amlodipin + hidroklorotiazid | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol Plus | caps. tvrda 30x(5 mg+5 mg+12,5 mg) | 0,0991 | 2,97 | R | 5% |
| C09BX03 172 | | ramipril + amlodipin + hidroklorotiazid | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol Plus | caps. tvrda 30x(5 mg+5 mg+25 mg) | 0,0991 | 2,97 | R | 5% |
| C09BX03 173 | | ramipril + amlodipin + hidroklorotiazid | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol Plus | caps. tvrda 30x(10 mg+5 mg+25 mg) | 0,1322 | 3,97 | R | 5% |
| C09BX03 174 | | ramipril + amlodipin + hidroklorotiazid | | | O | Genericon Pharma Gesellschaft m.b.H. | Adamed Pharma S.A. | Pinmirol Plus | caps. tvrda 30x(10 mg+10 mg+25 mg) | 0,1392 | 4,18 | R | 5% |
| C09CA01 101 | | losartan | 50 mg | 0,0730 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Losartic | tbl. 28x50 mg | 0,0730 | 2,04 | RRC02 | 5% |
| C09CA01 121 | | losartan | 50 mg | 0,0730 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Lotan | tbl. film obl. 28x50 mg | 0,0730 | 2,04 | RRC02 | 5% |
| C09CA01 125 | | losartan | 50 mg | 0,0730 | O | Alkaloid d.o.o. | Alkaloid | Lotar | tbl. film obl. 30x50 mg | 0,0730 | 2,19 | RRC02 | 5% |
| C09CA01 126 | | losartan | 50 mg | 0,0765 | O | Alkaloid d.o.o. | Alkaloid | Lotar | tbl. film obl. 30x100 mg | 0,1531 | 4,59 | RRC02 | 5% |
| C09CA01 131 | | losartan | 50 mg | 0,0730 | O | KRKA-FARMA d.o.o. | Krka d.d. | Lorista | tbl. 28 x 50 mg | 0,0730 | 2,04 | RRC02 | 5% |
| C09CA01 132 | | losartan | 50 mg | 0,0765 | O | KRKA-FARMA d.o.o. | Krka d.d. | Lorista | tbl. 28x100 mg | 0,1531 | 4,29 | RRC02 | 5% |
| C09CA03 111 | | valsartan | 80 mg | 0,0730 | O | Belupo d.d. | Belupo | Val | tbl. film obl. 28x80 mg | 0,0730 | 2,04 | RRC02 | 5% |
| C09CA03 112 | | valsartan | 80 mg | 0,0765 | O | Belupo d.d. | Belupo | Val | tbl. film obl. 28x160 mg | 0,1531 | 4,29 | RRC02 | 5% |
| C09CA03 113 | | valsartan | 80 mg | 0,0730 | O | Belupo d.d. | Belupo | Val | tbl. film obl. 56x80 mg | 0,0730 | 4,09 | RRC02 | 5% |
| C09CA03 114 | | valsartan | 80 mg | 0,0768 | O | Belupo d.d. | Belupo | Val | tbl. film obl. 56x160 mg | 0,1535 | 8,60 | RRC02 | 5% |
| C09CA03 121 | | valsartan | 80 mg | 0,0730 | O | Sandoz d.o.o. | Sandoz-Lek | Valnorm | tbl. film obl. 30x80 mg | 0,0730 | 2,19 | RRC02 | 5% |
| C09CA03 122 | | valsartan | 80 mg | 0,0765 | O | Sandoz d.o.o. | Sandoz-Lek | Valnorm | tbl. film obl. 30x160 mg | 0,1531 | 4,59 | RRC02 | 5% |
| C09CA03 124 | | valsartan | 80 mg | 0,0702 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Desart | tbl. film obl. 28x80 mg | 0,0702 | 1,96 | RRC02 | 5% |
| C09CA03 125 | | valsartan | 80 mg | 0,0765 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Desart | tbl. film obl. 28x160 mg | 0,1531 | 4,29 | RRC02 | 5% |
| C09CA03 132 | | valsartan | 80 mg | 0,0730 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Valsacor | tbl. film obl. 28x80 mg | 0,0730 | 2,04 | RRC02 | 5% |
| C09CA03 133 | | valsartan | 80 mg | 0,0765 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Valsacor | tbl. film obl. 28x160 mg | 0,1531 | 4,29 | RRC02 | 5% |
| C09CA03 134 | | valsartan | 80 mg | 0,0773 | O | KRKA-FARMA d.o.o. | Krka d.d. | Valsacor | tbl. film obl. 28x320 mg | 0,3092 | 8,66 | RRC02 | 5% |
| C09CA06 122 | | kandesartan | 8 mg | 0,0765 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Kandepres | tbl. 28x16 mg | 0,1531 | 4,29 | RRC02 | 5% |
| C09CA07 131 | | telmisartan | 40 mg | 0,0730 | O | Krka d.d., Novo mesto | Krka d.d., Krka Polska | Tolura | tbl. 30x40 mg | 0,0730 | 2,19 | RRC02 | 5% |
| C09CA07 132 | | telmisartan | 40 mg | 0,0765 | O | Krka d.d., Novo mesto | Krka d.d., Krka Polska | Tolura | tbl. 30x80 mg | 0,1531 | 4,59 | RRC02 | 5% |
| C09DA01 101 | | losartan + hidroklorotiazid | | | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Losartic plus | tbl. 28x(50 mg +12,5 mg) | 0,1261 | 3,53 | RRC02 | 5% |
| C09DA01 121 | | losartan + hidroklorotiazid | | | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Lotan H | tbl. 28x(50 mg +12,5 mg) | 0,1261 | 3,53 | RRC02 | 5% |
| C09DA01 131 | | losartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Lorista H | tbl. film obl. 28x(50 mg +12,5 mg) | 0,1261 | 3,53 | RRC02 | 5% |
| C09DA01 132 | | losartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Lorista HD | tbl. film obl. 30x(100 mg +25 mg) | 0,1531 | 4,59 | RRC02 | 5% |
| C09DA01 134 | | losartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | KRKA d.d. | Lorista H | tbl. film obl. 28x(100 mg+12,5 mg) | 0,1633 | 4,57 | RRC02 | 5% |
| C09DA01 161 | | losartan + hidroklorotiazid | | | O | Organon Pharma d.o.o. | Merck Sharp & Dohme | Hyzaar | tbl. 28x(50 mg +12,5 mg) | 0,1261 | 3,53 | RRC02 | 5% |
| C09DA01 162 | | losartan + hidroklorotiazid | | | O | Organon Pharma d.o.o. | Merck Sharp & Dohme | Fortzaar | tbl. 28x(100 mg +25 mg) | 0,1659 | 4,65 | RRC02 | 5% |
| C09DA01 163 | | losartan + hidroklorotiazid | | | O | Organon Pharma d.o.o. | Merck Sharp & Dohme | Hyzaar | tbl. film obl. 28x(100 mg+12,5 mg) | 0,1633 | 4,57 | RRC02 | 5% |
| C09DA03 111 | | valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Val Plus | tbl. film obl. 28x(80 mg +12,5 mg) | 0,1261 | 3,53 | RRC02 | 5% |
| C09DA03 112 | | valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Val Plus | tbl. film obl. 28x(160 mg +12,5 mg) | 0,1695 | 4,74 | RRC02 | 5% |
| C09DA03 113 | | valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Val Plus | tbl. film obl. 56x(80 mg +12,5 mg) | 0,1261 | 7,06 | RRC02 | 5% |
| C09DA03 114 | | valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo | Val Plus | tbl. film obl. 56x(160 mg +12,5 mg) | 0,1695 | 9,49 | RRC02 | 5% |
| C09DA03 121 | | valsartan + hidroklorotiazid | | | O | Sandoz d.o.o. | Sandoz-Lek | Valnorm H | tbl. film obl. 30x(80 mg +12,5 mg) | 0,1261 | 3,78 | RRC02 | 5% |
| C09DA03 122 | | valsartan + hidroklorotiazid | | | O | Sandoz d.o.o. | Sandoz-Lek | Valnorm H | tbl. film obl. 30x(160 mg +12,5 mg) | 0,1694 | 5,08 | RRC02 | 5% |
| C09DA03 124 | | valsartan + hidroklorotiazid | | | O | Sandoz d.o.o. | Sandoz-Lek | Valnorm H | tbl. film obl. 30x(160 mg +25 mg) | 0,1694 | 5,08 | RRC02 | 5% |
| C09DA03 131 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Valsacombi | tbl. film obl. 28x(80 mg +12,5 mg) | 0,1261 | 3,53 | RRC02 | 5% |
| C09DA03 132 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Valsacombi | tbl. film obl. 56x(80 mg +12,5 mg) | 0,1261 | 7,06 | RRC02 | 5% |
| C09DA03 133 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Valsacombi | tbl. film obl. 28x(160 mg +12,5 mg) | 0,1695 | 4,74 | RRC02 | 5% |
| C09DA03 134 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Valsacombi | tbl. film obl. 56x(160 mg +12,5 mg) | 0,1695 | 9,49 | RRC02 | 5% |
| C09DA03 135 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Valsacombi | tbl. film obl. 28x(160 mg +25 mg) | 0,1695 | 4,74 | RRC02 | 5% |
| C09DA03 136 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Valsacombi | tbl. film obl. 56x(160 mg +25 mg) | 0,1695 | 9,49 | RRC02 | 5% |
| C09DA03 137 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Valsacombi | tbl. film obl. 28x(320 mg+12,5 mg) | 0,3614 | 10,12 | RRC02 | 5% |
| C09DA03 139 | | valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Valsacombi | tbl. film obl. 28x(320 mg+25 mg) | 0,3614 | 10,12 | RRC02 | 5% |
| C09DA03 163 | | valsartan + hidroklorotiazid | | | O | Novartis Hrvatska d.o.o. | Novartis Farma S.p.A., Novartis Pharma GmbH | Co-Diovan | tbl. film obl. 28x(160 mg +25 mg) | 0,1695 | 4,74 | RRC02 | 5% |
| C09DA03 164 | | valsartan + hidroklorotiazid | | | O | Novartis Hrvatska d.o.o. | Novartis Farma S.p.A., Novartis Pharma GmbH | Co-Diovan | tbl. film obl. 28x(320 mg +12,5 mg) | 0,3614 | 10,12 | RRC02 | 5% |
| C09DA07 137 | | telmisartan + hidroklorotiazid | | | O | Krka d.d., Novo mesto | Krka d.d., Krka Polska Sp. zo. o., TAD Pharma GmbH | Tolucombi | tbl. 28x(40 mg+12,5 mg) | 0,1261 | 3,53 | RRC02 | 5% |
| C09DA07 138 | | telmisartan + hidroklorotiazid | | | O | Krka d.d., Novo mesto | Krka d.d., Krka Polska Sp. zo. o., TAD Pharma GmbH | Tolucombi | tbl. 28x(80 mg+12,5 mg) | 0,1695 | 4,74 | RRC02 | 5% |
| C09DA07 139 | | telmisartan + hidroklorotiazid | | | O | Krka d.d., Novo mesto | Krka d.d., Krka Polska Sp. zo. o., TAD Pharma GmbH | Tolucombi | tbl. 28x(80 mg+25 mg) | 0,1695 | 4,74 | RRC02 | 5% |
| C09DB01 111 | | amlodipin + valsartan | | | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Vainas | tbl. film obl. 30x(5 mg+80 mg) | 0,0692 | 2,08 | RRC02 | 5% |
| C09DB01 112 | | amlodipin + valsartan | | | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Vainas | tbl. film obl. 30x(5 mg+160 mg) | 0,1345 | 4,03 | RRC02 | 5% |
| C09DB01 113 | | amlodipin + valsartan | | | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Vainas | tbl. film obl. 30x(10 mg+160 mg) | 0,1345 | 4,03 | RRC02 | 5% |
| C09DB01 121 | | amlodipin + valsartan | | | O | Sandoz d.o.o. | Novartis Pharma GmbH | Amlodipin/valsartan Sandoz | tbl. film obl. 28x(5 mg+80 mg) | 0,0729 | 2,04 | RRC02 | 5% |
| C09DB01 122 | | amlodipin + valsartan | | | O | Sandoz d.o.o. | Novartis Pharma GmbH | Amlodipin/valsartan Sandoz | tbl. film obl. 28x(5 mg+160 mg) | 0,1344 | 3,76 | RRC02 | 5% |
| C09DB01 123 | | amlodipin + valsartan | | | O | Sandoz d.o.o. | Novartis Pharma GmbH | Amlodipin/valsartan Sandoz | tbl. film obl. 28x(10 mg+160 mg) | 0,1415 | 3,96 | RRC02 | 5% |
| C09DB01 141 | | amlodipin + valsartan | | | O | KRKA-FARMA d.o.o. | Krka d.d., Krka-farma d.o.o. | Wamlox | tbl. film obl. 30x(5 mg+160 mg) | 0,1345 | 4,03 | RRC02 | 5% |
| C09DB01 142 | | amlodipin + valsartan | | | O | KRKA-FARMA d.o.o. | Krka d.d., Krka-farma d.o.o. | Wamlox | tbl. film obl. 30x(10 mg+160 mg) | 0,1415 | 4,25 | RRC02 | 5% |
| C09DB01 143 | | amlodipin + valsartan | | | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma Gmbh | Wamlox | tbl. film obl. 30x(5 mg+80 mg) | 0,0729 | 2,19 | RRC02 | 5% |
| C09DX01 111 | | amlodipin + valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Vainas HCT | tbl. film obl. 30x(5 mg+160 mg+12,5 mg) | 0,1474 | 4,42 | RRC02 | 5% |
| C09DX01 112 | | amlodipin + valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Vainas HCT | tbl. film obl. 30x(5 mg+160 mg+25 mg) | 0,1474 | 4,42 | RRC02 | 5% |
| C09DX01 113 | | amlodipin + valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Vainas HCT | tbl. film obl. 30x(10 mg+160 mg+12,5 mg) | 0,1562 | 4,69 | RRC02 | 5% |
| C09DX01 114 | | amlodipin + valsartan + hidroklorotiazid | | | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Vainas HCT | tbl. film obl. 30x(10 mg+160 mg+25 mg) | 0,1562 | 4,69 | RRC02 | 5% |
| C09DX01 124 | | amlodipin + valsartan + hidroklorotiazid | | | O | Sandoz d.o.o. | Salutas Pharma GmbH | Dipperam HCT | tbl. film obl. 28x(5 mg+160 mg+12,5 mg) | 0,1551 | 4,34 | RRC02 | 5% |
| C09DX01 125 | | amlodipin + valsartan + hidroklorotiazid | | | O | Sandoz d.o.o. | Salutas Pharma GmbH | Dipperam HCT | tbl. film obl. 28x(5 mg+160 mg+25 mg) | 0,1551 | 4,34 | RRC02 | 5% |
| C09DX01 126 | | amlodipin + valsartan + hidroklorotiazid | | | O | Sandoz d.o.o. | Salutas Pharma GmbH | Dipperam HCT | tbl. film obl. 28x(10 mg+160 mg+12,5 mg) | 0,1562 | 4,37 | RRC02 | 5% |
| C09DX01 131 | | amlodipin + valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GMBH | Valtricom | tbl. film obl. 30x(5 mg+160 mg+12,5 mg) | 0,1552 | 4,65 | RRC02 | 5% |
| C09DX01 132 | | amlodipin + valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GMBH | Valtricom | tbl. film obl. 30x(10 mg+160 mg+12,5 mg) | 0,1562 | 4,69 | RRC02 | 5% |
| C09DX01 133 | | amlodipin + valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GMBH | Valtricom | tbl. film obl. 30x(5 mg+160 mg+25 mg) | 0,1552 | 4,65 | RRC02 | 5% |
| C09DX01 134 | | amlodipin + valsartan + hidroklorotiazid | | | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GMBH | Valtricom | tbl. film obl. 30x(10 mg+320 mg+25 mg) | 0,2948 | 8,84 | RRC02 | 5% |
| C10AA01 106 | | simvastatin | 30 mg | 0,1513 | O | Alkaloid d.o.o. | Alkaloid | Lipterra | tbl. film obl. 28x10 mg | 0,0504 | 1,41 | RRC03 | 5% |
| C10AA01 108 | | simvastatin | 30 mg | 0,0998 | O | Alkaloid d.o.o. | Alkaloid | Lipterra | tbl. film obl. 28x20 mg | 0,0665 | 1,86 | RRC03 | 5% |
| C10AA01 109 | | simvastatin | 30 mg | 0,1043 | O | Alkaloid d.o.o. | Alkaloid | Lipterra | tbl. film obl. 28x40 mg | 0,1390 | 3,89 | RRC03 | 5% |
| C10AA01 112 | | simvastatin | 30 mg | 0,1513 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Simvax | tbl. film obl. 28x10 mg | 0,0504 | 1,41 | RRC03 | 5% |
| C10AA01 114 | | simvastatin | 30 mg | 0,0998 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Simvax | tbl. film obl. 28x20 mg | 0,0665 | 1,86 | RRC03 | 5% |
| C10AA01 116 | | simvastatin | 30 mg | 0,1043 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Simvax | tbl. film obl. 28x40 mg | 0,1390 | 3,89 | RRC03 | 5% |
| C10AA01 131 | | simvastatin | 30 mg | 0,1513 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 20x10 mg | 0,0504 | 1,01 | RRC03 | 5% |
| C10AA01 132 | | simvastatin | 30 mg | 0,1513 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 28x10 mg | 0,0504 | 1,41 | RRC03 | 5% |
| C10AA01 133 | | simvastatin | 30 mg | 0,0997 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 20x20 mg | 0,0665 | 1,33 | RRC03 | 5% |
| C10AA01 134 | | simvastatin | 30 mg | 0,0998 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 28x20 mg | 0,0665 | 1,86 | RRC03 | 5% |
| C10AA01 135 | | simvastatin | 30 mg | 0,1043 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 28x40 mg | 0,1390 | 3,89 | RRC03 | 5% |
| C10AA01 136 | | simvastatin | 30 mg | 0,1513 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 60x10 mg | 0,0504 | 3,03 | RRC03 | 5% |
| C10AA01 137 | | simvastatin | 30 mg | 0,0997 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 60x20 mg | 0,0665 | 3,99 | RRC03 | 5% |
| C10AA01 138 | | simvastatin | 30 mg | 0,1042 | O | KRKA-FARMA d.o.o. | Krka d.d. | Vasilip | tbl. film obl. 60x40 mg | 0,1389 | 8,33 | RRC03 | 5% |
| C10AA01 141 | | simvastatin | 30 mg | 0,1513 | O | Belupo d.d. | Belupo | Protecta | tbl. film obl. 28x10 mg | 0,0504 | 1,41 | RRC03 | 5% |
| C10AA01 142 | | simvastatin | 30 mg | 0,0998 | O | Belupo d.d. | Belupo | Protecta | tbl. film obl. 28x20 mg | 0,0665 | 1,86 | RRC03 | 5% |
| C10AA01 143 | | simvastatin | 30 mg | 0,1043 | O | Belupo d.d. | Belupo | Protecta | tbl. film obl. 28x40 mg | 0,1390 | 3,89 | RRC03 | 5% |
| C10AA01 144 | | simvastatin | 30 mg | 0,0998 | O | Belupo d.d. | Belupo | Protecta | tbl. film obl. 56x20 mg | 0,0665 | 3,72 | RRC03 | 5% |
| C10AA01 166 | | simvastatin | 30 mg | 0,0997 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Simvastatin Genericon | tbl. film obl. 30x20 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA01 167 | | simvastatin | 30 mg | 0,1043 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Simvastatin Genericon | tbl. film obl. 30x40 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 101 | | atorvastatin | 20 mg | 0,1330 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atorvox | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 102 | | atorvastatin | 20 mg | 0,1330 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atorvox | tbl. film obl. 60x10 mg | 0,0665 | 3,99 | RRC03 | 5% |
| C10AA05 103 | | atorvastatin | 20 mg | 0,1390 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atorvox | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 104 | | atorvastatin | 20 mg | 0,1390 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atorvox | tbl. film obl. 60x20 mg | 0,1390 | 8,34 | RRC03 | 5% |
| C10AA05 105 | | atorvastatin | 20 mg | 0,0892 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atorvox | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 106 | | atorvastatin | 20 mg | 0,0892 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atorvox | tbl. film obl. 60x40 mg | 0,1783 | 10,70 | RRC03 | 5% |
| C10AA05 107 | | atorvastatin | 20 mg | 0,0697 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Atorvox | tbl. film obl. 30x80 mg | 0,2787 | 8,36 | RRC03 | 5% |
| C10AA05 111 | | atorvastatin | 20 mg | 0,1330 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Liptin | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 112 | | atorvastatin | 20 mg | 0,1330 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Liptin | tbl. film obl. 60x10 mg | 0,0665 | 3,99 | RRC03 | 5% |
| C10AA05 113 | | atorvastatin | 20 mg | 0,1390 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Liptin | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 114 | | atorvastatin | 20 mg | 0,1390 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Liptin | tbl. film obl. 60x20 mg | 0,1390 | 8,34 | RRC03 | 5% |
| C10AA05 115 | | atorvastatin | 20 mg | 0,0892 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Liptin | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 121 | | atorvastatin | 20 mg | 0,1330 | O | Sandoz d.o.o. | Sandoz-Lek | Tulip | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 122 | | atorvastatin | 20 mg | 0,1390 | O | Sandoz d.o.o. | Sandoz-Lek | Tulip | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 123 | | atorvastatin | 20 mg | 0,1330 | O | Sandoz d.o.o. | Sandoz-Lek | Tulip | tbl. film obl. 60x10 mg | 0,0665 | 3,99 | RRC03 | 5% |
| C10AA05 124 | | atorvastatin | 20 mg | 0,1390 | O | Sandoz d.o.o. | Sandoz-Lek | Tulip | tbl. film obl. 60x20 mg | 0,1390 | 8,34 | RRC03 | 5% |
| C10AA05 125 | | atorvastatin | 20 mg | 0,0892 | O | Sandoz d.o.o. | Sandoz-Lek | Tulip | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 126 | | atorvastatin | 20 mg | 0,0892 | O | Sandoz d.o.o. | Sandoz-Lek | Tulip | tbl. film obl. 60x40 mg | 0,1783 | 10,70 | RRC03 | 5% |
| C10AA05 127 | | atorvastatin | 20 mg | 0,1330 | O | Mylan Hrvatska d.o.o. | Pharmathen International SA | Synordia | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 129 | | atorvastatin | 20 mg | 0,1390 | O | Mylan Hrvatska d.o.o. | Pharmathen International SA | Synordia | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 131 | | atorvastatin | 20 mg | 0,1330 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Atoris | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 132 | | atorvastatin | 20 mg | 0,1390 | O | KRKA-FARMA d.o.o. | Krka d.d.,KRKA-FARMA d.o.o. | Atoris | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 133 | | atorvastatin | 20 mg | 0,0892 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Atoris | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 134 | | atorvastatin | 20 mg | 0,0892 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Atoris | tbl. film obl. 60x40 mg | 0,1783 | 10,70 | RRC03 | 5% |
| C10AA05 136 | | atorvastatin | 20 mg | 0,1330 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Atoris | tbl. film obl. 60x10 mg | 0,0665 | 3,99 | RRC03 | 5% |
| C10AA05 137 | | atorvastatin | 20 mg | 0,1390 | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Atoris | tbl. film obl. 60x20 mg | 0,1390 | 8,34 | RRC03 | 5% |
| C10AA05 138 | | atorvastatin | 20 mg | 0,0892 | O | Mylan Hrvatska d.o.o. | Pharmathen International SA | Synordia | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 139 | | atorvastatin | 20 mg | 0,0697 | O | KRKA-FARMA d.o.o. | Krka d.d. | Atoris | tbl. film obl. 30x80 mg | 0,2787 | 8,36 | RRC03 | 5% |
| C10AA05 141 | | atorvastatin | 20 mg | 0,1330 | O | Belupo d.d. | Belupo | Torvas | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 142 | | atorvastatin | 20 mg | 0,1330 | O | Belupo d.d. | Belupo | Torvas | tbl. film obl. 60x10 mg | 0,0665 | 3,99 | RRC03 | 5% |
| C10AA05 143 | | atorvastatin | 20 mg | 0,1390 | O | Belupo d.d. | Belupo | Torvas | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 144 | | atorvastatin | 20 mg | 0,1390 | O | Belupo d.d. | Belupo | Torvas | tbl. film obl. 60x20 mg | 0,1390 | 8,34 | RRC03 | 5% |
| C10AA05 145 | | atorvastatin | 20 mg | 0,0892 | O | Belupo d.d. | Belupo | Torvas | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 146 | | atorvastatin | 20 mg | 0,0892 | O | Belupo d.d. | Belupo | Torvas | tbl. film obl. 60x40 mg | 0,1783 | 10,70 | RRC03 | 5% |
| C10AA05 171 | | atorvastatin | 20 mg | 0,1330 | O | Upjohn EESV | Goedecke GmbH za Pfizer | Sortis | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 172 | | atorvastatin | 20 mg | 0,1390 | O | Upjohn EESV | Goedecke GmbH za Pfizer | Sortis | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 173 | | atorvastatin | 20 mg | 0,0892 | O | Upjohn EESV | Goedecke GmbH za Pfizer | Sortis | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 174 | | atorvastatin | 20 mg | 0,0697 | O | Upjohn EESV | Goedecke GmbH za Pfizer | Sortis | tbl. film obl. 30x80 mg | 0,2787 | 8,36 | RRC03 | 5% |
| C10AA05 175 | | atorvastatin | 20 mg | 0,1330 | O | PharmaS d.o.o. | PharmaS d.o.o. | Atorvastatin PharmaS | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 176 | | atorvastatin | 20 mg | 0,1330 | O | PharmaS d.o.o. | PharmaS d.o.o. | Atorvastatin PharmaS | tbl. film obl. 60x10 mg | 0,0665 | 3,99 | RRC03 | 5% |
| C10AA05 177 | | atorvastatin | 20 mg | 0,1390 | O | PharmaS d.o.o. | PharmaS d.o.o. | Atorvastatin PharmaS | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 178 | | atorvastatin | 20 mg | 0,1390 | O | PharmaS d.o.o. | PharmaS d.o.o. | Atorvastatin PharmaS | tbl. film obl. 60x20 mg | 0,1390 | 8,34 | RRC03 | 5% |
| C10AA05 179 | | atorvastatin | 20 mg | 0,0892 | O | PharmaS d.o.o. | PharmaS d.o.o. | Atorvastatin PharmaS | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 180 | | atorvastatin | 20 mg | 0,0892 | O | PharmaS d.o.o. | PharmaS d.o.o. | Atorvastatin PharmaS | tbl. film obl. 60x40 mg | 0,1783 | 10,70 | RRC03 | 5% |
| C10AA05 181 | | atorvastatin | 20 mg | 0,1330 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Artas | tbl. film obl. 28x10 mg | 0,0665 | 1,86 | RRC03 | 5% |
| C10AA05 183 | | atorvastatin | 20 mg | 0,1225 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Artas | tbl. film obl. 28x20 mg | 0,1225 | 3,43 | RRC03 | 5% |
| C10AA05 184 | | atorvastatin | 20 mg | 0,1390 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Artas | tbl. film obl. 56x20 mg | 0,1390 | 7,78 | RRC03 | 5% |
| C10AA05 185 | | atorvastatin | 20 mg | 0,0843 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Artas | tbl. film obl. 28x40 mg | 0,1686 | 4,72 | RRC03 | 5% |
| C10AA05 191 | | atorvastatin | 20 mg | 0,1015 | O | KRKA-FARMA d.o.o. | Krka d.d. | Atoris | tbl. film obl. 30x30 mg | 0,1522 | 4,57 | RRC03 | 5% |
| C10AA05 192 | | atorvastatin | 20 mg | 0,1015 | O | KRKA-FARMA d.o.o. | Krka d.d. | Atoris | tbl. film obl. 60x30 mg | 0,1522 | 9,13 | RRC03 | 5% |
| C10AA05 193 | | atorvastatin | 20 mg | 0,0690 | O | KRKA-FARMA d.o.o. | Krka d.d. | Atoris | tbl. film obl. 30x60 mg | 0,2071 | 6,21 | RRC03 | 5% |
| C10AA05 195 | | atorvastatin | 20 mg | 0,1330 | O | Alkaloid d.o.o. | Alkaloid | Calipra | tbl. film obl. 30x10 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA05 196 | | atorvastatin | 20 mg | 0,1390 | O | Alkaloid d.o.o. | Alkaloid | Calipra | tbl. film obl. 30x20 mg | 0,1390 | 4,17 | RRC03 | 5% |
| C10AA05 197 | | atorvastatin | 20 mg | 0,0892 | O | Alkaloid d.o.o. | Alkaloid | Calipra | tbl. film obl. 30x40 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA05 198 | | atorvastatin | 20 mg | 0,0697 | O | Alkaloid d.o.o. | Alkaloid | Calipra | tbl. film obl. 30x80 mg | 0,2787 | 8,36 | RRC03 | 5% |
| C10AA07 105 | | rosuvastatin | 10 mg | 0,1015 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o.; Merckle GmbH; HBM Pharma s.r.o.; Teva Pharma B.V.; Teva Operations Poland | Epri | tbl. film obl. 30x15 mg | 0,1522 | 4,57 | RRC03 | 5% |
| C10AA07 106 | | rosuvastatin | 10 mg | 0,0690 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o.; Merckle GmbH; HBM Pharma s.r.o.; Teva Pharma B.V.; Teva Operations Poland | Epri | tbl. film obl. 30x30 mg | 0,2071 | 6,21 | RRC03 | 5% |
| C10AA07 107 | | rosuvastatin | 10 mg | 0,1330 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Epri | tbl. film obl. 30x5 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA07 108 | | rosuvastatin | 10 mg | 0,1354 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Epri | tbl. film obl. 30x10 mg | 0,1354 | 4,06 | RRC03 | 5% |
| C10AA07 109 | | rosuvastatin | 10 mg | 0,0892 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Epri | tbl. film obl. 30x20 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA07 110 | | rosuvastatin | 10 mg | 0,0576 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Epri | tbl. film obl. 30x40 mg | 0,2305 | 6,91 | RRC03 | 5% |
| C10AA07 112 | | rosuvastatin | 10 mg | 0,1390 | O | Belupo d.d. | Belupo | Rosix | tbl. film obl. 28x10 mg | 0,1390 | 3,89 | RRC03 | 5% |
| C10AA07 113 | | rosuvastatin | 10 mg | 0,0891 | O | Belupo d.d. | Belupo | Rosix | tbl. film obl. 28x20 mg | 0,1783 | 4,99 | RRC03 | 5% |
| C10AA07 114 | | rosuvastatin | 10 mg | 0,0697 | O | Belupo d.d. | Belupo | Rosix | tbl. film obl. 28x40 mg | 0,2787 | 7,80 | RRC03 | 5% |
| C10AA07 121 | | rosuvastatin | 10 mg | 0,1390 | O | Sandoz d.o.o. | Sandoz-Lek | Coupet | tbl. film obl. 28x10 mg | 0,1390 | 3,89 | RRC03 | 5% |
| C10AA07 122 | | rosuvastatin | 10 mg | 0,0891 | O | Sandoz d.o.o. | Sandoz-Lek | Coupet | tbl. film obl. 28x20 mg | 0,1783 | 4,99 | RRC03 | 5% |
| C10AA07 123 | | rosuvastatin | 10 mg | 0,0697 | O | Sandoz d.o.o. | Sandoz-Lek | Coupet | tbl. film obl. 28x40 mg | 0,2787 | 7,80 | RRC03 | 5% |
| C10AA07 128 | | rosuvastatin | 10 mg | 0,1149 | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Coupet | tbl. film obl. 60x10 mg | 0,1149 | 6,89 | RRC03 | 5% |
| C10AA07 129 | | rosuvastatin | 10 mg | 0,0892 | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Coupet | tbl. film obl. 60x20 mg | 0,1783 | 10,70 | RRC03 | 5% |
| C10AA07 130 | | rosuvastatin | 10 mg | 0,0534 | O | Sandoz d.o.o. | Lek Pharmaceuticals d.d. | Coupet | tbl. film obl. 60x40 mg | 0,2137 | 12,82 | RRC03 | 5% |
| C10AA07 131 | | rosuvastatin | 10 mg | 0,1330 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Roswera | tbl. film obl. 28x5 mg | 0,0665 | 1,86 | RRC03 | 5% |
| C10AA07 132 | | rosuvastatin | 10 mg | 0,1390 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Roswera | tbl. film obl. 28x10 mg | 0,1390 | 3,89 | RRC03 | 5% |
| C10AA07 133 | | rosuvastatin | 10 mg | 0,0891 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Roswera | tbl. film obl. 28x20 mg | 0,1783 | 4,99 | RRC03 | 5% |
| C10AA07 134 | | rosuvastatin | 10 mg | 0,0697 | O | KRKA-FARMA d.o.o. | KRKA-FARMA d.o.o. | Roswera | tbl. film obl. 28x40 mg | 0,2787 | 7,80 | RRC03 | 5% |
| C10AA07 135 | | rosuvastatin | 10 mg | 0,1015 | O | KRKA-FARMA d.o.o. | Krka d.d. | Roswera | tbl. film obl. 28x15 mg | 0,1522 | 4,26 | RRC03 | 5% |
| C10AA07 136 | | rosuvastatin | 10 mg | 0,0690 | O | KRKA-FARMA d.o.o. | Krka d.d. | Roswera | tbl. film obl. 28x30 mg | 0,2071 | 5,80 | RRC03 | 5% |
| C10AA07 141 | | rosuvastatin | 10 mg | 0,0892 | O | Genericon Pharma Gesellschaft m.b.H. | Pharmaceutical Works Polpharma S.A.; Genericon Pharma Gesellschaft m.b.H. | Rosuvastatin Genericon | tbl. film obl. 30x20 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA07 142 | | rosuvastatin | 10 mg | 0,1340 | O | Genericon Pharma Gesellschaft m.b.H. | Pharmaceutical Works Polpharma S.A.; Genericon Pharma Gesellschaft m.b.H. | Rosuvastatin Genericon | tbl. film obl. 30x10 mg | 0,1340 | 4,02 | RRC03 | 5% |
| C10AA07 143 | | rosuvastatin | 10 mg | 0,0576 | O | Genericon Pharma Gesellschaft m.b.H. | Pharmaceutical Works Polpharma S.A.; Genericon Pharma Gesellschaft m.b.H. | Rosuvastatin Genericon | tbl. film obl. 30x40 mg | 0,2305 | 6,91 | RRC03 | 5% |
| C10AA07 144 | | rosuvastatin | 10 mg | 0,1330 | O | Alkaloid-INT d.o.o. | Alkaloid – INT | Ropuido | tbl. film obl. 30x5 mg | 0,0665 | 1,99 | RRC03 | 5% |
| C10AA07 145 | | rosuvastatin | 10 mg | 0,1273 | O | Alkaloid-INT d.o.o. | Alkaloid – INT | Ropuido | tbl. film obl. 30x10 mg | 0,1273 | 3,82 | RRC03 | 5% |
| C10AA07 146 | | rosuvastatin | 10 mg | 0,0892 | O | Alkaloid-INT d.o.o. | Alkaloid – INT | Ropuido | tbl. film obl. 30x20 mg | 0,1783 | 5,35 | RRC03 | 5% |
| C10AA07 147 | | rosuvastatin | 10 mg | 0,0576 | O | Alkaloid-INT d.o.o. | Alkaloid – INT | Ropuido | tbl. film obl. 30x40 mg | 0,2305 | 6,91 | RRC03 | 5% |
| C10AA07 165 | | rosuvastatin | 10 mg | 0,1286 | O | Jadran – Galenski Laboratorij d.d. | Teva Pharma S.L.U. | Rosuvastatin JGL | tbl. film obl. 28x5 mg | 0,0643 | 1,80 | RRC03 | 5% |
| C10AA07 166 | | rosuvastatin | 10 mg | 0,1209 | O | Jadran – Galenski Laboratorij d.d. | Teva Pharma S.L.U. | Rosuvastatin JGL | tbl. film obl. 28x10 mg | 0,1209 | 3,39 | RRC03 | 5% |
| C10AA07 167 | | rosuvastatin | 10 mg | 0,0891 | O | Jadran – Galenski Laboratorij d.d. | Teva Pharma S.L.U. | Rosuvastatin JGL | tbl. film obl. 28x20 mg | 0,1783 | 4,99 | RRC03 | 5% |
| C10AA07 168 | | rosuvastatin | 10 mg | 0,0658 | O | Jadran – Galenski Laboratorij d.d. | Teva Pharma S.L.U. | Rosuvastatin JGL | tbl. film obl. 28x40 mg | 0,2631 | 7,37 | RRC03 | 5% |
| C10AA07 181 | | rosuvastatin | 10 mg | 0,1330 | O | Viatris Limited | McDermott Laboratories Limited, t/a Gerard Laboratories, Generics [UK] Limited | Rosacol | tbl. film obl. 28x5 mg | 0,0665 | 1,86 | RRC03 | 5% |
| C10AA07 182 | | rosuvastatin | 10 mg | 0,1273 | O | Viatris Limited | McDermott Laboratories Limited, t/a Gerard Laboratories, Generics [UK] Limited | Rosacol | tbl. film obl. 28x10 mg | 0,1273 | 3,56 | RRC03 | 5% |
| C10AA07 183 | | rosuvastatin | 10 mg | 0,0891 | O | Viatris Limited | McDermott Laboratories Limited, t/a Gerard Laboratories, Generics [UK] Limited | Rosacol | tbl. film obl. 28x20 mg | 0,1783 | 4,99 | RRC03 | 5% |
| C10AA07 184 | | rosuvastatin | 10 mg | 0,0697 | O | Viatris Limited | McDermott Laboratories Limited, t/a Gerard Laboratories, Generics [UK] Limited | Rosacol | tbl. film obl. 28x40 mg | 0,2787 | 7,80 | RRC03 | 5% |
| C10AB05 101 | | fenofibrat | 200 mg | 0,1948 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o., Teva Operations Poland Sp.z.o.o. | Zigotrig | tbl. film obl. 30x160 mg | 0,1559 | 4,68 | RRC04 | 5% |
| C10AB05 141 | | fenofibrat | 200 mg | 0,1948 | O | Alkaloid d.o.o. | Alkaloid | Ziglip | tbl. 30x145 mg | 0,1413 | 4,24 | RRC04 | 5% |
| C10AB05 171 | | fenofibrat | 200 mg | 0,1948 | O | Bausch Health Ireland Limited | SMB Technology S.A. | Fenolip | caps. 30x160 mg | 0,1559 | 4,68 | RRC04 | 5% |
| C10AC01 354 | | kolestiramin | 14 g | | O | | | | | | | R | 5% |
| C10AX09 161 | | ezetimib | 10 mg | 0,3316 | O | Organon Pharma d.o.o. | Merck Sharp & Dohme | Ezetrol | tbl. 28x10 mg | 0,3316 | 9,29 | RSRC08 | 5% |
| C10AX13 061 | | evolokumab | | | P | Amgen Europe B.V. | Amgen Europe B.V. | Repatha | otop. za inj., brizg. napunj. 2x1 ml (140 mg/ml) | 190,3922 | 380,78 | RS RC11 | 5% |
| C10AX14 061 | | alirokumab | 5,4 mg | 13,7082 | P | sanofi-aventis groupe | Sanofi-Aventis Deutschland GmbH | Praluent | otop. za inj., brizg. napunj. 2x1 ml (75 mg/ml) | 190,3922 | 380,78 | RSRC11 | 5% |
| C10AX14 062 | | alirokumab | 5,4 mg | 6,8541 | P | sanofi-aventis groupe | Sanofi-Aventis Deutschland GmbH | Praluent | otop. za inj., brizg. napunj. 2x1 ml (150 mg/ml) | 190,3922 | 380,78 | RSRC11 | 5% |
| C10AX14 063 | | alirokumab | 5,4 mg | 6,8541 | P | sanofi-aventis groupe | Sanofi-Aventis Deutschland GmbH | Praluent | otop. za inj., brizg. napunj. 1x2 ml (150 mg/ml) | 380,7844 | 380,78 | RSRC11 | 5% |
| C10AX16 071 | | inklisiran | | | P | Novartis Europharm Limited Irska | APO-CARE Pharma GmbH | Leqvio | otop. za inj., štrc. napunj. 1,5 ml (189 mg/ml) | 2.099,7983 | 2.099,80 | RSRC11 | 5% |
| C10BA05 121 | | ezetimib + atorvastatin | | | O | Sandoz d.o.o. | Sandoz-Lek | Tulip Combi | tbl. film obl. 30x(10 mg+10 mg) | 0,3150 | 9,45 | RSpc08 | 5% |
| C10BA05 122 | | ezetimib + atorvastatin | | | O | Sandoz d.o.o. | Sandoz-Lek | Tulip Combi | tbl. film obl. 30x(10 mg+20 mg) | 0,3389 | 10,17 | RSpc08 | 5% |
| C10BA05 123 | | ezetimib + atorvastatin | | | O | Sandoz d.o.o. | Sandoz-Lek | Tulip Combi | tbl. film obl. 30x(10 mg+40 mg) | 0,3838 | 11,51 | RSpc08 | 5% |
| C10BA05 124 | | ezetimib + atorvastatin | | | O | Sandoz d.o.o. | Sandoz-Lek | Tulip Combi | tbl. film obl. 30x(10 mg+80 mg) | 0,5782 | 17,35 | RSpc08 | 5% |
| C10BA05 161 | | ezetimib + atorvastatin | | | O | Organon Pharma d.o.o. | Merck Sharp & Dohme B.V. | Atozet | tbl. film obl. 30x(10 mg+10 mg) | 0,3316 | 9,95 | RSpc08 | 5% |
| C10BA05 162 | | ezetimib + atorvastatin | | | O | Organon Pharma d.o.o. | Merck Sharp & Dohme B.V. | Atozet | tbl. film obl. 30x(10 mg+20 mg) | 0,3568 | 10,70 | RSpc08 | 5% |
| C10BA05 163 | | ezetimib + atorvastatin | | | O | Organon Pharma d.o.o. | Merck Sharp & Dohme B.V. | Atozet | tbl. film obl. 30x(10 mg+40 mg) | 0,4039 | 12,12 | RSpc08 | 5% |
| C10BA05 171 | | ezetimib + atorvastatin | | | O | PLIVA HRVATSKA d.o.o. | Merckle GmbH, Elpen Pharmaceutical Co. Inc. | Co-Atorvox | tbl. film obl. 30x(10 mg+10 mg) | 0,3316 | 9,95 | RSpc08 | 5% |
| C10BA05 172 | | ezetimib + atorvastatin | | | O | PLIVA HRVATSKA d.o.o. | Merckle GmbH, Elpen Pharmaceutical Co. Inc. | Co-Atorvox | tbl. film obl. 30x(10 mg+20 mg) | 0,3568 | 10,70 | RSpc08 | 5% |
| C10BA05 173 | | ezetimib + atorvastatin | | | O | PLIVA HRVATSKA d.o.o. | Merckle GmbH, Elpen Pharmaceutical Co. Inc. | Co-Atorvox | tbl. film obl. 30x(10 mg+40 mg) | 0,4039 | 12,12 | RSpc08 | 5% |
| C10BA05 174 | | ezetimib + atorvastatin | | | O | PLIVA HRVATSKA d.o.o. | Merckle GmbH, Elpen Pharmaceutical Co. Inc. | Co-Atorvox | tbl. film obl. 30x(10 mg+80 mg) | 0,6105 | 18,32 | RSpc08 | 5% |
| C10BA06 101 | | rosuvastatin + ezetimib | | | O | PLIVA HRVATSKA d.o.o. | Teva Operations Poland Sp. z o.o. | Eprizet | tbl. 30x(10 mg+10 mg) | 0,3568 | 10,70 | RSpc08 | 5% |
| C10BA06 102 | | rosuvastatin + ezetimib | | | O | PLIVA HRVATSKA d.o.o. | Teva Operations Poland Sp. z o.o. | Eprizet | tbl. 30x(20 mg+10 mg) | 0,4039 | 12,12 | RSpc08 | 5% |
| C10BA06 111 | | rosuvastatin + ezetimib | | | O | Belupo d.d. | Adamed Sp. z o.o. | Rosix Combi | tbl. 30x(5 mg+10 mg) | 0,3316 | 9,95 | RSpc08 | 5% |
| C10BA06 112 | | rosuvastatin + ezetimib | | | O | Belupo d.d. | Adamed Sp. z o.o. | Rosix Combi | tbl. 30x(10 mg+10 mg) | 0,3568 | 10,70 | RSpc08 | 5% |
| C10BA06 113 | | rosuvastatin + ezetimib | | | O | Belupo d.d. | Adamed Sp. z o.o. | Rosix Combi | tbl. 30x(20 mg+10 mg) | 0,4039 | 12,12 | RSpc08 | 5% |
| C10BA06 122 | | rosuvastatin + ezetimib | | | O | Jadran – Galenski Laboratorij d.d. | Pabianickie Zaklady Farmaceutyczne Polfa S.A., JGL d.d. | Ezotera | tbl. 28x(10 mg+10 mg) | 0,3567 | 9,99 | RSpc08 | 5% |
| C10BA06 123 | | rosuvastatin + ezetimib | | | O | Jadran – Galenski Laboratorij d.d. | Pabianickie Zaklady Farmaceutyczne Polfa S.A., JGL d.d. | Ezotera | tbl. 28x(20 mg+10 mg) | 0,4039 | 11,31 | RSpc08 | 5% |
| C10BA06 131 | | rosuvastatin + ezetimib | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Co-Roswera | tbl. 30x(10 mg+10 mg) | 0,3568 | 10,70 | RSpc08 | 5% |
| C10BA06 132 | | rosuvastatin + ezetimib | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Co-Roswera | tbl. 30x(20 mg+10 mg) | 0,4039 | 12,12 | RSpc08 | 5% |
| C10BA06 133 | | rosuvastatin + ezetimib | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Co-Roswera | tbl. 30x(40 mg+10 mg) | 0,6105 | 18,32 | RSpc08 | 5% |
| C10BA06 171 | | rosuvastatin + ezetimib | | | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma Gesellschaft m.b.H., Pabianickie Zaklady Farmaceutyczne Polfa S.A. | Rosuvastatin/Ezetimib Genericon | tbl. 30x(5 mg+10 mg) | 0,3316 | 9,95 | RSpc08 | 5% |
| C10BA06 172 | | rosuvastatin + ezetimib | | | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma Gesellschaft m.b.H., Pabianickie Zaklady Farmaceutyczne Polfa S.A. | Rosuvastatin/Ezetimib Genericon | tbl. 30x(10 mg+10 mg) | 0,3568 | 10,70 | RSpc08 | 5% |
| C10BA06 173 | | rosuvastatin + ezetimib | | | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma Gesellschaft m.b.H., Pabianickie Zaklady Farmaceutyczne Polfa S.A. | Rosuvastatin/Ezetimib Genericon | tbl. 30x(20 mg+10 mg) | 0,4039 | 12,12 | RSpc08 | 5% |
| C10BX03 131 | | amlodipin + atorvastatin | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Atordapin | tbl. film obl. 30x(5 mg+10 mg) | 0,0712 | 2,14 | RRC03 | 5% |
| C10BX03 133 | | amlodipin + atorvastatin | | | O | KRKA-FARMA d.o.o. | Krka d.d., KRKA-FARMA d.o.o. | Atordapin | tbl. film obl. 30x(10 mg+10 mg) | 0,0712 | 2,14 | RRC03 | 5% |
| C10BX09 111 | | rosuvastatin + amlodipin | | | O | Belupo d.d. | Adamed Sp. z o.o. | Rosix-Am | caps. tvrda 30x(10 mg+5 mg) | 0,1857 | 5,57 | RRC03 | 5% |
| C10BX09 112 | | rosuvastatin + amlodipin | | | O | Belupo d.d. | Adamed Sp. z o.o. | Rosix-Am | caps. tvrda 30x(10 mg+10 mg) | 0,1947 | 5,84 | RRC03 | 5% |
| C10BX09 113 | | rosuvastatin + amlodipin | | | O | Belupo d.d. | Adamed Sp. z o.o. | Rosix-Am | caps. tvrda 30x(20 mg+5 mg) | 0,2183 | 6,55 | RRC03 | 5% |
| C10BX09 114 | | rosuvastatin + amlodipin | | | O | Belupo d.d. | Adamed Sp. z o.o. | Rosix-Am | caps. tvrda 30x(20 mg+10 mg) | 0,2382 | 7,15 | RRC03 | 5% |
| C10BX13 131 | | rosuvastatin + perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Roxiper | tbl. 30 x (10 mg+ 4 mg+ 1.25 mg) | 0,2167 | 6,50 | RRC03 | 5% |
| C10BX13 132 | | rosuvastatin + perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Roxiper | tbl. 30 x (10 mg+ 8 mg+ 2.5 mg) | 0,2722 | 8,17 | RRC03 | 5% |
| C10BX13 133 | | rosuvastatin + perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Roxiper | tbl. 30 x (20 mg+ 4 mg+ 1.25 mg) | 0,2996 | 8,99 | RRC03 | 5% |
| C10BX13 134 | | rosuvastatin + perindopril + indapamid | | | O | KRKA-FARMA d.o.o. | Krka d.d. | Roxiper | tbl. 30 x (20 mg+ 8 mg+ 2.5 mg) | 0,3551 | 10,65 | RRC03 | 5% |
| D01BA02 111 | | terbinafin | 0,25 g | 0,6160 | O | Belupo d.d. | Belupo | Terbinax | tbl. 14x250 mg | 0,6160 | 8,62 | RRD01 | 5% |
| D01BA02 112 | | terbinafin | 0,25 g | 0,6160 | O | Belupo d.d. | Belupo | Terbinax | tbl. 42x250 mg | 0,6160 | 25,87 | RRD01 | 5% |
| D01BA02 162 | | terbinafin | 0,25 g | 0,6160 | O | Novartis Hrvatska d.o.o. | Lek d.d, PE PROIZVODNJA LENDAVA, Novartis Pharma GmbH | Lamisil | tbl. 14x250 mg | 0,6160 | 8,62 | Rpd01 | 5% |
| D05AX52 444 | | kalcipotriol + betametazon | | | L | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Psotriol | mast 60 g (50 mcg/g+0,5 mg/g) | 19,2753 | 19,28 | R | 5% |
| D05AX52 445 | | kalcipotriol + betametazon | | | L | LEO Pharma A/S | Colep Laupheim GmbH & Co. KG, LEO Laboratories Ltd. | Enstilar | pjena za kožu 60 g (50 mcg/g+0,5 mg/g) | 40,5336 | 40,53 | RSRD03 | 5% |
| D05BA02 151 | DS | metoksalen (metoksipsoralen)ND991 | 10 mg | | O | | | | | | | | 5% |
| D05BB02 161 | | acitretin | 35 mg | 1,6894 | O | ACTAVIS GROUP PTC ehf. | Cenexi | Neotigason | caps. 30x10 mg | 0,4827 | 14,48 | RSpd03 | 5% |
| D05BB02 162 | | acitretin | 35 mg | 1,4326 | O | ACTAVIS GROUP PTC ehf. | Cenexi | Neotigason | caps. 30x25 mg | 1,0233 | 30,70 | RSpd03 | 5% |
| D06AX01 461 | | fusidatna kiselina | | | L | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Fusicutan | krema 15 g (20 mg/g) | 2,7527 | 2,75 | R | 5% |
| D06AX01 462 | | fusidatna kiselina | | | L | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Fusicutan | mast 15 g (20 mg/g) | 2,7527 | 2,75 | R | 5% |
| D06AX02 451 | DS | kloramfenikol | | | L | | | | | | | | 5% |
| D06AX09 402 | | mupirocin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Betrion | mast 2%, 1x15 g | 3,8529 | 3,85 | R | 5% |
| D06AX09 411 | | mupirocin | | | L | Belupo d.d. | Belupo | Mirobact | mast 2%, 1x15 g | 3,8529 | 3,85 | R | 5% |
| D06AX09 415 | | mupirocin | | | L | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Mupiron | mast 1x15 g (20 mg/1g) | 3,8529 | 3,85 | R | 5% |
| D07AB10 411 | | alklometazon | | | L | Belupo d.d. | Belupo | Afloderm | mast 1x20 g (0,5 mg/g) | 2,8668 | 2,87 | R | 5% |
| D07AB10 413 | | alklometazon | | | L | Belupo d.d. | Belupo | Afloderm | krema 1x20 g (0,5 mg/g) | 2,8668 | 2,87 | R | 5% |
| D07AB10 414 | | alklometazon | | | L | Belupo d.d. | Belupo | Afloderm | krema 1x40 g (0,5 mg/g) | 5,5478 | 5,55 | R | 5% |
| D07AC01 412 | | betametazon | | | L | Belupo d.d. | Belupo | Beloderm | mast 1x30 g (0,5 mg/g) | 2,3519 | 2,35 | R | 5% |
| D07AC01 414 | | betametazon | | | L | Belupo d.d. | Belupo | Beloderm | krema 1x30 g (0,5 mg/g) | 2,3519 | 2,35 | R | 5% |
| D07AC01 418 | | betametazon | | | L | Belupo d.d. | Belupo | Beloderm losion | boč. polietil. 1x50 ml (0,5 mg/1g) | 4,4077 | 4,41 | R | 5% |
| D07AC01 431 | | betametazon | | | L | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Betazon | krema 1x25 g (0,5 mg/g) | 1,9603 | 1,96 | R | 5% |
| D07AC01 432 | | betametazon | | | L | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Betazon | mast 1x25 g (0,5 mg/g) | 1,9603 | 1,96 | R | 5% |
| D07CC01 401 | | betametazon + gentamicin | | | L | Belupo d.d. | Belupo | Belogent | mast 1x15 g (0,5+1 mg/g) | 2,1222 | 2,12 | R | 5% |
| D07CC01 402 | | betametazon + gentamicin | | | L | Belupo d.d. | Belupo | Belogent | krema 1x15 g (0,5+1 mg/g) | 2,1222 | 2,12 | R | 5% |
| D07CC01 441 | | betametazon + gentamicin | | | L | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Cazal | mast 1x20 g (0,5+1 mg/g) | 2,6876 | 2,69 | R | 5% |
| D07CC01 442 | | betametazon + gentamicin | | | L | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Cazal | krema 1x20 g (0,5+1 mg/g) | 2,6876 | 2,69 | R | 5% |
| D07CC01 461 | | betametazon + gentamicin | | | L | Organon Pharma d.o.o. | Schering- Plough | Diprogenta | krema 1x15 g (0,5+1 mg/g) | 2,1222 | 2,12 | R | 5% |
| D07CC01 462 | | betametazon + gentamicin | | | L | Organon Pharma d.o.o. | Schering- Plough | Diprogenta | mast 1x15 g (0,5+1 mg/g) | 2,1222 | 2,12 | R | 5% |
| D07XC01 411 | | betametazon + salicilna kiselina | | | L | Belupo d.d. | Belupo | Belosalic | mast 1x30 g (0,5 mg/g+30 mg/g) | 3,8437 | 3,84 | R | 5% |
| D07XC01 712 | | betametazon + salicilna kiselina | | | L | Belupo d.d. | Belupo | Belosalic | losion 1x100 ml (0,5 mg/g+20 mg/g) | 11,6464 | 11,65 | R | 5% |
| D07XC01 761 | | betametazon + salicilna kiselina | | | L | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Soderm plus | otop. za kožu 1x50 ml (0,64 mg/g +20 mg/g) | 5,2412 | 5,24 | R | 5% |
| D07XC01 762 | | betametazon + salicilna kiselina | | | L | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Soderm plus | otop. za kožu 1x100 ml (0,64 mg/g +20 mg/g) | 10,4825 | 10,48 | R | 5% |
| D08AC02 901 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept pjenušavi 4,5% | boca 1x500 ml | 7,5480 | 7,55 | | 5% |
| D08AC02 902 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept glukonat 5% | boca 1x1000 ml | 8,2036 | 8,20 | | 5% |
| D08AC02 903 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept pjenušavi 4,5% | boca 1x3.000 ml | 29,6529 | 29,65 | | 5% |
| D08AC02 905 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept blue 0,8% | boca 1x200 ml | 2,4421 | 2,44 | | 5% |
| D08AC02 906 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept blue 0,8% | boca 1x500 ml | 3,6632 | 3,66 | | 5% |
| D08AC02 907 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept blue 0,8% | boca 1x3.000 ml | 14,6526 | 14,65 | | 5% |
| D08AC02 909 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept tinkt. 0,5% | boca 1x1.000 ml | 3,9684 | 3,97 | | 5% |
| D08AC02 910 | DS | klorheksidin | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept tinkt. 0,5% | boca 1x3.000 ml | 10,9895 | 10,99 | | 5% |
| D08AG02 943 | | povidon-jod | | | L | Alkaloid d.o.o. | Alkaloid | Betadine | otop. 10%, 1x100 ml | 2,9265 | 2,93 | R | 5% |
| D08AG02 944 | DS | povidon-jod | | | L | Alkaloid d.o.o. | Alkaloid | Betadine | otop. 10%, 1x1000 ml | 8,2341 | 8,23 | | 5% |
| D08AG02 946 | DS | povidon-jod | | | L | Alkaloid d.o.o. | Alkaloid | Betadine | otop. 7,5%, 1x1000 ml | 7,9607 | 7,96 | | 5% |
| D08AJ57 961 | DS | oktenidin + fenoksietanol | | | L | Schülke & Mayr GmbH | Schulke | Octenisept otopina | boca plast. 1x1000 ml (0,1%+2%) | 7,6183 | 7,62 | | 5% |
| D08AX08 963 | DS | etanol + bifenilol | | | L | Oktal Pharma d.o.o. | Schulke | Desderman pure | boca 1x500 ml | 2,8854 | 2,89 | | 5% |
| D08AX08 964 | DS | etanol + bifenilol | | | L | Oktal Pharma d.o.o. | Schulke | Desderman pure | boca 1x1000 ml | 5,2439 | 5,24 | | 5% |
| D08AX08 965 | DS | etanol + bifenilol | | | L | Oktal Pharma d.o.o. | Schulke | Desderman pure | kanister 1x5000 ml | 18,2706 | 18,27 | | 5% |
| D08AX08 966 | DS | etanol | | | L | Oktal Pharma d.o.o. | Schulke | Desderman Care | boca 1x500 ml | 2,8854 | 2,89 | | 5% |
| D08AX08 967 | DS | etanol | | | L | Oktal Pharma d.o.o. | Schulke | Desderman Care | boca 1x1000 ml | 5,2439 | 5,24 | | 5% |
| D08AX54 901 | DS | izopropanol + butandiol | | | L | Antiseptica d.o.o. | Antiseptica Pulheim | Manorapid rfu | boč. 1x150 ml | 1,8050 | 1,81 | | 5% |
| D08AX54 902 | DS | izopropanol + butandiol | | | L | Antiseptica d.o.o. | Antiseptica Pulheim | Manorapid rfu | boca 1x500 ml | 3,5822 | 3,58 | | 5% |
| D08AX54 903 | DS | izopropanol + butandiol | | | L | Antiseptica d.o.o. | Antiseptica Pulheim | Manorapid rfu | kanister 1x5 L | 23,8237 | 23,82 | | 5% |
| D08AX54 904 | DS | izopropanol + butandiol | | | L | Antiseptica d.o.o. | Antiseptica Pulheim | Skindes obojeni | boč. rasprš. 1x200 ml | 3,4375 | 3,44 | | 5% |
| D08AX54 905 | DS | izopropanol + butandiol | | | L | Antiseptica d.o.o. | Antiseptica Pulheim | Skindes obojeni | boca 1x1000 ml | 6,6229 | 6,62 | | 5% |
| D08AX54 906 | DS | izopropanol + butandiol | | | L | Antiseptica d.o.o. | Antiseptica Pulheim | Skindes neobojeni | boč. rasprš. 1x200 ml | 3,3048 | 3,30 | | 5% |
| D08AX54 907 | DS | izopropanol + butandiol | | | L | Antiseptica d.o.o. | Antiseptica Pulheim | Skindes neobojeni | boca 1x1000 ml | 5,2956 | 5,30 | | 5% |
| D08AX54 911 | DS | izopropanol + etanol | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept lucid | boca 1x200 ml | 2,4076 | 2,41 | | 5% |
| D08AX54 912 | DS | izopropanol + etanol | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept lucid | boca 1x500 ml | 3,2238 | 3,22 | | 5% |
| D08AX54 913 | DS | izopropanol + etanol | | | L | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Plivasept lucid | boca 1x3000 ml | 14,2943 | 14,29 | | 5% |
| D11AH01 962 | | takrolimus hidrat | | | L | LEO Pharma A/S | Astellas Ireland Co. Ltd. | Protopic 0,03% | mast, 1x30 g | 22,5098 | 22,51 | RSRD02 | 5% |
| D11AH05 061 | DS | dupilumabNR509 | 21,4 mg | 61,5558 | P | sanofi-aventis groupe | Sanofi-Aventis Deutschland GmbH | Dupixent | otop. za inj., štrc. napunj. 2x200 mg/1,14 ml | 575,2883 | 1.150,58 | | 5% |
| D11AH05 062 | DS | dupilumabNR509 | 21,4 mg | 41,0372 | P | sanofi-aventis groupe | Sanofi-Aventis Deutschland GmbH | Dupixent | otop. za inj., brizg. napunj. 2x300 mg/2 ml | 575,2883 | 1.150,58 | | 5% |
| G01AA01 651 | | nistatin | 0,1 M i.j. | | V | | | | | | | R | 5% |
| G02AB01 051 | PR | metilergometrin | 0,2 mg | | P | | | | | | | | 5% |
| G02AB01 251 | | metilergometrin | 0,2 mg | | O | | | | | | | R | 5% |
| G02AB03 051 | PR | ergometrin | 0,2 mg | | P | | | | | | | | 5% |
| G02AD02 664 | DS | dinoproston | 0,5 mg | 9,0660 | V | Pfizer Croatia d.o.o. | Pfizer | Prostin E2 | vag. gel 1x2 mg/3 g | 36,2639 | 36,26 | | 5% |
| G02AD02 665 | DS | dinoproston | 0,5 mg | 16,9872 | V | Pfizer Croatia d.o.o. | Pfizer | Prepidil | gel 1x0,5 mg/3 g | 16,9872 | 16,99 | | 5% |
| G02AD02 671 | DS | dinoprostonNG306 | 0,5 mg | 4,1799 | V | Ferring GmbH | Ferring GmbH | Propess | sust. za isporuku u rodnicu, vreć. 5x10 mg | 83,5973 | 417,99 | | 5% |
| G02AD04 066 | DS | karboprost | 2,5 mg | 146,6322 | P | Pfizer Croatia d.o.o. | Pfizer | Prostin 15M | amp. 1x0,25 mg/ml | 14,6632 | 14,66 | | 5% |
| G02AD06 161 | DS | mizoprostolNG307 | 0,2 mg | 92,4176 | O | Norgine B.V. | Azanta Danmark A/S, Norgine B.V. | Angusta | tbl. 8x25 mcg | 11,5522 | 92,42 | | 5% |
| G02BA03 671 | PO | levonorgestrelNG301 | | | V | Gedeon Richter Plc. | Odyssea Pharma S.P.R.L. | Levosert | sustav intrauter. 1x52 mg (20 mcg/24h) | 78,2282 | 78,23 | | 5% |
| G02BA03 861 | PO | levonorgestrelNG301 | | | V | Bayer d.o.o. | Bayer Oy | Mirena | sustav intrauter. 1x52 mg (20 mcg/24h) | 101,4706 | 101,47 | | 5% |
| G02CA03 051 | DS | fenoterol | | | P | | | | | | | | 5% |
| G02CB01 151 | | bromokriptin | 5 mg | | O | | | | | | | R | 5% |
| G02CB03 171 | | kabergolin | 0.5 mg | 2,8010 | O | Pfizer Croatia d.o.o. | Pfizer Italia S.r.l. | Dostinex | tbl. 8x0,5 mg | 2,8010 | 22,41 | RSRG08 | 5% |
| G02CX01 061 | DS | atosibanNG201 | 165 mg | 576,3220 | P | Ferring Pharmaceuticals A/S | Ferring | Tractocile | boč. 1x6,75 mg/0,9 ml (7,5 mg/ml) | 23,5716 | 23,57 | | 5% |
| G02CX01 062 | DS | atosibanNG201 | 165 mg | 315,5977 | P | Ferring Pharmaceuticals A/S | Ferring | Tractocile | boč. 1x37,5 mg/5 ml (7,5 mg /ml) | 71,7354 | 71,74 | | 5% |
| G02CX01 071 | DS | atosibanNG201 | 165 mg | 403,4254 | P | ALPHA-MEDICAL d.o.o. | PharmIdea SIA | Atosiban Alpha-Medical | boč. 1x6,75 mg/0,9 ml | 16,5001 | 16,50 | | 5% |
| G02CX01 072 | DS | atosibanNG201 | 165 mg | 246,7196 | P | ALPHA-MEDICAL d.o.o. | PharmIdea SIA | Atosiban Alpha-Medical | boč. 1x37,5 mg/5 ml | 56,0794 | 56,08 | | 5% |
| G03BA03 052 | PR | testosteron | 18 mg | | P | | | | | | | | 5% |
| G03BA03 071 | PO | testosteronNG302 | 18 mg | 1,7677 | P | Bayer d.o.o. | Bayer AG | Nebido | otop. za inj., boč.1x1000 mg/4 ml | 98,2056 | 98,21 | | 5% |
| G03BA03 151 | | testosteron | 0,12 g | | O | | | | | | | R | 5% |
| G03BA03 961 | | testosteron | 50 mg | 1,4418 | TD | Besins Healthcare S.A. | Besins Manufacturing Belgium | Androgel gel | vreć. 30x50 mg/5 g | 1,4418 | 43,25 | RSRG01 | 5% |
| G03CA03 051 | DS | estradiol | 1 mg | | P | | | | | | | | 5% |
| G03CA03 171 | | estradiol | 2 mg | 0,1274 | O | Novo Nordisk A/S | Novo Nordisk | Estrofem | tbl. 1x28/2 mg | 0,1274 | 3,57 | R | 5% |
| G03CA03 172 | | estradiol | 2 mg | 0,2797 | O | Novo Nordisk A/S | Novo Nordisk | Estrofem | tbl. 1x28/1 mg | 0,1398 | 3,92 | R | 5% |
| G03DA02 161 | | medroksiprogesteron | 5 mg | 0,0796 | O | Pfizer Croatia d.o.o. | Pfizer | Provera | tbl. 24x5 mg | 0,0796 | 1,91 | R | 5% |
| G03DA02 162 | | medroksiprogesteron | 5 mg | 0,0491 | O | Pfizer Croatia d.o.o. | Pfizer | Provera | tbl. 30x10 mg | 0,0982 | 2,95 | R | 5% |
| G03DA04 051 | DS | progesteron | 5 mg | | P | | | | | | | | 5% |
| G03DA04 161 | | progesteron | 0,3 g | 0,5296 | O | Besins Healthcare S.A. | Cyndea Pharma S.L., Besins Manufacturing Belgium | Utrogestan | caps. 30x100 mg | 0,1765 | 5,30 | R | 5% |
| G03DA04 671 | | progesteron | 90 mg | 0,1840 | V | Besins Healthcare Ireland Limited | Cyndea Pharma S.L., Besins Manufacturing Belgium | Utrogestan | meke caps. za rodnicu 15x200 mg | 0,4088 | 6,13 | R | 5% |
| G03DA04 861 | | progesteron | 90 mg | 2,6813 | V | MERCK d.o.o. | Central Pharma | Crinone | gel za rodnicu 8%, aplik. plast. napunj. 15x1 doza (90 mg/1,125g) | 2,6813 | 40,22 | R | 5% |
| G03DA04 871 | | progesteron | 90 mg | 0,1870 | V | Gedeon Richter Plc. | Actavis UK Limited, Gedeon Richter Plc. | Cyclogest | vag. 15x400 mg | 0,8313 | 12,47 | R | 5% |
| G03GA01 051 | DS | koriogonadotropinNG303 | 250 i.j. | | P | | | | | | | | 5% |
| G03GA02 063 | DS | menotropin (FSH + LH)NG304 | 75 i.j. | 20,1877 | P | Ferring GmbH | Ferring | Menopur | praš. i otap. za otop. za inj., boč. 1x1200 IU | 323,0035 | 323,00 | | 5% |
| G03GA02 064 | DS | menotropin (FSH + LH)NG304 | 75 i.j. | 17,2978 | P | Ferring GmbH | Ferring | Menopur | praš. i otap. za otop. za inj., boč. 10x75 IU | 17,2978 | 172,98 | | 5% |
| G03GA02 065 | DS | menotropin (FSH + LH)NG304 | 75 i.j. | 17,5123 | P | Ferring GmbH | Ferring GmbH | Menopur | praš. i otap. za otop. za inj., boč. 1x600 IU | 140,0982 | 140,10 | | 5% |
| G03GA05 001 | DS | folitropin alfaNG304 | 75 i.j. | 20,9062 | P | Theramex Ireland Limited | Merckle Biotec GmbH, Teva Pharmaceuticals Europe B.V. | Ovaleap | otop. za inj., pen-štrcaljka 1x300 IU (22 mcg)/0,5 ml | 83,6247 | 83,62 | | 5% |
| G03GA05 002 | DS | folitropin alfaNG304 | 75 i.j. | 19,7034 | P | Theramex Ireland Limited | Merckle Biotec GmbH, Teva Pharmaceuticals Europe B.V. | Ovaleap | otop. za inj., pen-štrcaljka 1x450 IU (33 mcg)/0,75 ml | 118,2202 | 118,22 | | 5% |
| G03GA05 003 | DS | folitropin alfaNG304 | 75 i.j. | 20,7061 | P | Theramex Ireland Limited | Merckle Biotec GmbH, Teva Pharmaceuticals Europe B.V. | Ovaleap | otop. za inj., pen-štrcaljka 1x900 IU (66 mcg)/1,5 ml | 248,4730 | 248,47 | | 5% |
| G03GA05 071 | DS | folitropin alfaNG304 | 75 i.j. | 23,4866 | P | Merck Europe B.V. | Merck | Gonal-f | amp. 1x75 i.j. | 23,4866 | 23,49 | | 5% |
| G03GA05 072 | DS | folitropin alfaNG304 | 75 i.j. | 21,2157 | P | Merck Europe B.V. | Merck | Gonal-f | otop. za inj., pen-štrcaljka 1x300 IU (22 mcg)/0,5 ml | 84,8630 | 84,86 | | 5% |
| G03GA05 073 | DS | folitropin alfaNG304 | 75 i.j. | 20,2225 | P | Merck Europe B.V. | Merck | Gonal-f | otop. za inj., pen-štrcaljka 1x450 IU (33 mcg)/0,75 ml | 121,3352 | 121,34 | | 5% |
| G03GA05 074 | DS | folitropin alfaNG304 | 75 i.j. | 22,2260 | P | Merck Europe B.V. | Merck | Gonal-f | otop. za inj., pen-štrcaljka 1x900 IU (66 mcg)/1,5 ml | 266,7118 | 266,71 | | 5% |
| G03GA05 081 | DS | folitropin alfaNG304 | 75 i.j. | 18,7936 | P | Gedeon Richter Plc. | Finox Biotech AG | Bemfola | otop. za inj., brizg. napunj.1x75 IU/0,125 ml | 18,7936 | 18,79 | | 5% |
| G03GA05 082 | DS | folitropin alfaNG304 | 75 i.j. | 18,9050 | P | Gedeon Richter Plc. | Finox Biotech AG | Bemfola | otop. za inj., brizg. napunj. 1x150 IU/0,25 ml | 37,8101 | 37,81 | | 5% |
| G03GA05 083 | DS | folitropin alfaNG304 | 75 i.j. | 18,2012 | P | Gedeon Richter Plc. | Finox Biotech AG | Bemfola | otop. za inj., brizg. napunj. 1x225 IU/0,375 ml | 54,6035 | 54,60 | | 5% |
| G03GA05 084 | DS | folitropin alfaNG304 | 75 i.j. | 21,2157 | P | Gedeon Richter Plc. | Finox Biotech AG | Bemfola | otop. za inj., brizg. napunj. 1x300 IU/0,50 ml | 84,8630 | 84,86 | | 5% |
| G03GA05 085 | DS | folitropin alfaNG304 | 75 i.j. | 20,2225 | P | Gedeon Richter Plc. | Finox Biotech AG | Bemfola | otop. za inj., brozg. napunj. 1x450 IU/0,75 ml | 121,3352 | 121,34 | | 5% |
| G03GA06 076 | DS | folitropin betaNG304 | 75 i.j. | 23,1913 | P | Organon N.V. | N.V. Organon | Puregon | otop. za inj. 1x300 IU/0,36 ml, uložak i 6 igala | 92,7653 | 92,77 | | 5% |
| G03GA06 077 | DS | folitropin betaNG304 | 75 i.j. | 23,6401 | P | Organon N.V. | N.V. Organon | Puregon | otop. za inj. u ulošku i 9 igala (1 uložak, 900 IU/1,08 ml) | 283,6817 | 283,68 | | 5% |
| G03GA08 073 | DS | koriogonadotropinNG303 | 250 mcg | 27,1325 | P | Merck Europe B.V. | Serono | Ovitrelle | otop. za inj., brizg. napunj. 1x250 mcg | 27,1325 | 27,13 | | 5% |
| G03GA09 061 | DS | korifolitropin alfaNG304 | 0,15 mg | 637,6906 | P | Organon N.V. | Organon | Elonva | otop. za inj., štrc. napunj. 1x100 mcg/0,5 ml | 425,1483 | 425,15 | | 5% |
| G03GA09 062 | DS | korifolitropin alfaNG304 | 0,15 mg | 466,7237 | P | Organon N.V. | Organon | Elonva | otop. za inj., štrc. napunj. 1x150 mcg/0,5 ml | 466,7237 | 466,72 | | 5% |
| G03GA10 074 | DS | folitropin deltaNG304 | 12 mcg | 80,4844 | P | Ferring Pharmaceuticals A/S | Ferring GmbH | Rekovelle | otop. za inj. 1x12 mcg/0,36 ml, napunjena brizgalica i 3 igle | 80,4844 | 80,48 | | 5% |
| G03GA10 075 | DS | folitropin deltaNG304 | 12 mcg | 81,1489 | P | Ferring Pharmaceuticals A/S | Ferring GmbH | Rekovelle | otop. za inj. 1x36 mcg/1,08 ml, napunjena brizgalica i 6 igala | 243,4468 | 243,45 | | 5% |
| G03GA10 076 | DS | folitropin deltaNG304 | 12 mcg | 77,4690 | P | Ferring Pharmaceuticals A/S | Ferring GmbH | Rekovelle | otop. za inj. 1x72 mcg/2,16 ml, napunjena brizgalica i 9 igala | 464,8139 | 464,81 | | 5% |
| G03GA30 061 | DS | folitropin alfa + lutropin alfaNG305 | | | P | Merck Europe B.V. | Merck Serono S.p.A. | Pergoveris | praš. i otap. za otop. za inj., 1 x (150 IU+75 IU) | 68,3761 | 68,38 | | 5% |
| G03GA30 062 | DS | folitropin alfa + lutropin alfaNG305 | | | P | Merck Europe B.V. | Merck Serono S.A. | Pergoveris | otop. za inj., brizg. napunj., (300 IU+150 IU)/0,48 ml | 137,3270 | 137,33 | | 5% |
| G03GA30 063 | DS | folitropin alfa + lutropin alfaNG305 | | | P | Merck Europe B.V. | Merck Serono S.A. | Pergoveris | otop. za inj., brizg. napunj., (450 IU+225 IU)/0,72 ml | 204,2670 | 204,27 | | 5% |
| G03GA30 064 | DS | folitropin alfa + lutropin alfaNG305 | | | P | Merck Europe B.V. | Merck Serono S.A. | Pergoveris | otop. za inj., brizg. napunj., (900 IU+450 IU)/1,44 ml | 399,2700 | 399,27 | | 5% |
| G03GB02 151 | | klomifen | 9 mg | | O | | | | | | | R | 5% |
| G03HA01 161 | | ciproteron-acetat | 0,1 g | 0,9361 | O | Bayer d.o.o. | Delpharm Lille SAS., Bayer Weimar GmbH und Co. KG. | Androcur | tbl. 50x50 mg | 0,4681 | 23,40 | R | 5% |
| G03HB01 141 | | ciproteron-acetat + etinilestradiol | | | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Axira 35 | tbl. film obl. 63x(2 mg+0,035 mg) | 0,1405 | 8,85 | RSRG02 | 5% |
| G03XA01 151 | | danazol | 0,6 g | | O | | | | | | | RSRG91 | 5% |
| G03XC01 161 | | raloksifen | 60 mg | 0,4615 | O | DAIICHI SANKYO EUROPE GmbH | Lilly S.A. | Evista | tbl. 28x60 mg | 0,4615 | 12,92 | RSRG03 | 5% |
| G04BD04 151 | | oksibutinin | 15 mg | | O | | | | | | | RRG09 | 5% |
| G04BD08 101 | | solifenacin | 5 mg | 0,2941 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Urotrim | tbl. film obl. 30x5 mg | 0,2941 | 8,82 | RRG04 | 5% |
| G04BD08 102 | | solifenacin | 5 mg | 0,3230 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Urotrim | tbl. film obl. 30x10 mg | 0,6459 | 19,38 | RRG04 | 5% |
| G04BD08 111 | | solifenacin | 5 mg | 0,2941 | O | Belupo d.d. | Belupo d.d. | Beloflux | tbl. film obl. 30x5 mg | 0,2941 | 8,82 | RRG04 | 5% |
| G04BD08 112 | | solifenacin | 5 mg | 0,2400 | O | Belupo d.d. | Belupo d.d. | Beloflux | tbl. film obl. 30x10 mg | 0,4800 | 14,40 | RRG04 | 5% |
| G04BD08 121 | | solifenacin | 5 mg | 0,2941 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Spazur | tbl. film obl. 30x5 mg | 0,2941 | 8,82 | RRG04 | 5% |
| G04BD08 122 | | solifenacin | 5 mg | 0,2807 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Spazur | tbl. film obl. 30x10 mg | 0,5614 | 16,84 | RRG04 | 5% |
| G04BD08 141 | | solifenacin | 5 mg | 0,2941 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Soline | tbl. film obl. 30x5 mg | 0,2941 | 8,82 | RRG04 | 5% |
| G04BD08 142 | | solifenacin | 5 mg | 0,3230 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Soline | tbl. film obl. 30x10 mg | 0,6459 | 19,38 | RRG04 | 5% |
| G04BD08 161 | | solifenacin | 5 mg | 0,2941 | O | Astellas d.o.o. | Astellas Pharma Europe B.V. | Vesicare | tbl. film obl. 30x5 mg | 0,2941 | 8,82 | RRG04 | 5% |
| G04BD08 162 | | solifenacin | 5 mg | 0,3230 | O | Astellas d.o.o. | Astellas Pharma Europe B.V. | Vesicare | tbl. film obl. 30x10 mg | 0,6459 | 19,38 | RRG04 | 5% |
| G04BD08 181 | | solifenacin | 5 mg | 0,2941 | O | Viatris Limited | Mylan Hungary Kft, McDermott Laboratories Limited t/a Gerard Laboratories, Mylan Dublin B.V. | Solven | tbl. film obl. 30x5 mg | 0,2941 | 8,82 | RRG04 | 5% |
| G04BD08 182 | | solifenacin | 5 mg | 0,3121 | O | Viatris Limited | Mylan Hungary Kft, McDermott Laboratories Limited t/a Gerard Laboratories, Mylan B.V. | Solven | tbl. film obl. 30x10 mg | 0,6242 | 18,73 | RRG04 | 5% |
| G04BD08 183 | | solifenacin | 5 mg | 0,2941 | O | STADA d.o.o. | STADA Arzneimittel GmbH | Solifenacin STADA | tbl. film obl. 30x5 mg | 0,2941 | 8,82 | RRG04 | 5% |
| G04BD08 184 | | solifenacin | 5 mg | 0,2526 | O | STADA d.o.o. | STADA Arzneimittel GmbH | Solifenacin STADA | tbl. film obl. 30x10 mg | 0,5053 | 15,16 | RRG04 | 5% |
| G04BD08 185 | | solifenacin | 5 mg | 0,2794 | O | BE Pharma d.o.o. | Genepharm S.A. | Solifenacin Be Pharma | tbl. film obl. 30x5 mg | 0,2794 | 8,38 | RRG04 | 5% |
| G04BD08 186 | | solifenacin | 5 mg | 0,2280 | O | BE Pharma d.o.o. | Genepharm S.A. | Solifenacin Be Pharma | tbl. film obl. 30x10 mg | 0,4560 | 13,68 | RRG04 | 5% |
| G04BD09 022 | PR | trospij | | | P | Sandoz d.o.o. | Sandoz-Lek | Spasmex | amp. 50x0,2 mg/5 ml | 0,3597 | 17,98 | | 5% |
| G04BD12 161 | | mirabegron | 50 mg | 2,2359 | O | Astellas Pharma Europe B.V. | Astellas Pharma Europe B.V. | Betmiga | tbl. s prod. otpušt. 30x25 mg | 1,1180 | 33,54 | RSRG07 | 5% |
| G04BD12 162 | | mirabegron | 50 mg | 1,1180 | O | Astellas Pharma Europe B.V. | Astellas Pharma Europe B.V. | Betmiga | tbl. s prod. otpušt. 30x50 mg | 1,1180 | 33,54 | RSRG07 | 5% |
| G04BD13 101 | | desfesoterodin | 3.5 mg | 0,2941 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Tovedeso | tbl. s prod. oslob. 28x3,5 mg | 0,2941 | 8,23 | RRG04 | 5% |
| G04BD13 102 | | desfesoterodin | 3.5 mg | 0,2809 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Tovedeso | tbl. s prod. oslob. 28x7 mg | 0,5618 | 15,73 | RRG04 | 5% |
| G04BE03 101 | DS | sildenafilNG401 | 50 mg | 7,9280 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o. | Sildenafil Pliva | tbl. film obl. 90x20 mg | 3,1712 | 285,41 | | 5% |
| G04BE03 161 | DS | sildenafilNG401 | 50 mg | 7,9280 | O | Pfizer Europe MA EEIG | Pfizer | Revatio | tbl. film obl. 90x20 mg | 3,1712 | 285,41 | | 5% |
| G04BE03 171 | DS | sildenafilNG401 | 50 mg | 7,9280 | O | Accord Healthcare S.L.U. | Accord Healthcare Limited | Granpidam | tbl. film obl. 90x20 mg | 3,1712 | 285,41 | | 5% |
| G04BE03 172 | DS | sildenafilNG401 | 50 mg | 7,9280 | O | Accord Healthcare S.L.U. | Accord Healthcare Limited | Granpidam | tbl. film obl. 300x20 mg | 3,1712 | 951,36 | | 5% |
| G04BE03 173 | DS | sildenafilNG401 | 50 mg | 7,9280 | O | ALPHA-MEDICAL d.o.o. | Mawdsley Brooks & Co. Ltd. | Sildenafil Alpha-Medical | tbl. film obl. 90x20 mg | 3,1712 | 285,41 | | 5% |
| G04CA02 103 | | tamsulozin | 0,4 mg | 0,1393 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Bazetham | tbl. s prod. oslob. 30x0,4 mg | 0,1393 | 4,18 | RSRG05 | 5% |
| G04CA02 111 | | tamsulozin | 0,4 mg | 0,1393 | O | Belupo d.d. | Belupo | Tamosin | caps. s prod. oslob. tvrda 30x0,4 mg | 0,1393 | 4,18 | RSRG05 | 5% |
| G04CA02 112 | | tamsulozin | 0,4 mg | 0,0914 | O | Belupo d.d. | Belupo lijekovi i kozmetika d.d. | Tamosin | caps. s prilag. oslob. tvrda 100x0,4 mg | 0,0914 | 9,14 | RSRG05 | 5% |
| G04CA02 131 | | tamsulozin | 0,4 mg | 0,1393 | O | KRKA-FARMA d.o.o. | Krka d.d. | Tanyz | caps. s prod. oslob. tvrda 30x0,4 mg | 0,1393 | 4,18 | RSRG05 | 5% |
| G04CA02 132 | | tamsulozin | 0,4 mg | 0,1128 | O | KRKA-FARMA d.o.o. | Krka d.d. | Tanyz | caps. s prod. oslob. tvrda 60x0,4 mg | 0,1128 | 6,77 | RSRG05 | 5% |
| G04CA02 133 | | tamsulozin | 0,4 mg | 0,1254 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Tanyz ERAS | tbl. s prod. oslob. 30x0,4 mg | 0,1254 | 3,76 | RSRG05 | 5% |
| G04CA02 134 | | tamsulozin | 0,4 mg | 0,1128 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Tanyz ERAS | tbl. s prod. oslob. 60x0,4 mg | 0,1128 | 6,77 | RSRG05 | 5% |
| G04CA02 145 | | tamsulozin | 0,4 mg | 0,1393 | O | PharmaS d.o.o. | PharmaS d.o.o. | Tamsulozin PharmaS | caps. s prod. oslob. tvrda 30x0,4 mg | 0,1393 | 4,18 | RSRG05 | 5% |
| G04CA02 146 | | tamsulozin | 0,4 mg | 0,1128 | O | PharmaS d.o.o. | PharmaS d.o.o. | Tamsulozin PharmaS | caps. tvrda s prod. oslob. 60x0,4 mg | 0,1128 | 6,77 | RSRG05 | 5% |
| G04CA02 147 | | tamsulozin | 0,4 mg | 0,1015 | O | Alkaloid-INT d.o.o. | Alkaloid-INT d.o.o. | Tamaliz | caps. s prilag. oslob., tvrda 30x0,4 mg | 0,1015 | 3,05 | RSRG05 | 5% |
| G04CA02 148 | | tamsulozin | 0,4 mg | 0,0963 | O | Alkaloid-INT d.o.o. | Alkaloid-INT d.o.o. | Tamaliz | caps. s prilag. oslob., tvrda 100x0,4 mg | 0,0963 | 9,63 | RSRG05 | 5% |
| G04CA02 161 | | tamsulozin | 0,4 mg | 0,1393 | O | Astellas d.o.o. | Astellas Pharma Europe B.V. | Omnic | caps. s prod. otp. 30x0,4 mg | 0,1393 | 4,18 | RSRG05 | 5% |
| G04CA02 163 | | tamsulozin | 0,4 mg | 0,1393 | O | Menarini International Operations Luxembourg S.A. | Menarini-Von Heyden GmbH; Synthon Hispania S.L. | Flosin | caps. s prilag. oslob. tvrda 30x0,4 mg | 0,1393 | 4,18 | RSRG05 | 5% |
| G04CA02 164 | | tamsulozin | 0,4 mg | 0,1128 | O | Menarini International Operations Luxembourg S.A. | Menarini-Von Heyden GmbH; Synthon Hispania S.L. | Flosin | caps. s prilag. oslob. tvrda 100x0,4 mg | 0,1128 | 11,28 | RSRG05 | 5% |
| G04CA02 172 | | tamsulozin | 0,4 mg | 0,1393 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma G.m.b.H | Tamsu Genericon | caps. s prod. oslob. tvrda 30x0,4 mg | 0,1393 | 4,18 | RSRG05 | 5% |
| G04CA02 181 | | tamsulozin | 0,4 mg | 0,1284 | O | Zentiva k.s. | Synthon BV, Synthon Hispania S.L. | Tamsich | caps. s prilag. oslob. tvrda 30x0,4 mg | 0,1284 | 3,85 | RSRG05 | 5% |
| G04CA52 101 | | dutasterid + tamsulozin | | | O | PLIVA HRVATSKA d.o.o. | Laboratorios Leon Farma S.A. | Duster Duo | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 102 | | dutasterid + tamsulozin | | | O | PLIVA HRVATSKA d.o.o. | Laboratorios Leon Farma S.A. | Duster Duo | caps. tvrda 90x(0,5 mg+0,4 mg) | 0,2185 | 19,66 | RSpg03 | 5% |
| G04CA52 111 | | dutasterid + tamsulozin | | | O | Belupo d.d. | Belupo | Kllotas | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 121 | | dutasterid + tamsulozin | | | O | Jadran – Galenski Laboratorij d.d. | Laboratorios Leon Farma S.A. | Dulmod | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 141 | | dutasterid + tamsulozin | | | O | PharmaS d.o.o. | Laboratorios Leon Farma S.A. | Atekago | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 142 | | dutasterid + tamsulozin | | | O | Alkaloid-INT d.o.o. | Alkaloid – INT d.o.o. | Tamaliz Duo | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 162 | | dutasterid + tamsulozin | | | O | Mylan Ireland Limited | Laboratorios Leon Farma S.A. | Vasgar | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 163 | | dutasterid + tamsulozin | | | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma Gesellschaft m.b.H., Laboratorios Leon Farma S.A. | Duitam | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 171 | | dutasterid + tamsulozin | | | O | ALPHA-MEDICAL d.o.o. | Laboratorios Leon Farma S.A. | Duostin | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 181 | | dutasterid + tamsulozin | | | O | Zentiva k.s. | Laboratorios Leon Farma S.A. | Dupro plus | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CA52 191 | | dutasterid + tamsulozin | | | O | STADA d.o.o. | STADA Arzneimittel AG | Dutasterid/tamsulozin Stada | caps. tvrda 30x(0,5 mg+0,4 mg) | 0,2421 | 7,26 | RSpg03 | 5% |
| G04CB01 141 | | finasterid | 5 mg | 0,1138 | O | PharmaS d.o.o. | PharmaS d.o.o. | Finasterid PharmaS | tbl. film obl. 28x5 mg | 0,1138 | 3,19 | RSRG06 | 5% |
| G04CB01 171 | | finasterid | 5 mg | 0,1138 | O | PharmaS d.o.o. | Cipla | Fincar | tbl. film obl. 28x5 mg | 0,1138 | 3,19 | RSRG06 | 5% |
| G04CB01 181 | | finasterid | 5 mg | 0,1137 | O | Genericon Pharma Gesellschaft m.b.H. | Genericon Pharma GmbH | Finasterid Genericon | tbl. film obl. 30x5 mg | 0,1137 | 3,41 | RSRG06 | 5% |
| H01AA02 051 | KL | tetrakozaktid (tetracosactrin) | 0,25 mg | | P | | | | | | | | 5% |
| H01AB01 061 | KL | tirotropin alfaNH101 | 0,9 mg | 321,7214 | P | Genzyme Europe B.V. | Genzyme | Thyrogen | praš. za otop. za inj., boč. 2x0,9 mg | 321,7214 | 643,44 | | 5% |
| H01AC01 021 | | somatropinNH505 | 2 i.j. | 9,8707 | P | Sandoz GmbH | Sandoz | Omnitrope | uložak stakl. 1x5 mg/1,5 ml (1 mg =3 i.j.) | 74,0301 | 74,03 | RSRH06 | 5% |
| H01AC01 022 | | somatropinNH505 | 2 i.j. | 9,8706 | P | Sandoz GmbH | Sandoz | Omnitrope | uložak stakl. 1x10 mg/1,5 ml (1 mg =3 i.j.) | 148,0589 | 148,06 | RSRH06 | 5% |
| H01AC01 023 | | somatropinNH505 | 2 i.j. | 9,8706 | P | Sandoz GmbH | Sandoz | Omnitrope | uložak stakl. 1x15 mg/1,5 ml (1 mg =3 i.j.) | 222,0891 | 222,09 | RSRH06 | 5% |
| H01AC01 062 | | somatropinNH505 | 2 i.j. | 9,8706 | P | Pfizer Croatia d.o.o. | Pfizer | Genotropin | praš. i otap. za otop. za inj., uložak dvodijelni stakl. 5x5,3 mg/ml (5x16 i.j.) | 78,9648 | 394,82 | RSRH06 | 5% |
| H01AC01 065 | | somatropinNH505 | 2 i.j. | 88,8354 | P | Pfizer Croatia d.o.o. | Pfizer | Genotropin | praš. i otap. za otop. za inj., uložak dvodijelni stakl. 5x12 mg/ml (5x36 i.j.) | 177,6707 | 888,35 | RSRH06 | 5% |
| H01AC01 066 | | somatropinNH505 | 2 i.j. | 9,8706 | P | Pfizer Croatia d.o.o. | Pfizer | Genotropin | praš. i otap. za otop. za inj., uložak dvodijelni stakl. u višedoznoj napunj. brizg. GoQuick 5x5,3 mg/ml (5x16 i.j.) | 78,9648 | 394,82 | RSRH06 | 5% |
| H01AC01 067 | | somatropinNH505 | 2 i.j. | 9,8706 | P | Pfizer Croatia d.o.o. | Pfizer | Genotropin | praš. i otap. za otop. za inj., uložak dvodijelni stakl. u višedoznoj napunj. brizg. GoQuick 5x12 mg/ml (5x36 i.j.) | 177,6707 | 888,35 | RSRH06 | 5% |
| H01AC01 086 | | somatropinNH506 | 2 i.j. | 15,9234 | P | Novo Nordisk A/S | Novo Nordisk A/S | Norditropin NordiFlex | otop. za inj., napunj. brizg. 1x5 mg/1,5 ml (1 mg =3 i.j.) | 119,4253 | 119,43 | RSRH06 | 5% |
| H01AC01 087 | | somatropinNH506 | 2 i.j. | 15,8521 | P | Novo Nordisk A/S | Novo Nordisk A/S | Norditropin NordiFlex | otop. za inj., napunj. brizg. 1x10 mg/1,5 ml (1 mg =3 i.j.) | 237,7809 | 237,78 | RSRH06 | 5% |
| H01AC01 088 | | somatropinNH506 | 2 i.j. | 16,0455 | P | Novo Nordisk A/S | Novo Nordisk A/S | Norditropin NordiFlex | otop. za inj., napunj. brizg. 1x15 mg/1,5 ml (1 mg =3 i.j.) | 361,0233 | 361,02 | RSRH06 | 5% |
| H01AX01 081 | DS | pegvisomantNH507 | | | P | Pfizer Europe MA EEIG | Pfizer Manufacturing Belgium NV | Somavert | praš. i otap. za otop. za inj., 30x10 mg | 64,4268 | 1.932,80 | | 5% |
| H01AX01 082 | DS | pegvisomantNH507 | | | P | Pfizer Europe MA EEIG | Pfizer Manufacturing Belgium NV | Somavert | praš. i otap. za otop. za inj., 30x20 mg | 128,4244 | 3.852,73 | | 5% |
| H01BA02 052 | PR | dezmopresin | 4 mcg | | P | | | | | | | | 5% |
| H01BA02 163 | | dezmopresin | 0,4 mg | 3,8944 | O | Ferring GmbH | Ferring | Minirin Melt | liofilizat oral. 30x60 mcg | 0,5842 | 17,52 | RSRH01 | 5% |
| H01BA02 164 | | dezmopresin | 0,4 mg | 3,8944 | O | Ferring GmbH | Ferring | Minirin Melt | liofilizat oral. 30x120 mcg | 1,1683 | 35,05 | RSRH01 | 5% |
| H01BA02 751 | | dezmopresin | 25 mcg | 1,0550 | N | | | | | 21,1003 | 21,10 | RSRH02 | 5% |
| H01BA02 761 | | dezmopresin | 25 mcg | 1,0550 | N | Ferring GmbH | Ferring | Minirin | rasprš. za nos 1x5 ml (0,1 mg/ml, 50 doza) | 21,1003 | 21,10 | RSRH02 | 5% |
| H01BA04 071 | DS | terlipresinNH106 | 12 mg | 342,1586 | P | Ferring GmbH | Ferring GmbH | Glypressin | praš. i otap. za otop. za inj. štrc. 5x1 mg | 28,5155 | 142,58 | | 5% |
| H01BB02 062 | PR | oksitocin | 15 i.j. | 1,0683 | P | Mylan Hrvatska d.o.o. | Mylan S.A.S. | Syntocinon | amp. 10x5 i.j./ ml. | 0,3561 | 3,56 | | 5% |
| H01BB02 763 | PR | oksitocin | 15 i.j. | 0,3335 | N | Mylan Hrvatska d.o.o. | Delpharm Huningue S. A. S. | Syntocinon | rasprš. 1x5 ml (40 i.j./ml) | 4,4462 | 4,45 | | 5% |
| H01CA01 751 | | gonadorelin | | | N | | | | | | | RSRH91 | 5% |
| H01CB02 001 | DS | oktreotidNH105 | 0,7 mg | 21,6324 | P | Teva B.V. | Pliva Hrvatska d.o.o., Merckle GmbH | Oktreotid Teva | boč. 1x20 mg | 618,0689 | 618,07 | | 5% |
| H01CB02 002 | DS | oktreotidNH105 | 0,7 mg | 18,4583 | P | Teva B.V. | Pliva Hrvatska d.o.o., Merckle GmbH | Oktreotid Teva | boč. 1x30 mg | 791,0678 | 791,07 | | 5% |
| H01CB02 065 | DS | oktreotidNH104 | 0,7 mg | 35,3686 | P | Novartis Hrvatska d.o.o. | Novartis Farmacéutica S.A., Novartis Pharma GmbH | Sandostatin | amp. 5x0,10 mg | 5,0528 | 25,26 | | 5% |
| H01CB02 066 | DS | oktreotidNH104 | 0,7 mg | 31,9685 | P | Novartis Hrvatska d.o.o. | Novartis Farmacéutica S.A., Novartis Pharma GmbH | Sandostatin | amp. 5x0,50 mg | 22,8344 | 114,17 | | 5% |
| H01CB02 068 | DS | oktreotidNH105 | 0,7 mg | 23,8607 | P | Novartis Hrvatska d.o.o. | Novartis Farmacéutica S.A., Novartis Pharma GmbH | Sandostatin Lar | boč. 1x20 mg | 691,9610 | 691,96 | | 5% |
| H01CB02 069 | DS | oktreotidNH105 | 0,7 mg | 20,3459 | P | Novartis Hrvatska d.o.o. | Novartis Farma S.p.A., Novartis Pharma GmbH | Sandostatin Lar | boč. 1x30 mg | 874,8743 | 874,87 | | 5% |
| H01CB05 061 | DS | pasireotidNH507 | 1,2 mg | 87,4429 | P | Recordati Rare Diseases | Novartis Pharma GmbH | Signifor | praš. i otap. za susp. za inj., 1x40 mg | 2.914,7601 | 2.914,76 | | 5% |
| H01CB05 062 | DS | pasireotidNH507 | 1,2 mg | 64,3730 | P | Recordati Rare Diseases | Novartis Pharma GmbH | Signifor | praš. i otap. za susp. za inj., 1x60 mg | 3.218,6515 | 3.218,65 | | 5% |
| H01CC01 061 | DS | ganireliks | 0.25 mg | 26,7450 | P | Organon N.V. | Organon | Orgalutran | otop. za inj., štrc. napunj. 1x0,25 mg/0,5 ml | 26,7450 | 26,74 | | 5% |
| H01CC02 071 | DS | cetroreliks | 0,25 mg | 34,7256 | P | Merck Europe B.V. | Baxter | Cetrotide | praš. i otap. za otop. za inj. boč. 1x0,25 mg+napunj. štrc. | 34,7256 | 34,73 | | 5% |
| H02AA02 151 | | fludrokortizon | 0,1 mg | | O | | | | | | | R | 5% |
| H02AB02 021 | PR | deksametazon | 1,5 mg | 0,1725 | P | Sandoz d.o.o. | Sandoz-Salutas | Deksametazon Sandoz | otop. za inj., amp. 10x4 mg/ml | 0,4599 | 4,60 | | 5% |
| H02AB02 032 | PR | deksametazon | 1,5 mg | 0,2659 | P | KRKA-FARMA d.o.o. | Krka d.d. | Dexamethason/Deksametazon Krka | amp. 25x4 mg/ml / otop. za inj./inf., 25x4 mg/ml | 0,7127 | 17,82 | | 5% |
| H02AB02 071 | PR | deksametazon | 1,5 mg | 0,1639 | P | hameln pharma gmbh | hameln rds s.r.o., Siegfried Hameln GmbH | Deksametazon hameln | otop. za inj., amp. 10x4 mg/1 ml | 0,4369 | 4,37 | | 5% |
| H02AB02 101 | | deksametazon | 1,5 mg | 0,2012 | O | PLIVA HRVATSKA d.o.o. | Merckle GmbH | Deksametazon Pliva | tbl. 20x4 mg | 0,5366 | 10,73 | R | 5% |
| H02AB02 102 | | deksametazon | 1,5 mg | 0,1323 | O | PLIVA HRVATSKA d.o.o. | Merckle GmbH | Deksametazon Pliva | tbl. 20x8 mg | 0,7054 | 14,11 | R | 5% |
| H02AB02 131 | | deksametazon | 1,5 mg | 0,5893 | O | KRKA-FARMA d.o.o. | Krka d.d. | Dexamethason/Deksametazon Krka | tbl. 10x0,5 mg | 0,1964 | 1,96 | R | 5% |
| H02AB02 132 | | deksametazon | 1,5 mg | 0,2119 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Deksametazon Krka | tbl. 20x4 mg | 0,5649 | 11,30 | R | 5% |
| H02AB02 133 | | deksametazon | 1,5 mg | 0,1542 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Deksametazon Krka | tbl. 20x20 mg | 2,0562 | 41,12 | RSRV03 | 5% |
| H02AB04 064 | PO | metilprednizolon-sukcinat-natrij | 20 mg | 0,7293 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Medrol | amp. 1x40 mg/ml | 1,4586 | 1,46 | | 5% |
| H02AB04 065 | DS | metilprednizolon-acetat | 20 mg | 0,5953 | P | Pfizer Croatia d.o.o. | Pfizer | Depo Medrol | amp. 1x40 mg/ml | 1,1905 | 1,19 | | 5% |
| H02AB04 066 | PO | metilprednizolon-sukcinat-natrij | 20 mg | 0,4856 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Medrol | amp. 1x125 mg/2 ml | 2,9133 | 2,91 | | 5% |
| H02AB04 067 | DS | metilprednizolon-sukcinat-natrij | 20 mg | 0,3681 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Medrol | amp. 1x500 mg/8 ml | 9,2030 | 9,20 | | 5% |
| H02AB04 068 | DS | metilprednizolon-sukcinat-natrij | 20 mg | 0,3350 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Medrol | amp. 1x250 mg | 4,1874 | 4,19 | | 5% |
| H02AB04 069 | DS | metilprednizolon-sukcinat-natrij | 20 mg | 0,1981 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Medrol | amp. 1x1.000 mg/16 ml | 9,9038 | 9,90 | | 5% |
| H02AB04 161 | | metilprednizolon-acetat | 7,5 mg | 0,0850 | O | Pfizer Croatia d.o.o. | Pfizer | Medrol | tbl. 50x16 mg | 0,1814 | 9,07 | R | 5% |
| H02AB07 172 | | prednizon | 10 mg | 0,0823 | O | MERCK d.o.o. | Merck | Decortin | tbl. 10x20 mg | 0,1646 | 1,65 | R | 5% |
| H02AB07 174 | | prednizon | 10 mg | 0,0770 | O | MERCK d.o.o. | Merck | Decortin | tbl. 50x20 mg | 0,1540 | 7,70 | R | 5% |
| H02AB07 551 | DS | prednizon | | | R | | | | | | | | 5% |
| H02AB09 083 | PR | hidrokortizon | 30 mg | 0,4951 | P | Pfizer Croatia d.o.o. | Pfizer | Solu Cortef | amp. 1x100 mg /2 ml | 1,4852 | 1,49 | | 5% |
| H02AB09 161 | | hidrokortizon | 30 mg | 46,3487 | O | Diurnal Europe B.V. | Delpharm Lille SAS | Alkindi | gran. u caps. za otvaranje 50x0,5 mg | 0,7725 | 38,62 | RSRH92 | 5% |
| H02AB09 162 | | hidrokortizon | 30 mg | 46,3459 | O | Diurnal Europe B.V. | Delpharm Lille SAS | Alkindi | gran. u caps. za otvaranje 50x1 mg | 1,5449 | 77,24 | RSRH92 | 5% |
| H02AB09 163 | | hidrokortizon | 30 mg | 35,1188 | O | Diurnal Europe B.V. | Delpharm Lille SAS | Alkindi | gran. u caps. za otvaranje 50x2 mg | 2,3412 | 117,06 | RSRH92 | 5% |
| H02AB09 182 | | hidrokortizon | 30 mg | 0,2230 | O | Pfizer Croatia d.o.o. | Pharmacia & Upjohn | Cortef | tbl. 100x10 mg | 0,0743 | 7,43 | R | 5% |
| H03AA01 051 | DS | levotiroksin | 0,15 mg | | P | | | | | | | | 5% |
| H03AA01 171 | | levotiroksin | 0,15 mg | 0,0547 | O | Berlin Chemie AG | Berlin-Chemie AG | Letrox 50 | tbl. 100x50 mcg | 0,0182 | 1,82 | R | 5% |
| H03AA01 172 | | levotiroksin | 0,15 mg | 0,0370 | O | Berlin Chemie AG | Berlin-Chemie AG | Letrox 100 | tbl. 100x100 mcg | 0,0247 | 2,46 | R | 5% |
| H03AA01 173 | | levotiroksin | 0,15 mg | 0,0310 | O | Berlin Chemie AG | Berlin-Chemie AG | Letrox 150 | tbl. 100x150 mcg | 0,0310 | 3,10 | R | 5% |
| H03AA02 051 | DS | liotironin | 60 mcg | | P | | | | | | | | 5% |
| H03BA02 142 | | propiltiouracil | 0,1 g | 0,3716 | O | Alkaloid d.o.o. | Alkaloid | Propiltiouracil Alkaloid | tbl. 60x50 mg | 0,1858 | 11,15 | R | 5% |
| H03BB02 051 | DS | tiamazol | | | P | | | | | | | | 5% |
| H03BB02 111 | | tiamazol | 10 mg | 0,1858 | O | Jadran – Galenski Laboratorij d.d. | JGL d.d. | Athyrazol | tbl. 30x10 mg | 0,1858 | 5,57 | R | 5% |
| H04AA01 061 | PR | glukagon | 1 mg | 14,3341 | P | Novo Nordisk A/S | Novo Nordisk | GlucaGen Hypokit | lio boč. 1x1 mg+štrcaljka | 14,3341 | 14,33 | R | 5% |
| H04AA01 761 | | glukagon | 3 mg | 57,7742 | N | Eli Lilly Nederland B.V. | Lilly France S.A.S. | Baqsimi | praš. za nos, 3 mg (1 monodoza) | 57,7742 | 57,77 | RRH08 | 5% |
| H05AA02 001 | RL | teriparatid | 20 mcg | 6,6059 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o., Teva Pharma B.V. | Teriparatid Pliva | otop. za inj., brizg. napunj. 1x600 mcg/2,4 ml (250 mcg/ml) | 198,1777 | 198,18 | RSRH07 | 5% |
| H05AA02 071 | RL | teriparatid | 20 mcg | 6,6059 | P | Eli Lilly Nederland B.V. | Lilly France | Forsteo | otop. za inj., brizg. napunj. 1x600 mcg/2,4 ml (250 mcg/ml) | 198,1777 | 198,18 | RSRH07 | 5% |
| H05AA02 072 | RL | teriparatid | 20 mcg | 5,9598 | P | STADA Arzneimittel AG | Gedeon Richter Plc. | Movymia | otop. za inj., uložak 1x600 mcg/2,4 ml (250 mcg/ml) | 178,7949 | 178,79 | RSRH07 | 5% |
| H05AA02 073 | RL | teriparatid | 20 mcg | 6,6059 | P | STADA Arzneimittel AG | Gedeon Richter Plc | Movymia starter kit | otop. za inj., brizgalica i uložak 1x600 mcg/2,4 ml (250 mcg/ml) | 198,1777 | 198,18 | RSRH07 | 5% |
| H05AA02 074 | RL | teriparatid | 20 mcg | 5,5955 | P | STADA Arzneimittel AG | Gedeon Richter Plc. | Movymia | otop. za inj., uložak 3x600 mcg/2,4 ml (250 mcg/ml) | 167,8638 | 503,59 | RSRH07 | 5% |
| H05AA02 081 | RL | teriparatid | 20 mcg | 6,6059 | P | Gedeon Richter Plc. | Richter-Helm BioLogics GmbH & Co. KG | Terrosa | otop. za inj., brizgalica Terrosa Pen i uložak 1x600 mcg/2,4 ml (250 mcg/ml) | 198,1777 | 198,18 | RSRH07 | 5% |
| H05AA02 082 | RL | teriparatid | 20 mcg | 5,9598 | P | Gedeon Richter Plc. | Richter-Helm BioLogics GmbH & Co. KG | Terrosa | otop. za inj., uložak 1x600 mcg/2,4 ml (250 mcg/ml) | 178,7949 | 178,79 | RSRH07 | 5% |
| H05AA02 083 | RL | teriparatid | 20 mcg | 6,6059 | P | Zentiva k.s. | GP Pharm S.A. | Teriparatid Zentiva | otop. za inj., brizg. napunj. 1x600 mcg/2,4 ml (250 mcg/ml) | 198,1777 | 198,18 | RSRH07 | 5% |
| H05AA02 084 | RL | teriparatid | 20 mcg | 6,6059 | P | Accord Healthcare S.L.U. | Accord Healthcare BV, Accord Healthcare Polska Sp. z o.o. | Sondelbay | otop. za inj., brizg. napunj. 1x600 mcg/2,4 ml (250 mcg/ml) | 198,1777 | 198,18 | RSRH07 | 5% |
| H05BX01 141 | DS | sinakalcetNH502 | 60 mg | 6,3574 | O | Accord Healthcare S.L.U. | Accord Healthcare Limited, Laboratori Fundacio Dau | Cinakalcet Accordpharma | tbl. film obl. 28x30 mg | 3,1787 | 89,00 | | 5% |
| H05BX01 142 | DS | sinakalcetNH502 | 60 mg | 6,3574 | O | Accord Healthcare S.L.U. | Accord Healthcare Limited, Laboratori Fundacio Dau | Cinakalcet Accordpharma | tbl. film obl. 28x60 mg | 6,3574 | 178,01 | | 5% |
| H05BX01 161 | DS | sinakalcetNH502 | 60 mg | 7,4437 | O | Amgen Europe B.V. | Amgen Europe B.V. | Mimpara | tbl. film obl. 28x30 mg | 3,7218 | 104,21 | | 5% |
| H05BX01 162 | DS | sinakalcetNH502 | 60 mg | 6,9538 | O | Amgen Europe B.V. | Amgen Europe B.V. | Mimpara | tbl. film obl. 28x60 mg | 6,9538 | 194,71 | | 5% |
| H05BX01 181 | DS | sinakalcetNH502 | 60 mg | 6,6993 | O | ALPHA-MEDICAL d.o.o. | Remedica Ltd. | Cinet | tbl. film obl. 28x30 mg | 3,3496 | 93,79 | | 5% |
| H05BX01 182 | DS | sinakalcetNH502 | 60 mg | 6,6993 | O | ALPHA-MEDICAL d.o.o. | Remedica Ltd. | Cinet | tbl. film obl. 28x60 mg | 6,6993 | 187,58 | | 5% |
| H05BX02 061 | DS | parikalcitolNH503 | 2 mcg | 5,4775 | P | AbbVie d.o.o. | AbbVie S.r.l. | Zemplar | boč. 5x5 mcg/ml | 13,6938 | 68,47 | | 5% |
| H05BX02 161 | | parikalcitol | 2 mcg | 5,1922 | O | AbbVie d.o.o. | Aesica Queenborough Limited, AbbVie Deutschland GmbH & Co.KG | Zemplar | caps. meke 28x1 mcg | 2,5961 | 72,69 | RSRH05 | 5% |
| H05BX02 162 | | parikalcitol | 2 mcg | 5,4268 | O | AbbVie d.o.o. | Aesica Queenborough Limited, AbbVie Deutschland GmbH & Co.KG | Zemplar | caps. meke 28x2 mcg | 5,4268 | 151,95 | RSRH05 | 5% |
| H05BX02 171 | | parikalcitol | 2 mcg | 3,6345 | O | ALPHA-MEDICAL d.o.o. | Yasenka d.o.o. | Parkol | caps. meke 28x1 mcg | 1,8173 | 50,88 | RSRH05 | 5% |
| H05BX02 172 | | parikalcitol | 2 mcg | 3,7987 | O | ALPHA-MEDICAL d.o.o. | Yasenka d.o.o. | Parkol | caps. meke 28x2 mcg | 3,7987 | 106,36 | RSRH05 | 5% |
| H05BX04 061 | DS | etelkalcetidNH504 | | | P | Amgen Europe B.V. | Amgen Europe B.V. | Parsabiv | otop. za inj., boč. stakl. 6x2,5 mg/0,5 ml (5 mg/ml) | 16,2990 | 97,79 | | 5% |
| H05BX04 062 | DS | etelkalcetidNH504 | | | P | Amgen Europe B.V. | Amgen Europe B.V. | Parsabiv | otop. za inj., boč. stakl. 6x5 mg/1 ml (5 mg/ml) | 32,5324 | 195,19 | | 5% |
| J01AA02 112 | | doksiciklin | 0,1 g | 0,1327 | O | Belupo d.d. | Belupo | Doksiciklin Belupo | caps. 25x100 mg | 0,1327 | 3,32 | R | 5% |
| J01AA12 061 | DS | tigeciklinNJ101 | 0,1 g | 77,6800 | P | Pfizer Europe MA EEIG | Wyeth | Tygacil | praš. za otop. za inf., boč. stakl. 10x50 mg (10 mg/ml) | 38,8400 | 388,40 | | 5% |
| J01AA12 071 | DS | tigeciklinNJ101 | 0,1 g | 54,3739 | P | Accord Healthcare S.L.U. | Accord Healthcare Limited, Accord Healthcare Polska Sp.z.o.o. | Tigeciklin Accord | praš. za otop. za inf., boč. stakl. 10x50 mg (10 mg/ml) | 27,1869 | 271,87 | | 5% |
| J01BA01 052 | DS | kloramfenikolNJ101 | 3 g | | P | | | | | | | | 5% |
| J01CA01 051 | PR | ampicilin | 6 g | | P | | | | 500 mg | | | | 5% |
| J01CA01 052 | DS | ampicilin | 6 g | | P | | | | 1 g | | | | 5% |
| J01CA04 118 | | amoksicilin | 1.5 g | 0,2270 | O | Belupo d.d. | Belupo | Amoksicilin Belupo | tbl. za oral. susp. 16x500 mg | 0,0757 | 1,21 | RRJ01 | 5% |
| J01CA04 119 | | amoksicilin | 1.5 g | 0,2302 | O | Belupo d.d. | Belupo | Amoksicilin Belupo | tbl. za oral. susp. 16x1000 mg | 0,1535 | 2,46 | RRJ01 | 5% |
| J01CA04 121 | | amoksicilin | 1.5 g | 0,2302 | O | Sandoz d.o.o. | Sandoz GmbH | Ospamox | tbl. za oral. susp. 16x1 g | 0,1535 | 2,46 | RRJ01 | 5% |
| J01CA04 141 | | amoksicilin | 1.5 g | 0,2270 | O | Alkaloid d.o.o. | Alkaloid | Almacin | caps. 16x500 mg | 0,0757 | 1,21 | RRJ01 | 5% |
| J01CA04 311 | | amoksicilin | 1.5 g | 0,4778 | O | Belupo d.d. | Belupo | Amoksicilin Belupo | sirup 1x100 ml (250 mg/5 ml) | 1,5927 | 1,59 | RRJ01 | 5% |
| J01CA04 342 | | amoksicilin | 1.5 g | 0,4778 | O | Alkaloid d.o.o. | Alkaloid | Almacin | praš. za oral susp. 100 ml (250 mg/5 ml) | 1,5927 | 1,59 | RRJ01 | 5% |
| J01CE01 051 | PO | benzilpenicilin | 3,6 g | | P | | | | | | | | 5% |
| J01CE02 116 | | fenoksimetilpenicilin | 2 g | 0,5795 | O | Belupo d.d. | Belupo d.d. | Silapen K | tbl. film obl. 30x1.500.000 i.j. | 0,2608 | 7,82 | RRJ02 | 5% |
| J01CE02 117 | | fenoksimetilpenicilin | 2 g | 0,6045 | O | Sandoz d.o.o. | Sandoz | Ospen K | tbl. film obl. 30x1.000.000 i.j. | 0,1813 | 5,44 | RRJ02 | 5% |
| J01CE02 118 | | fenoksimetilpenicilin | 2 g | 0,5795 | O | Sandoz d.o.o. | Sandoz | Ospen K | tbl. film obl. 30x1.500.000 i.j. | 0,2608 | 7,82 | RRJ02 | 5% |
| J01CE02 171 | | fenoksimetilpenicilin | 2 g | 0,6147 | O | ALPHA-MEDICAL d.o.o. | Remedica Ltd. | Penon | tbl. film obl. 30x800 mg | 0,2459 | 7,38 | RRJ02 | 5% |
| J01CE02 172 | | fenoksimetilpenicilin | 2 g | 0,5893 | O | ALPHA-MEDICAL d.o.o. | Remedica Ltd. | Penon | tbl. film obl. 30x1000 mg | 0,2946 | 8,84 | RRJ02 | 5% |
| J01CE02 313 | | fenoksimetilpenicilin | 2 g | 5,4268 | O | Belupo d.d. | Belupo | Silapen K | praš. za oral. otop. 1x100 ml (250 mg/5 ml) | 13,5669 | 13,57 | RRJ02 | 5% |
| J01CE02 363 | | fenoksimetilpenicilin | 2 g | 5,1555 | O | ALPHA-MEDICAL d.o.o. | Laboratorios Atral S.A. | Penon | praš. za oral. otop. 1x100 ml (250 mg/5 ml) | 12,8887 | 12,89 | RRJ02 | 5% |
| J01CE08 051 | PO | benzatin benzilpenicilin | 3,6 g | | P | | | | | | | | 5% |
| J01CE09 051 | PO | prokain benzilpenicilin | | | P | | | | | | | | 5% |
| J01CE30 051 | PO | benzilpenicilin prokainpenicilin (depo-bipenicilin) | | | P | | | | | | | | 5% |
| J01CF05 061 | DS | flukloksacilinnatrij | 2 g | 4,7409 | P | Altamedics d.o.o. | MITIM S.r.l. | Flukloksacilin Altamedics | praš. za otop. za inj./inf., boč. stakl. 10x1 g | 2,3704 | 23,70 | | 5% |
| J01CF05 063 | DS | flukloksacilin | 2 g | 4,9612 | P | Altamedics d.o.o. | MITIM S.r.l. | Flukloksacilin Altamedics | praš. za otop. za inj. ili inf., boč. stakl. 10x2 g | 4,9612 | 49,61 | | 5% |
| J01CF05 171 | | flukloksacilin | 2 g | 2,0413 | O | Altamedics d.o.o. | Athlone Laboratories Limited, Co. Roscommon | Flukloksacilin Altamedics | caps. tvrda 20x500 mg | 0,5103 | 10,21 | R | 5% |
| J01CR01 051 | DS | ampicilin + sulbaktamNJ101 | 6 g | | P | | | | | | | | 5% |
| J01CR01 071 | DS | ampicilin + sulbaktamNJ101 | 6 g | 11,5068 | P | Apta Medica International d.o.o. | MITIM S.r.l. | Ampicilin/sulbaktam AptaPharma | praš. za otop. za inj./inf., boč. 10x(1 g + 0,5 g) | 1,9179 | 19,18 | | 5% |
| J01CR01 072 | DS | ampicilin + sulbaktamNJ101 | 6 g | 11,5072 | P | Apta Medica International d.o.o. | MITIM S.r.l. | Ampicilin/sulbaktam AptaPharma | praš. za otop. za inj./inf., boč. 10x(2 g + 1 g) | 3,8357 | 38,36 | | 5% |
| J01CR02 005 | PO | amoksicilin + klavulanska kiselina | 3 g | 19,9220 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Klavocin | boč. 5x(500 +100 mg) | 3,3202 | 16,60 | | 5% |
| J01CR02 006 | PR | amoksicilin + klavulanska kiselina | 3 g | 9,8123 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Klavocin | boč. 5x(1.000 + 200 mg) | 3,2708 | 16,35 | | 5% |
| J01CR02 061 | PR | amoksicilin + klavulanska kiselina | 3 g | 6,8685 | P | Medochemie Ltd. | Medochemie Ltd. | Medoclav | boč. 10x(1.000 mg+200 mg) | 2,2895 | 22,89 | | 5% |
| J01CR02 071 | PR | amoksicilin + klavulanska kiselina | 3 g | 6,5061 | P | Apta Medica International d.o.o. | Laboratorio Reig Jofre S.A. | Amoksicilin/klavulanska kiselina AptaPharma | boč. 10x(1.000 mg+200 mg) | 2,1687 | 21,69 | | 5% |
| J01CR02 108 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,5363 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Klavocin bid | tbl. film obl. 14x1 g (875 mg +125 mg) | 0,3129 | 4,38 | RRJ04 | 5% |
| J01CR02 111 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,4095 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Klavax bid | tbl. film obl. 14x1 g (875 mg +125 mg) | 0,2389 | 3,34 | RRJ04 | 5% |
| J01CR02 115 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,5363 | O | Belupo d.d. | Belupo | Klavobel BID | tbl. film obl. 14x1 g (875 mg +125 mg) | 0,3129 | 4,38 | RRJ04 | 5% |
| J01CR02 131 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,3686 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Betaklav | tbl. film obl. 14x1 g (875 mg +125 mg) | 0,2150 | 3,01 | RRJ04 | 5% |
| J01CR02 141 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,3605 | O | PharmaS d.o.o. | PharmaS d.o.o. | KlavoPhar | tbl. film obl. 14x1 g (875 mg +125 mg) | 0,2103 | 2,94 | RRJ04 | 5% |
| J01CR02 161 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,3603 | O | Medochemie Ltd. | Medochemie Ltd. | Medoclav | tbl. film obl. 14x1 g (875 mg +125 mg) | 0,2102 | 2,94 | RRJ04 | 5% |
| J01CR02 171 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,5363 | O | GlaxoSmithKline Trading Services Limited | SmithKline Beecham Pharmaceuticals, Glaxo Wellcome Production | Augmentin | tbl. film obl. 14x1 g (875 mg +125 mg) | 0,3129 | 4,38 | RRJ04 | 5% |
| J01CR02 209 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,7981 | O | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Klavocin bid sirup | susp. 70 ml (400 mg +57 mg)/5 ml | 2,9796 | 2,98 | RRJ04 | 5% |
| J01CR02 212 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,7981 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Klavax bid sirup | susp. 70 ml (400 mg +57 mg)/5 ml | 2,9796 | 2,98 | RRJ04 | 5% |
| J01CR02 231 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,7185 | O | KRKA-FARMA d.o.o. | Krka d.d., TAD Pharma GmbH | Betaklav | praš. za oral. susp. 1x70 ml (400 mg +57 mg/5 ml) | 2,6823 | 2,68 | RRJ04 | 5% |
| J01CR02 273 | | amoksicilin + klavulanska kiselina | 1.5 g | 0,7981 | O | GlaxoSmithKline Trading Services Limited | SmithKline Beecham Pharmaceuticals, Glaxo Wellcome Production | Augmentin | susp. 70 ml(400 mg +57 mg)/5 ml | 2,9796 | 2,98 | RRJ04 | 5% |
| J01CR05 001 | DS | piperacilin + tazobaktamNJ101 | 14 g | 28,2485 | P | PLIVA HRVATSKA d.o.o. | Pliva Hrvatska d.o.o. | Acipirin | praš. za inj. ili inf. 10x4,5 g | 8,0709 | 80,71 | | 5% |
| J01CR05 041 | DS | piperacilin + tazobaktamNJ101 | 14 g | 28,7191 | P | Sandoz d.o.o. | Sandoz | Piperacilin/tazobaktam Sandoz | praš. za otop. za inf., boč. 10x(4,0 g+0,5 g)/100ml | 8,2053 | 82,05 | | 5% |
| J01CR05 074 | DS | piperacilin + tazobaktamNJ101 | 14 g | 57,5553 | P | Fresenius Kabi d.o.o. | Laboratorio Farmaceutico, Labesfal-Laboratorios Almiro | Piperacilin/Tazobactam Fresenius Kabi | praš. za otop. za inf., boč. 10x(2,0 g+0,25 g)/50 ml | 5,7555 | 57,56 | | 5% |
| J01CR05 075 | DS | piperacilin + tazobaktamNJ101 | 14 g | 28,2485 | P | Fresenius Kabi d.o.o. | Laboratorio Farmaceutico, Labesfal-Laboratorios Almiro | Piperacilin/Tazobactam Fresenius Kabi | praš. za otop. za inf., boč. 10x(4,0 g+0,5 g)/50 ml | 8,0709 | 80,71 | | 5% |
| J01DB01 111 | | cefaleksin | 2 g | 0,6955 | O | Belupo d.d. | Belupo | Cefaleksin Belupo | caps. 16x500 mg | 0,1739 | 2,78 | RRJ05 | 5% |
| J01DB01 142 | | cefaleksin | 2 g | 0,6955 | O | Alkaloid d.o.o. | Alkaloid | Cefalexin Alkaloid | caps. 16x500 mg | 0,1739 | 2,78 | RRJ05 | 5% |
| J01DB01 313 | | cefaleksin | 2 g | 1,0639 | O | Belupo d.d. | Belupo | Cefaleksin Belupo | praš. za oral. susp. 1x100 ml (250 mg/5 ml) | 2,6598 | 2,66 | RRJ05 | 5% |
| J01DB01 343 | | cefaleksin | 2 g | 1,0639 | O | Alkaloid d.o.o. | Alkaloid | Cefalexin Alkaloid | praš. za oral. susp. 1x100 ml (250 mg/5 ml) | 2,6598 | 2,66 | RRJ05 | 5% |
| J01DB04 061 | PR | cefazolin | 3 g | 3,3800 | P | Medochemie Ltd. | Medochemie Ltd | Zepilen | praš. za otop. za inj. ili inf. boč. stakl. 10x1 g/10 ml | 1,0140 | 10,14 | | 5% |
| J01DB04 082 | PR | cefazolin | 3 g | 2,8910 | P | ALPHA-MEDICAL d.o.o. | PJSC SIC Borshchahivskiy CPP | Cefazolin Alpha-Medical | praš. za otop. za inj. ili inf., boč. stakl. 1x1 g/10 ml | 0,9636 | 0,96 | | 5% |
| J01DB04 083 | PR | cefazolin | 3 g | 2,7462 | P | Apta Medica International d.o.o. | ACS Dobfar S.p.A. | Cefazolin AptaPharma | praš. za otop. za inj. ili inf. boč. 10x1 g/10 ml | 0,9154 | 9,15 | | 5% |
| J01DC02 061 | DS | cefuroksim NJ102 | 3 g | 3,4508 | P | Medochemie Ltd. | Medochemie Ltd. | Axetine | praš. za otop. za inj. ili inf. boč. 10x750 mg | 0,8627 | 8,63 | | 5% |
| J01DC02 062 | DS | cefuroksim NJ102 | 3 g | 2,6545 | P | Medochemie Ltd. | Medochemie Ltd. | Axetine | praš. za otop. za inj. ili inf. boč. 10x1,5 g | 1,3272 | 13,27 | | 5% |
| J01DC02 076 | DS | cefuroksim NJ102 | 3 g | 3,4508 | P | Apta Medica International d.o.o. | ACS Dobfar S.p.A. | Cefuroksim AptaPharma | praš. za otop. za inj. ili inf., boč. stakl. 10x750 mg | 0,8627 | 8,63 | | 5% |
| J01DC02 077 | DS | cefuroksim NJ102 | 3 g | 2,5217 | P | Apta Medica International d.o.o. | ACS Dobfar S.p.A. | Cefuroksim AptaPharma | praš. za otop. za inj. ili inf., boč. stakl. 10x1500 mg | 1,2609 | 12,61 | | 5% |
| J01DC02 081 | DS | cefuroksim NJ102 | 3 g | 5,7926 | P | MIP Pharma Croatia d.o.o. | Chephasaar Chemisch-pharmazeutische Fabrik GmbH | Cefuroxim-MIP | praš. za otop. za inj., boč. stakl. 10x750 mg | 1,4481 | 14,48 | | 5% |
| J01DC02 082 | DS | cefuroksimNJ102 | 3 g | 3,4574 | P | MIP Pharma Croatia d.o.o. | Chephasaar Chemisch-pharmazeutische Fabrik GmbH | Cefuroxim-MIP | praš. za otop. za inj. ili inf., boč. stakl. 10x1500 mg | 1,7287 | 17,29 | | 5% |
| J01DC02 111 | | cefuroksimNJ102 | 0,5 g | 0,3544 | O | Mibe Pharmaceuticals d.o.o. | mibe GmbH Arzneimittel | Efox | tbl. film obl. 10x500 mg | 0,3544 | 3,54 | RRJ06 | 5% |
| J01DC02 113 | | cefuroksimNJ102 | 0,5 g | 0,5543 | O | Belupo d.d. | Belupo d.d. | Beloxim | tbl. film obl. 10x250 mg | 0,2771 | 2,77 | RRJ06 | 5% |
| J01DC02 114 | | cefuroksimNJ102 | 0,5 g | 0,3544 | O | Belupo d.d. | Belupo d.d. | Beloxim | tbl. film obl. 10x500 mg | 0,3544 | 3,54 | RRJ06 | 5% |
| J01DC02 123 | | cefuroksimNJ102 | 0,5 g | 0,3544 | O | Sandoz d.o.o. | Sandoz | Xorimax | tbl. film obl. 10x500 mg | 0,3544 | 3,54 | RRJ06 | 5% |
| J01DC02 124 | | cefuroksimNJ102 | 0,5 g | 0,3544 | O | Sandoz d.o.o. | Sandoz | Xorimax | tbl. film obl. 16x500 mg | 0,3544 | 5,67 | RRJ06 | 5% |
| J01DC02 144 | | cefuroksimNJ102 | 0,5 g | 0,3544 | O | KRKA-FARMA d.o.o. | Krka d.d. | Furocef | tbl. film obl. 14x500 mg | 0,3544 | 4,96 | RRJ06 | 5% |
| J01DC02 162 | | cefuroksimNJ102 | 0,5 g | 0,5543 | O | GlaxoSmithKline d.o.o. | Glaxo Operations UK Ltd., GlaxoSmithKline Trading Services Limited | Zinnat | tbl. film obl. 10x250 mg | 0,2771 | 2,77 | RRJ06 | 5% |
| J01DC02 163 | | cefuroksimNJ102 | 0,5 g | 0,3544 | O | GlaxoSmithKline d.o.o. | Glaxo Operations UK Ltd., GlaxoSmithKline Trading Services Limited | Zinnat | tbl. film obl. 10x500 mg | 0,3544 | 3,54 | RRJ06 | 5% |
| J01DC02 262 | | cefuroksimNJ102 | 0,5 g | 1,6458 | O | GlaxoSmithKline d.o.o. | Glaxo Operations UK Ltd., GlaxoSmithKline Trading Services Limited | Zinnat | suspenzija 1x100 ml (125 mg/5 ml) | 8,2288 | 8,23 | RRJ06 | 5% |
| J01DD01 051 | DS | cefotaksimNJ101 | 4 g | | P | | | | | | | | 5% |
| J01DD01 061 | DS | cefotaksimNJ101 | 4 g | 11,6053 | P | Apta Medica International d.o.o. | ACS Dobfar S.p.A. | Cefotaksim AptaPharma | praš. za otop. za inj/inf., boč. 10x1 g | 2,9013 | 29,01 | | 5% |
| J01DD01 062 | DS | cefotaksimNJ101 | 4 g | 11,5843 | P | Apta Medica International d.o.o. | ACS Dobfar S.p.A. | Cefotaksim AptaPharma | praš. za otop. za inj/inf., boč. 10x2 g | 5,7922 | 57,92 | | 5% |
| J01DD02 042 | DS | ceftazidimNJ101 | 4 g | 18,3189 | P | Alkaloid d.o.o. | Alkaloid | Cefaz | praš. za otop. za inj., boč. 5x1000 mg/10 ml | 4,5797 | 22,90 | | 5% |
| J01DD02 043 | DS | ceftazidimNJ101 | 4 g | 15,5896 | P | Alkaloid d.o.o. | Alkaloid – INT d.o.o. | Cefaz | praš. za otop. za inj./inf., boč. 10x1000 mg/10 ml | 3,8974 | 38,97 | | 5% |
| J01DD02 071 | DS | ceftazidimNJ101 | 4 g | 20,0358 | P | Fresenius Kabi d.o.o. | Labesfal-Laboratorios Almiro S.A | Ceftazidim Kabi | praš. za otop. za inj., boč. 1x500 mg/10 ml | 2,5045 | 2,50 | | 5% |
| J01DD02 072 | DS | ceftazidimNJ101 | 4 g | 20,0358 | P | Fresenius Kabi d.o.o. | Labesfal-Laboratorios Almiro S.A | Ceftazidim Kabi | praš. za otop. za inj., boč. 10x500 mg/10 ml | 2,5045 | 25,04 | | 5% |
| J01DD02 073 | DS | ceftazidimNJ101 | 4 g | 22,9451 | P | Fresenius Kabi d.o.o. | Labesfal-Laboratorios Almiro S.A | Ceftazidim Kabi | praš. za otop. za inj., boč. 1x1000 mg/10 ml | 5,7363 | 5,74 | | 5% |
| J01DD02 074 | DS | ceftazidimNJ101 | 4 g | 16,4099 | P | Fresenius Kabi d.o.o. | Labesfal-Laboratorios Almiro S.A | Ceftazidim Kabi | praš. za otop. za inj., boč. 10x1000 mg/10 ml | 4,1025 | 41,02 | | 5% |
| J01DD02 077 | DS | ceftazidimNJ101 | 4 g | 16,4099 | P | Apta Medica International d.o.o. | ACS Dobfar S.p.A. | Ceftazidim AptaPharma | praš. za otop. za inj./inf., boč. 10x1000 mg/10 ml | 4,1025 | 41,02 | | 5% |
| J01DD02 078 | DS | ceftazidimNJ101 | 4 g | 15,5894 | P | Apta Medica International d.o.o. | ACS Dobfar S.p.A. | Ceftazidim AptaPharma | praš. za otop. za inj./inf., b |